{
"graphs":  [
{
    "graph": {
        "nodes": [
            {
                "metadata": {
                    "yloc": 640.2628784179688, 
                    "viewx": 0.2835222143002701, 
                    "viewy": 0.3753817813896057, 
                    "xloc": 1610.3079833984375, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(SCHEM:\"Benzo(a)pyrene\")", 
                "label": "a(SCHEM:\"Benzo(a)pyrene\")"
            }, 
            {
                "metadata": {
                    "yloc": 456.3613586425781, 
                    "viewx": 0.647944191980178, 
                    "viewy": 0.2495700362326258, 
                    "xloc": 3019.72900390625, 
                    "synonyms": [
                        "CP12", 
                        "P3-450", 
                        "P450(PA)", 
                        "CYPIA2", 
                        "P450 form 4", 
                        "aryl hydrocarbon hydroxylase", 
                        "cytochrome P(3)450", 
                        "cytochrome P450 1A2", 
                        "cytochrome P450 4", 
                        "cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 2", 
                        "cytochrome P450-P3", 
                        "dioxin-inducible P3-450", 
                        "flavoprotein-linked monooxygenase", 
                        "microsomal monooxygenase", 
                        "xenobiotic monooxygenase", 
                        "CP1A2_HUMAN", 
                        "cytochrome P450, family 1, subfamily A, polypeptide 2"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:CYP1A2)", 
                "label": "p(HGNC:CYP1A2)"
            }, 
            {
                "metadata": {
                    "yloc": 1443.169677734375, 
                    "viewx": 0.48928150323803427, 
                    "viewy": 0.9246709103961394, 
                    "xloc": 2406.0927734375, 
                    "synonyms": [
                        "CAR", 
                        "CAR1", 
                        "MB67", 
                        "constitutive activator of retinoid response", 
                        "constitutive active receptor", 
                        "constitutive active response", 
                        "constitutive androstane nuclear receptor variant 2", 
                        "constitutive androstane nuclear receptor variant 3", 
                        "constitutive androstane nuclear receptor variant 4", 
                        "constitutive androstane nuclear receptor variant 5", 
                        "constitutive androstane receptor", 
                        "nuclear receptor subfamily 1 group I member 3", 
                        "orphan nuclear hormone receptor", 
                        "orphan nuclear receptor MB67", 
                        "NR1I3_HUMAN", 
                        "nuclear receptor subfamily 1, group I, member 3"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:NR1I3)", 
                "label": "p(HGNC:NR1I3)"
            }, 
            {
                "metadata": {
                    "yloc": 581.9708251953125, 
                    "viewx": 0.8145184720027323, 
                    "viewy": 0.3355026930945054, 
                    "xloc": 3663.9637266154195, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(SCHEM:\"Smoke condensate, cigarette\")", 
                "label": "a(SCHEM:\"Smoke condensate, cigarette\")"
            }, 
            {
                "metadata": {
                    "yloc": 290.8567810058594, 
                    "viewx": 0.3167325609154359, 
                    "viewy": 0.13634411091468351, 
                    "xloc": 1738.750732421875, 
                    "synonyms": [
                        "HIF-1-beta", 
                        "HIF-1beta", 
                        "HIF1-beta", 
                        "HIF1B", 
                        "HIF1BETA", 
                        "TANGO", 
                        "bHLHe2", 
                        "class E basic helix-loop-helix protein 2", 
                        "dioxin receptor, nuclear translocator", 
                        "hypoxia-inducible factor 1, beta subunit", 
                        "ARNT_HUMAN", 
                        "aryl hydrocarbon receptor nuclear translocator", 
                        "bHLHe76", 
                        "AH-receptor", 
                        "ah receptor", 
                        "aromatic hydrocarbon receptor", 
                        "class E basic helix-loop-helix protein 76", 
                        "AHR_HUMAN", 
                        "aryl hydrocarbon receptor"
                    ], 
                    "belnodetype": "complexAbundance"
                }, 
                "id": "complex(p(HGNC:ARNT),p(HGNC:AHR))", 
                "label": "complex(p(HGNC:ARNT),p(HGNC:AHR))"
            }, 
            {
                "metadata": {
                    "yloc": 250.64505004882812, 
                    "viewx": 0.09021015107843683, 
                    "viewy": 0.10883423468491646, 
                    "xloc": 862.6634885268849, 
                    "synonyms": [
                        "EL52", 
                        "HSP86", 
                        "HSP89A", 
                        "HSP90A", 
                        "HSP90N", 
                        "HSPC1", 
                        "HSPCA", 
                        "HSPCAL1", 
                        "HSPCAL4", 
                        "HSPN", 
                        "Hsp89", 
                        "Hsp90", 
                        "LAP2", 
                        "HSP 86", 
                        "epididymis luminal secretory protein 52", 
                        "heat shock 86 kDa", 
                        "heat shock 90kD protein 1, alpha", 
                        "heat shock 90kD protein 1, alpha-like 4", 
                        "heat shock 90kD protein, alpha-like 4", 
                        "heat shock 90kDa protein 1, alpha", 
                        "heat shock protein HSP 90-alpha", 
                        "renal carcinoma antigen NY-REN-38", 
                        "HS90A_HUMAN", 
                        "heat shock protein 90kDa alpha (cytosolic), class A member 1"
                    ], 
                    "belnodetype": "catalyticActivity"
                }, 
                "id": "cat(p(HGNC:HSP90AA1))", 
                "label": "cat(p(HGNC:HSP90AA1))"
            }, 
            {
                "metadata": {
                    "yloc": 1053.2742919921875, 
                    "viewx": 0.24673010319266733, 
                    "viewy": 0.6579334795756099, 
                    "xloc": 1468.0125732421875, 
                    "synonyms": [
                        "HAST1/HAST2", 
                        "P-PST", 
                        "PST", 
                        "ST1A1", 
                        "ST1A3", 
                        "STP", 
                        "STP1", 
                        "TSPST1", 
                        "P-PST 1", 
                        "aryl sulfotransferase 1", 
                        "phenol-sulfating phenol sulfotransferase 1", 
                        "sulfotransferase 1A1", 
                        "thermostable phenol sulfotransferase1", 
                        "ts-PST", 
                        "ST1A1_HUMAN", 
                        "sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:SULT1A1)", 
                "label": "p(HGNC:SULT1A1)"
            }, 
            {
                "metadata": {
                    "yloc": 282.08042306924335, 
                    "viewx": 0.7946405036694444, 
                    "viewy": 0.1303399794127984, 
                    "xloc": 3587.0846465108352, 
                    "synonyms": [
                        "CP35", 
                        "CYPIIIA5", 
                        "P450PCN3", 
                        "PCN3", 
                        "aryl hydrocarbon hydroxylase", 
                        "cytochrome P450 3A5", 
                        "cytochrome P450 HLp2", 
                        "cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 5", 
                        "cytochrome P450-PCN3", 
                        "flavoprotein-linked monooxygenase", 
                        "microsomal monooxygenase", 
                        "xenobiotic monooxygenase", 
                        "CP3A5_HUMAN", 
                        "cytochrome P450, family 3, subfamily A, polypeptide 5"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:CYP3A5)", 
                "label": "p(HGNC:CYP3A5)"
            }, 
            {
                "metadata": {
                    "yloc": 611.9014892578125, 
                    "viewx": 0.6959607496106207, 
                    "viewy": 0.3559790278415461, 
                    "xloc": 3205.435546875, 
                    "synonyms": [
                        "CP1B", 
                        "CYPIB1", 
                        "GLC3A", 
                        "P4501B1", 
                        "aryl hydrocarbon hydroxylase", 
                        "cytochrome P450 1B1", 
                        "cytochrome P450, subfamily I (dioxin-inducible), polypeptide 1 (glaucoma 3, primary infantile)", 
                        "flavoprotein-linked monooxygenase", 
                        "microsomal monooxygenase", 
                        "xenobiotic monooxygenase", 
                        "CP1B1_HUMAN", 
                        "cytochrome P450, family 1, subfamily B, polypeptide 1"
                    ], 
                    "belnodetype": "catalyticActivity"
                }, 
                "id": "cat(p(HGNC:CYP1B1))", 
                "label": "cat(p(HGNC:CYP1B1))"
            }, 
            {
                "metadata": {
                    "yloc": 158.00170297646986, 
                    "viewx": 0.8270584692024674, 
                    "viewy": 0.045454545454545456, 
                    "xloc": 3712.46282033896, 
                    "synonyms": [
                        "GCCR", 
                        "GCR", 
                        "GR", 
                        "GRL", 
                        "glucocorticoid nuclear receptor variant 1", 
                        "glucocorticoid receptor", 
                        "GCR_HUMAN", 
                        "nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)"
                    ], 
                    "belnodetype": "transcriptionalActivity"
                }, 
                "id": "tscript(p(HGNC:NR3C1))", 
                "label": "tscript(p(HGNC:NR3C1))"
            }, 
            {
                "metadata": {
                    "yloc": 1429.399658203125, 
                    "viewx": 0.3542406714195097, 
                    "viewy": 0.9152504869532653, 
                    "xloc": 1883.8153076171875, 
                    "synonyms": [
                        "EPHX", 
                        "EPOX", 
                        "HYL1", 
                        "MEH", 
                        "epoxide hydratase", 
                        "epoxide hydrolase 1", 
                        "HYEP_HUMAN", 
                        "epoxide hydrolase 1, microsomal (xenobiotic)"
                    ], 
                    "belnodetype": "catalyticActivity"
                }, 
                "id": "cat(p(HGNC:EPHX1))", 
                "label": "cat(p(HGNC:EPHX1))"
            }, 
            {
                "metadata": {
                    "yloc": 1250.7410888671875, 
                    "viewx": 0.34371458075500433, 
                    "viewy": 0.7930255786281114, 
                    "xloc": 1843.1051025390625, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(SCHEM:\"4-Hydroxy-2-nonenal\")", 
                "label": "a(SCHEM:\"4-Hydroxy-2-nonenal\")"
            }, 
            {
                "metadata": {
                    "yloc": 525.77978515625, 
                    "viewx": 0.44272604519152103, 
                    "viewy": 0.29706096179106345, 
                    "xloc": 2226.037109375, 
                    "synonyms": [
                        "CP1B", 
                        "CYPIB1", 
                        "GLC3A", 
                        "P4501B1", 
                        "aryl hydrocarbon hydroxylase", 
                        "cytochrome P450 1B1", 
                        "cytochrome P450, subfamily I (dioxin-inducible), polypeptide 1 (glaucoma 3, primary infantile)", 
                        "flavoprotein-linked monooxygenase", 
                        "microsomal monooxygenase", 
                        "xenobiotic monooxygenase", 
                        "CP1B1_HUMAN", 
                        "cytochrome P450, family 1, subfamily B, polypeptide 1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:CYP1B1)", 
                "label": "p(HGNC:CYP1B1)"
            }, 
            {
                "metadata": {
                    "yloc": 443.4562683105469, 
                    "viewx": 0.174814789246706, 
                    "viewy": 0.24074133303286796, 
                    "xloc": 1189.8763427734375, 
                    "synonyms": [
                        "BRCAI", 
                        "BRCC1", 
                        "BROVCA1", 
                        "IRIS", 
                        "PNCA4", 
                        "PPP1R53", 
                        "PSCP", 
                        "RNF53", 
                        "BRCA1/BRCA2-containing complex, subunit 1", 
                        "RING finger protein 53", 
                        "breast and ovarian cancer susceptibility protein 1", 
                        "breast and ovarian cancer sususceptibility protein 1", 
                        "breast cancer type 1 susceptibility protein", 
                        "protein phosphatase 1, regulatory subunit 53", 
                        "BRCA1_HUMAN", 
                        "breast cancer 1, early onset"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:BRCA1)", 
                "label": "p(HGNC:BRCA1)"
            }, 
            {
                "metadata": {
                    "yloc": 601.7586059570312, 
                    "viewx": 0.045454545454545456, 
                    "viewy": 0.34904002129851464, 
                    "xloc": 689.56884765625, 
                    "synonyms": [
                        "ER", 
                        "ESR", 
                        "ESRA", 
                        "Era", 
                        "NR3A1", 
                        "ER-alpha", 
                        "estradiol receptor", 
                        "estrogen nuclear receptor alpha", 
                        "estrogen receptor", 
                        "estrogen receptor alpha 3*,4,5,6,7*/822 isoform", 
                        "estrogen receptor alpha E1-E2-1-2", 
                        "estrogen receptor alpha E1-N2-E2-1-2", 
                        "estrogen receptor alpha delta 3*,4,5,6,7*,8*/941 isoform", 
                        "estrogen receptor alpha delta 3*,4,5,6,7*/819-2 isoform", 
                        "estrogen receptor alpha delta 4 +49 isoform", 
                        "estrogen receptor alpha delta 4*,5,6,7*/654 isoform", 
                        "estrogen receptor alpha delta 4*,5,6,7,8*/901 isoform", 
                        "nuclear receptor subfamily 3 group A member 1", 
                        "ESR1_HUMAN", 
                        "estrogen receptor 1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:ESR1)", 
                "label": "p(HGNC:ESR1)"
            }, 
            {
                "metadata": {
                    "yloc": 545.0202026367188, 
                    "viewx": 0.317770101438852, 
                    "viewy": 0.31022382473924975, 
                    "xloc": 1742.763474552965, 
                    "synonyms": [
                        "AHH", 
                        "AHHR", 
                        "bHLHe77", 
                        "ahR repressor", 
                        "aryl hydrocarbon hydroxylase regulator", 
                        "aryl hydrocarbon receptor repressor", 
                        "class E basic helix-loop-helix protein 77", 
                        "dioxin receptor repressor", 
                        "AHRR_HUMAN", 
                        "aryl-hydrocarbon receptor repressor"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:AHRR)", 
                "label": "p(HGNC:AHRR)"
            }, 
            {
                "metadata": {
                    "yloc": 1216.040283203125, 
                    "viewx": 0.5042901257203408, 
                    "viewy": 0.7692858676986907, 
                    "xloc": 2464.139404296875, 
                    "synonyms": [
                        "CAR", 
                        "CAR1", 
                        "MB67", 
                        "constitutive activator of retinoid response", 
                        "constitutive active receptor", 
                        "constitutive active response", 
                        "constitutive androstane nuclear receptor variant 2", 
                        "constitutive androstane nuclear receptor variant 3", 
                        "constitutive androstane nuclear receptor variant 4", 
                        "constitutive androstane nuclear receptor variant 5", 
                        "constitutive androstane receptor", 
                        "nuclear receptor subfamily 1 group I member 3", 
                        "orphan nuclear hormone receptor", 
                        "orphan nuclear receptor MB67", 
                        "NR1I3_HUMAN", 
                        "nuclear receptor subfamily 1, group I, member 3"
                    ], 
                    "belnodetype": "transcriptionalActivity"
                }, 
                "id": "tscript(p(HGNC:NR1I3))", 
                "label": "tscript(p(HGNC:NR1I3))"
            }, 
            {
                "metadata": {
                    "yloc": 1112.7996826171875, 
                    "viewx": 0.3284746038280809, 
                    "viewy": 0.6986563256120588, 
                    "xloc": 1784.1636962890625, 
                    "synonyms": [
                        "DFN7", 
                        "FAEES3", 
                        "GST3", 
                        "GSTP", 
                        "PI", 
                        "GST class-pi", 
                        "GSTP1-1", 
                        "deafness, X-linked 7", 
                        "fatty acid ethyl ester synthase III", 
                        "glutathione S-transferase P", 
                        "GSTP1_HUMAN", 
                        "glutathione S-transferase pi 1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:GSTP1)", 
                "label": "p(HGNC:GSTP1)"
            }, 
            {
                "metadata": {
                    "yloc": 932.9888916015625, 
                    "viewx": 0.27272825117035365, 
                    "viewy": 0.57564315289134, 
                    "xloc": 1568.561767578125, 
                    "synonyms": [
                        "NRF2", 
                        "HEBP1", 
                        "NF-E2-related factor 2", 
                        "NFE2-related factor 2", 
                        "nuclear factor erythroid 2-related factor 2", 
                        "nuclear factor erythroid-derived 2-like 2", 
                        "nuclear factor, erythroid derived 2, like 2", 
                        "NF2L2_HUMAN", 
                        "nuclear factor (erythroid-derived 2)-like 2"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:NFE2L2)", 
                "label": "p(HGNC:NFE2L2)"
            }, 
            {
                "metadata": {
                    "yloc": 201.1833038330078, 
                    "viewx": 0.2504943631010353, 
                    "viewy": 0.07499618583396435, 
                    "xloc": 1482.571044921875, 
                    "synonyms": [
                        "HIF-1-beta", 
                        "HIF-1beta", 
                        "HIF1-beta", 
                        "HIF1B", 
                        "HIF1BETA", 
                        "TANGO", 
                        "bHLHe2", 
                        "class E basic helix-loop-helix protein 2", 
                        "dioxin receptor, nuclear translocator", 
                        "hypoxia-inducible factor 1, beta subunit", 
                        "ARNT_HUMAN", 
                        "aryl hydrocarbon receptor nuclear translocator"
                    ], 
                    "belnodetype": "transcriptionalActivity"
                }, 
                "id": "tscript(p(HGNC:ARNT))", 
                "label": "tscript(p(HGNC:ARNT))"
            }, 
            {
                "metadata": {
                    "yloc": 1270.3603515625, 
                    "viewx": 0.4624979810931719, 
                    "viewy": 0.8064476193018656, 
                    "xloc": 2302.506103515625, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(SCHEM:Cotinine)", 
                "label": "a(SCHEM:Cotinine)"
            }, 
            {
                "metadata": {
                    "yloc": 753.48828125, 
                    "viewx": 0.22801236080400447, 
                    "viewy": 0.45284218271634974, 
                    "xloc": 1395.6207275390625, 
                    "synonyms": [
                        "NRF2", 
                        "HEBP1", 
                        "NF-E2-related factor 2", 
                        "NFE2-related factor 2", 
                        "nuclear factor erythroid 2-related factor 2", 
                        "nuclear factor erythroid-derived 2-like 2", 
                        "nuclear factor, erythroid derived 2, like 2", 
                        "NF2L2_HUMAN", 
                        "nuclear factor (erythroid-derived 2)-like 2"
                    ], 
                    "belnodetype": "transcriptionalActivity"
                }, 
                "id": "tscript(p(HGNC:NFE2L2))", 
                "label": "tscript(p(HGNC:NFE2L2))"
            }, 
            {
                "metadata": {
                    "yloc": 1211.5066620829152, 
                    "viewx": 0.8397431497274581, 
                    "viewy": 0.7661843012423026, 
                    "xloc": 3761.521484375, 
                    "synonyms": [
                        "CPB6", 
                        "CYP2B", 
                        "CYP2B7", 
                        "CYP2B7P", 
                        "CYPIIB6", 
                        "EFVM", 
                        "IIB1", 
                        "P450", 
                        "1,4-cineole 2-exo-monooxygenase", 
                        "cytochrome P450 2B6", 
                        "cytochrome P450 IIB1", 
                        "cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6", 
                        "CP2B6_HUMAN", 
                        "cytochrome P450, family 2, subfamily B, polypeptide 6"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:CYP2B6)", 
                "label": "p(HGNC:CYP2B6)"
            }, 
            {
                "metadata": {
                    "yloc": 781.5693359375, 
                    "viewx": 0.7172697880297122, 
                    "viewy": 0.47205315226351785, 
                    "xloc": 3287.849365234375, 
                    "synonyms": [
                        "AHH", 
                        "AHRR", 
                        "CP11", 
                        "CYP1", 
                        "P1-450", 
                        "P450-C", 
                        "P450DX", 
                        "CYPIA1", 
                        "aryl hydrocarbon hydroxylase", 
                        "cytochrome P1-450, dioxin-inducible", 
                        "cytochrome P450 1A1", 
                        "cytochrome P450 form 6", 
                        "cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 1", 
                        "cytochrome P450-C", 
                        "cytochrome P450-P1", 
                        "flavoprotein-linked monooxygenase", 
                        "xenobiotic monooxygenase", 
                        "CP1A1_HUMAN", 
                        "cytochrome P450, family 1, subfamily A, polypeptide 1"
                    ], 
                    "belnodetype": "catalyticActivity"
                }, 
                "id": "cat(p(HGNC:CYP1A1))", 
                "label": "cat(p(HGNC:CYP1A1))"
            }, 
            {
                "metadata": {
                    "yloc": 392.0027844495438, 
                    "viewx": 0.413687363683897, 
                    "viewy": 0.20554068538805406, 
                    "xloc": 2113.728492904492, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(SCHEM:Methylcholanthrene)", 
                "label": "a(SCHEM:Methylcholanthrene)"
            }, 
            {
                "metadata": {
                    "yloc": 1056.0172119140625, 
                    "viewx": 0.8244743876363477, 
                    "viewy": 0.6598099814262658, 
                    "xloc": 3702.46875, 
                    "synonyms": [
                        "CPE1", 
                        "CYP2E", 
                        "P450-J", 
                        "P450C2E", 
                        "4-nitrophenol 2-hydroxylase", 
                        "CYPIIE1", 
                        "cytochrome P450 2E1", 
                        "cytochrome P450, subfamily IIE (ethanol-inducible), polypeptide 1", 
                        "cytochrome P450-J", 
                        "flavoprotein-linked monooxygenase", 
                        "microsomal monooxygenase", 
                        "xenobiotic monooxygenase", 
                        "CP2E1_HUMAN", 
                        "cytochrome P450, family 2, subfamily E, polypeptide 1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:CYP2E1)", 
                "label": "p(HGNC:CYP2E1)"
            }, 
            {
                "metadata": {
                    "yloc": 356.27411181715337, 
                    "viewx": 0.13736257473356955, 
                    "viewy": 0.18109778430972923, 
                    "xloc": 1045.0279482406931, 
                    "synonyms": [
                        "EL52", 
                        "HSP86", 
                        "HSP89A", 
                        "HSP90A", 
                        "HSP90N", 
                        "HSPC1", 
                        "HSPCA", 
                        "HSPCAL1", 
                        "HSPCAL4", 
                        "HSPN", 
                        "Hsp89", 
                        "Hsp90", 
                        "LAP2", 
                        "HSP 86", 
                        "epididymis luminal secretory protein 52", 
                        "heat shock 86 kDa", 
                        "heat shock 90kD protein 1, alpha", 
                        "heat shock 90kD protein 1, alpha-like 4", 
                        "heat shock 90kD protein, alpha-like 4", 
                        "heat shock 90kDa protein 1, alpha", 
                        "heat shock protein HSP 90-alpha", 
                        "renal carcinoma antigen NY-REN-38", 
                        "HS90A_HUMAN", 
                        "heat shock protein 90kDa alpha (cytosolic), class A member 1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:HSP90AA1)", 
                "label": "p(HGNC:HSP90AA1)"
            }, 
            {
                "metadata": {
                    "yloc": 296.2334899902344, 
                    "viewx": 0.1691888677821532, 
                    "viewy": 0.14002245539683691, 
                    "xloc": 1168.1177978515625, 
                    "synonyms": [
                        "HIF-1-beta", 
                        "HIF-1beta", 
                        "HIF1-beta", 
                        "HIF1B", 
                        "HIF1BETA", 
                        "TANGO", 
                        "bHLHe2", 
                        "class E basic helix-loop-helix protein 2", 
                        "dioxin receptor, nuclear translocator", 
                        "hypoxia-inducible factor 1, beta subunit", 
                        "ARNT_HUMAN", 
                        "aryl hydrocarbon receptor nuclear translocator"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:ARNT)", 
                "label": "p(HGNC:ARNT)"
            }, 
            {
                "metadata": {
                    "yloc": 967.3506469726562, 
                    "viewx": 0.3538971116473877, 
                    "viewy": 0.5991509108216421, 
                    "xloc": 1882.486572265625, 
                    "synonyms": [
                        "BILIQTL1", 
                        "GNT1", 
                        "HUG-BR1", 
                        "UDPGT", 
                        "UDPGT 1-1", 
                        "UGT1", 
                        "UGT1A", 
                        "UDP glycosyltransferase 1 family, polypeptide A1", 
                        "UDP-glucuronosyltransferase 1-1", 
                        "UDP-glucuronosyltransferase 1-A", 
                        "UDP-glucuronosyltransferase 1A1", 
                        "UGT-1A", 
                        "UGT1*1", 
                        "UGT1-01", 
                        "UGT1.1", 
                        "bilirubin UDP-glucuronosyltransferase 1-1", 
                        "bilirubin UDP-glucuronosyltransferase isozyme 1", 
                        "bilirubin-specific UDPGT isozyme 1", 
                        "UD11_HUMAN", 
                        "UDP glucuronosyltransferase 1 family, polypeptide A1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:UGT1A1)", 
                "label": "p(HGNC:UGT1A1)"
            }, 
            {
                "metadata": {
                    "yloc": 1351.9737548828125, 
                    "viewx": 0.23413460541202244, 
                    "viewy": 0.8622814411890897, 
                    "xloc": 1419.298828125, 
                    "synonyms": [
                        "DFN7", 
                        "FAEES3", 
                        "GST3", 
                        "GSTP", 
                        "PI", 
                        "GST class-pi", 
                        "GSTP1-1", 
                        "deafness, X-linked 7", 
                        "fatty acid ethyl ester synthase III", 
                        "glutathione S-transferase P", 
                        "GSTP1_HUMAN", 
                        "glutathione S-transferase pi 1"
                    ], 
                    "belnodetype": "catalyticActivity"
                }, 
                "id": "cat(p(HGNC:GSTP1))", 
                "label": "cat(p(HGNC:GSTP1))"
            }, 
            {
                "metadata": {
                    "yloc": 1096.319580078125, 
                    "viewx": 0.19948291745062577, 
                    "viewy": 0.687381864893421, 
                    "xloc": 1285.2816162109375, 
                    "synonyms": [
                        "ABC29", 
                        "ABCC", 
                        "GS-X", 
                        "MRP", 
                        "MRP1", 
                        "ATP-binding cassette transporter variant ABCC1delta-ex13", 
                        "ATP-binding cassette transporter variant ABCC1delta-ex13&14", 
                        "ATP-binding cassette transporter variant ABCC1delta-ex25", 
                        "ATP-binding cassette transporter variant ABCC1delta-ex25&26", 
                        "LTC4 transporter", 
                        "leukotriene C(4) transporter", 
                        "multidrug resistance-associated protein 1", 
                        "MRP1_HUMAN", 
                        "ATP-binding cassette, sub-family C (CFTR/MRP), member 1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:ABCC1)", 
                "label": "p(HGNC:ABCC1)"
            }, 
            {
                "metadata": {
                    "yloc": 982.5963134765625, 
                    "viewx": 0.11494287123779899, 
                    "viewy": 0.6095808621960539, 
                    "xloc": 958.3185747235818, 
                    "synonyms": [
                        "ABC15", 
                        "ABCP", 
                        "BCRP", 
                        "BCRP1", 
                        "BMDP", 
                        "CD338", 
                        "CDw338", 
                        "EST157481", 
                        "GOUT1", 
                        "MRX", 
                        "MXR", 
                        "MXR1", 
                        "UAQTL1", 
                        "ABC transporter", 
                        "ATP-binding cassette sub-family G member 2", 
                        "ATP-binding cassette transporter G2", 
                        "breast cancer resistance protein", 
                        "mitoxantrone resistance-associated protein", 
                        "multi drug resistance efflux transport ATP-binding cassette sub-family G (WHITE) member 2", 
                        "placenta specific MDR protein", 
                        "placenta-specific ATP-binding cassette transporter", 
                        "ABCG2_HUMAN", 
                        "ATP-binding cassette, sub-family G (WHITE), member 2"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:ABCG2)", 
                "label": "p(HGNC:ABCG2)"
            }, 
            {
                "metadata": {
                    "yloc": 212.14541625976562, 
                    "viewx": 0.4751394131640313, 
                    "viewy": 0.0824956480281967, 
                    "xloc": 2351.3975018978613, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(CHEBI:\"hydrogen peroxide\")", 
                "label": "a(CHEBI:\"hydrogen peroxide\")"
            }, 
            {
                "metadata": {
                    "yloc": 995.7935791015625, 
                    "viewx": 0.5507454038204402, 
                    "viewy": 0.6186094500054933, 
                    "xloc": 2643.8076171875, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(SCHEM:\"Particulate Matter\")", 
                "label": "a(SCHEM:\"Particulate Matter\")"
            }, 
            {
                "metadata": {
                    "yloc": 909.759765625, 
                    "viewx": 0.39565617858588564, 
                    "viewy": 0.5597515121852052, 
                    "xloc": 2043.991943359375, 
                    "synonyms": [
                        "DHQU", 
                        "DIA4", 
                        "DTD", 
                        "NMOR1", 
                        "NMORI", 
                        "QR1", 
                        "DT-diaphorase", 
                        "NAD(P)H dehydrogenase [quinone] 1", 
                        "NAD(P)H:Quinone acceptor oxidoreductase type 1", 
                        "NAD(P)H:menadione oxidoreductase 1", 
                        "NAD(P)H:quinone oxidoreductase 1", 
                        "NAD(P)H:quinone oxireductase", 
                        "azoreductase", 
                        "diaphorase (NADH/NADPH) (cytochrome b-5 reductase)", 
                        "diaphorase-4", 
                        "dioxin-inducible 1", 
                        "menadione reductase", 
                        "phylloquinone reductase", 
                        "quinone reductase 1", 
                        "NQO1_HUMAN", 
                        "NAD(P)H dehydrogenase, quinone 1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:NQO1)", 
                "label": "p(HGNC:NQO1)"
            }, 
            {
                "metadata": {
                    "yloc": 325.58990478515625, 
                    "viewx": 0.3642094598427328, 
                    "viewy": 0.16010593149541535, 
                    "xloc": 1922.3701171875, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(SCHEM:\"8-Methyl-IQX\")", 
                "label": "a(SCHEM:\"8-Methyl-IQX\")"
            }, 
            {
                "metadata": {
                    "yloc": 904.2950531961965, 
                    "viewx": 0.9468238342522975, 
                    "viewy": 0.5560129622901934, 
                    "xloc": 4175.66162109375, 
                    "synonyms": [
                        "CPE1", 
                        "CYP2E", 
                        "P450-J", 
                        "P450C2E", 
                        "4-nitrophenol 2-hydroxylase", 
                        "CYPIIE1", 
                        "cytochrome P450 2E1", 
                        "cytochrome P450, subfamily IIE (ethanol-inducible), polypeptide 1", 
                        "cytochrome P450-J", 
                        "flavoprotein-linked monooxygenase", 
                        "microsomal monooxygenase", 
                        "xenobiotic monooxygenase", 
                        "CP2E1_HUMAN", 
                        "cytochrome P450, family 2, subfamily E, polypeptide 1"
                    ], 
                    "belnodetype": "catalyticActivity"
                }, 
                "id": "cat(p(HGNC:CYP2E1))", 
                "label": "cat(p(HGNC:CYP2E1))"
            }, 
            {
                "metadata": {
                    "yloc": 1320.1412353515625, 
                    "viewx": 0.630791516643462, 
                    "viewy": 0.8405039983497828, 
                    "xloc": 2953.39013671875, 
                    "synonyms": [
                        "GST5", 
                        "GSTB", 
                        "GSTM3-3", 
                        "GTM3", 
                        "GST class-mu 3", 
                        "S-(hydroxyalkyl)glutathione lyase M3", 
                        "brain GST", 
                        "brain type mu-glutathione S-transferase", 
                        "glutathione S-alkyltransferase M3", 
                        "glutathione S-aralkyltransferase M3", 
                        "glutathione S-aryltransferase M3", 
                        "glutathione S-transferase M3 (brain)", 
                        "glutathione S-transferase Mu 3", 
                        "glutathione S-transferase, Mu-3", 
                        "hGSTM3-3", 
                        "GSTM3_HUMAN", 
                        "glutathione S-transferase mu 3 (brain)"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:GSTM3)", 
                "label": "p(HGNC:GSTM3)"
            }, 
            {
                "metadata": {
                    "yloc": 709.7645263671875, 
                    "viewx": 0.519921416754271, 
                    "viewy": 0.42292964086600887, 
                    "xloc": 2524.59423828125, 
                    "synonyms": [
                        "AHH", 
                        "AHRR", 
                        "CP11", 
                        "CYP1", 
                        "P1-450", 
                        "P450-C", 
                        "P450DX", 
                        "CYPIA1", 
                        "aryl hydrocarbon hydroxylase", 
                        "cytochrome P1-450, dioxin-inducible", 
                        "cytochrome P450 1A1", 
                        "cytochrome P450 form 6", 
                        "cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 1", 
                        "cytochrome P450-C", 
                        "cytochrome P450-P1", 
                        "flavoprotein-linked monooxygenase", 
                        "xenobiotic monooxygenase", 
                        "CP1A1_HUMAN", 
                        "cytochrome P450, family 1, subfamily A, polypeptide 1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:CYP1A1)", 
                "label": "p(HGNC:CYP1A1)"
            }, 
            {
                "metadata": {
                    "yloc": 293.7574768066406, 
                    "viewx": 0.5578923939609786, 
                    "viewy": 0.13832855128968172, 
                    "xloc": 2671.448974609375, 
                    "synonyms": [
                        "BXR", 
                        "ONR1", 
                        "PAR", 
                        "PAR1", 
                        "PAR2", 
                        "PARq", 
                        "PRR", 
                        "PXR", 
                        "SAR", 
                        "SXR", 
                        "nuclear receptor subfamily 1 group I member 2", 
                        "orphan nuclear receptor PAR1", 
                        "orphan nuclear receptor PXR", 
                        "pregnane X nuclear receptor variant 2", 
                        "pregnane X receptor", 
                        "steroid and xenobiotic receptor", 
                        "NR1I2_HUMAN", 
                        "nuclear receptor subfamily 1, group I, member 2"
                    ], 
                    "belnodetype": "transcriptionalActivity"
                }, 
                "id": "tscript(p(HGNC:NR1I2))", 
                "label": "tscript(p(HGNC:NR1I2))"
            }, 
            {
                "metadata": {
                    "yloc": 937.2905883789062, 
                    "viewx": 0.7072640397081745, 
                    "viewy": 0.5785860539579261, 
                    "xloc": 3249.151611328125, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(CHEBI:\"reactive oxygen species\")", 
                "label": "a(CHEBI:\"reactive oxygen species\")"
            }, 
            {
                "metadata": {
                    "yloc": 1095.5067138671875, 
                    "viewx": 0.14736763019154164, 
                    "viewy": 0.6868257622755519, 
                    "xloc": 1083.7230224609375, 
                    "synonyms": [
                        "ABC15", 
                        "ABCP", 
                        "BCRP", 
                        "BCRP1", 
                        "BMDP", 
                        "CD338", 
                        "CDw338", 
                        "EST157481", 
                        "GOUT1", 
                        "MRX", 
                        "MXR", 
                        "MXR1", 
                        "UAQTL1", 
                        "ABC transporter", 
                        "ATP-binding cassette sub-family G member 2", 
                        "ATP-binding cassette transporter G2", 
                        "breast cancer resistance protein", 
                        "mitoxantrone resistance-associated protein", 
                        "multi drug resistance efflux transport ATP-binding cassette sub-family G (WHITE) member 2", 
                        "placenta specific MDR protein", 
                        "placenta-specific ATP-binding cassette transporter", 
                        "ABCG2_HUMAN", 
                        "ATP-binding cassette, sub-family G (WHITE), member 2"
                    ], 
                    "belnodetype": "transportActivity"
                }, 
                "id": "tport(p(HGNC:ABCG2))", 
                "label": "tport(p(HGNC:ABCG2))"
            }, 
            {
                "metadata": {
                    "yloc": 1371.393310546875, 
                    "viewx": 0.304229857414078, 
                    "viewy": 0.8755668571620128, 
                    "xloc": 1690.3958740234375, 
                    "synonyms": [
                        "EPHX", 
                        "EPOX", 
                        "HYL1", 
                        "MEH", 
                        "epoxide hydratase", 
                        "epoxide hydrolase 1", 
                        "HYEP_HUMAN", 
                        "epoxide hydrolase 1, microsomal (xenobiotic)"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:EPHX1)", 
                "label": "p(HGNC:EPHX1)"
            }, 
            {
                "metadata": {
                    "yloc": 1486.837890625, 
                    "viewx": 0.41280702328715996, 
                    "viewy": 0.9545454545454546, 
                    "xloc": 2110.32373046875, 
                    "synonyms": [], 
                    "belnodetype": "biologicalProcess"
                }, 
                "id": "bp(GO:\"xenobiotic metabolic process\")", 
                "label": "bp(GO:\"xenobiotic metabolic process\")"
            }, 
            {
                "metadata": {
                    "yloc": 162.95609722088838, 
                    "viewx": 0.7519260344064509, 
                    "viewy": 0.04884397359438514, 
                    "xloc": 3421.88420705771, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(CHEBI:dexamethasone)", 
                "label": "a(CHEBI:dexamethasone)"
            }, 
            {
                "metadata": {
                    "yloc": 1232.38671875, 
                    "viewx": 0.7451429801399159, 
                    "viewy": 0.7804688834005742, 
                    "xloc": 3395.650390625, 
                    "synonyms": [
                        "C2F1", 
                        "CYP2F", 
                        "CYPIIF1", 
                        "cytochrome P450 2F1", 
                        "cytochrome P450, subfamily IIF, polypeptide 1", 
                        "flavoprotein-linked monooxygenase", 
                        "microsomal monooxygenase", 
                        "xenobiotic monooxygenase", 
                        "CP2F1_HUMAN", 
                        "cytochrome P450, family 2, subfamily F, polypeptide 1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:CYP2F1)", 
                "label": "p(HGNC:CYP2F1)"
            }, 
            {
                "metadata": {
                    "yloc": 457.2216796875, 
                    "viewx": 0.29774265353687795, 
                    "viewy": 0.25015860391922834, 
                    "xloc": 1665.3062744140625, 
                    "synonyms": [
                        "ER", 
                        "ESR", 
                        "ESRA", 
                        "Era", 
                        "NR3A1", 
                        "ER-alpha", 
                        "estradiol receptor", 
                        "estrogen nuclear receptor alpha", 
                        "estrogen receptor", 
                        "estrogen receptor alpha 3*,4,5,6,7*/822 isoform", 
                        "estrogen receptor alpha E1-E2-1-2", 
                        "estrogen receptor alpha E1-N2-E2-1-2", 
                        "estrogen receptor alpha delta 3*,4,5,6,7*,8*/941 isoform", 
                        "estrogen receptor alpha delta 3*,4,5,6,7*/819-2 isoform", 
                        "estrogen receptor alpha delta 4 +49 isoform", 
                        "estrogen receptor alpha delta 4*,5,6,7*/654 isoform", 
                        "estrogen receptor alpha delta 4*,5,6,7,8*/901 isoform", 
                        "nuclear receptor subfamily 3 group A member 1", 
                        "ESR1_HUMAN", 
                        "estrogen receptor 1"
                    ], 
                    "belnodetype": "transcriptionalActivity"
                }, 
                "id": "tscript(p(HGNC:ESR1))", 
                "label": "tscript(p(HGNC:ESR1))"
            }, 
            {
                "metadata": {
                    "yloc": 1147.2132568359375, 
                    "viewx": 0.08833639160973568, 
                    "viewy": 0.7221995341447464, 
                    "xloc": 855.4166259765625, 
                    "synonyms": [
                        "ALDH3", 
                        "ALDHIII", 
                        "aldehyde dehydrogenase isozyme 3", 
                        "aldehyde dehydrogenase type III", 
                        "aldehyde dehydrogenase, dimeric NADP-preferring", 
                        "stomach aldehyde dehydrogenase", 
                        "AL3A1_HUMAN", 
                        "aldehyde dehydrogenase 3 family, member A1"
                    ], 
                    "belnodetype": "catalyticActivity"
                }, 
                "id": "cat(p(HGNC:ALDH3A1))", 
                "label": "cat(p(HGNC:ALDH3A1))"
            }, 
            {
                "metadata": {
                    "yloc": 1206.0940644266652, 
                    "viewx": 0.9545454545454545, 
                    "viewy": 0.7624814043994864, 
                    "xloc": 4205.525390625, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(CHEBI:phenobarbital)", 
                "label": "a(CHEBI:phenobarbital)"
            }, 
            {
                "metadata": {
                    "yloc": 461.25705249098155, 
                    "viewx": 0.09979437905048195, 
                    "viewy": 0.2529193059263956, 
                    "xloc": 899.7309904792627, 
                    "synonyms": [
                        "bHLHe76", 
                        "AH-receptor", 
                        "ah receptor", 
                        "aromatic hydrocarbon receptor", 
                        "class E basic helix-loop-helix protein 76", 
                        "AHR_HUMAN", 
                        "aryl hydrocarbon receptor", 
                        "EL52", 
                        "HSP86", 
                        "HSP89A", 
                        "HSP90A", 
                        "HSP90N", 
                        "HSPC1", 
                        "HSPCA", 
                        "HSPCAL1", 
                        "HSPCAL4", 
                        "HSPN", 
                        "Hsp89", 
                        "Hsp90", 
                        "LAP2", 
                        "HSP 86", 
                        "epididymis luminal secretory protein 52", 
                        "heat shock 86 kDa", 
                        "heat shock 90kD protein 1, alpha", 
                        "heat shock 90kD protein 1, alpha-like 4", 
                        "heat shock 90kD protein, alpha-like 4", 
                        "heat shock 90kDa protein 1, alpha", 
                        "heat shock protein HSP 90-alpha", 
                        "renal carcinoma antigen NY-REN-38", 
                        "HS90A_HUMAN", 
                        "heat shock protein 90kDa alpha (cytosolic), class A member 1"
                    ], 
                    "belnodetype": "complexAbundance"
                }, 
                "id": "complex(p(HGNC:AHR),p(HGNC:HSP90AA1))", 
                "label": "complex(p(HGNC:AHR),p(HGNC:HSP90AA1))"
            }, 
            {
                "metadata": {
                    "yloc": 1246.5145263671875, 
                    "viewx": 0.4390561892591215, 
                    "viewy": 0.7901340788471987, 
                    "xloc": 2211.84375, 
                    "synonyms": [
                        "AAC2", 
                        "NAT-2", 
                        "PNAT", 
                        "N-acetyltransferase type 2", 
                        "arylamide acetylase 2", 
                        "arylamine N-acetyltransferase 2", 
                        "ARY2_HUMAN", 
                        "N-acetyltransferase 2 (arylamine N-acetyltransferase)"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:NAT2)", 
                "label": "p(HGNC:NAT2)"
            }, 
            {
                "metadata": {
                    "yloc": 965.0217895507812, 
                    "viewx": 0.2365434691518801, 
                    "viewy": 0.5975576797443474, 
                    "xloc": 1428.615234375, 
                    "synonyms": [
                        "HAST1/HAST2", 
                        "P-PST", 
                        "PST", 
                        "ST1A1", 
                        "ST1A3", 
                        "STP", 
                        "STP1", 
                        "TSPST1", 
                        "P-PST 1", 
                        "aryl sulfotransferase 1", 
                        "phenol-sulfating phenol sulfotransferase 1", 
                        "sulfotransferase 1A1", 
                        "thermostable phenol sulfotransferase1", 
                        "ts-PST", 
                        "ST1A1_HUMAN", 
                        "sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1"
                    ], 
                    "belnodetype": "catalyticActivity"
                }, 
                "id": "cat(p(HGNC:SULT1A1))", 
                "label": "cat(p(HGNC:SULT1A1))"
            }, 
            {
                "metadata": {
                    "yloc": 1105.9169921875, 
                    "viewx": 0.6365090330054606, 
                    "viewy": 0.6939477006078074, 
                    "xloc": 2975.5029296875, 
                    "synonyms": [
                        "DHQU", 
                        "DIA4", 
                        "DTD", 
                        "NMOR1", 
                        "NMORI", 
                        "QR1", 
                        "DT-diaphorase", 
                        "NAD(P)H dehydrogenase [quinone] 1", 
                        "NAD(P)H:Quinone acceptor oxidoreductase type 1", 
                        "NAD(P)H:menadione oxidoreductase 1", 
                        "NAD(P)H:quinone oxidoreductase 1", 
                        "NAD(P)H:quinone oxireductase", 
                        "azoreductase", 
                        "diaphorase (NADH/NADPH) (cytochrome b-5 reductase)", 
                        "diaphorase-4", 
                        "dioxin-inducible 1", 
                        "menadione reductase", 
                        "phylloquinone reductase", 
                        "quinone reductase 1", 
                        "NQO1_HUMAN", 
                        "NAD(P)H dehydrogenase, quinone 1"
                    ], 
                    "belnodetype": "catalyticActivity"
                }, 
                "id": "cat(p(HGNC:NQO1))", 
                "label": "cat(p(HGNC:NQO1))"
            }, 
            {
                "metadata": {
                    "yloc": 907.7363984110402, 
                    "viewx": 0.8374752449166126, 
                    "viewy": 0.558367274792319, 
                    "xloc": 3752.750244140625, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(CHEBI:curcumin)", 
                "label": "a(CHEBI:curcumin)"
            }, 
            {
                "metadata": {
                    "yloc": 177.93629455566406, 
                    "viewx": 0.1681972315009838, 
                    "viewy": 0.059092310703213496, 
                    "xloc": 1164.2825927734375, 
                    "synonyms": [
                        "HIF-1-beta", 
                        "HIF-1beta", 
                        "HIF1-beta", 
                        "HIF1B", 
                        "HIF1BETA", 
                        "TANGO", 
                        "bHLHe2", 
                        "class E basic helix-loop-helix protein 2", 
                        "dioxin receptor, nuclear translocator", 
                        "hypoxia-inducible factor 1, beta subunit", 
                        "ARNT_HUMAN", 
                        "aryl hydrocarbon receptor nuclear translocator", 
                        "AHH", 
                        "AHRR", 
                        "CP11", 
                        "CYP1", 
                        "P1-450", 
                        "P450-C", 
                        "P450DX", 
                        "CYPIA1", 
                        "aryl hydrocarbon hydroxylase", 
                        "cytochrome P1-450, dioxin-inducible", 
                        "cytochrome P450 1A1", 
                        "cytochrome P450 form 6", 
                        "cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 1", 
                        "cytochrome P450-C", 
                        "cytochrome P450-P1", 
                        "flavoprotein-linked monooxygenase", 
                        "xenobiotic monooxygenase", 
                        "CP1A1_HUMAN", 
                        "cytochrome P450, family 1, subfamily A, polypeptide 1"
                    ], 
                    "belnodetype": "complexAbundance"
                }, 
                "id": "complex(p(HGNC:ARNT),g(HGNC:CYP1A1))", 
                "label": "complex(p(HGNC:ARNT),g(HGNC:CYP1A1))"
            }, 
            {
                "metadata": {
                    "yloc": 535.3446044921875, 
                    "viewx": 0.611917917740813, 
                    "viewy": 0.30360449995341937, 
                    "xloc": 2880.3955078125, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(SCHEM:Tetrachlorodibenzodioxin)", 
                "label": "a(SCHEM:Tetrachlorodibenzodioxin)"
            }, 
            {
                "metadata": {
                    "yloc": 746.2557983398438, 
                    "viewx": 0.3920580961878734, 
                    "viewy": 0.44789425570706703, 
                    "xloc": 2030.076171875, 
                    "synonyms": [
                        "bHLHe76", 
                        "AH-receptor", 
                        "ah receptor", 
                        "aromatic hydrocarbon receptor", 
                        "class E basic helix-loop-helix protein 76", 
                        "AHR_HUMAN", 
                        "aryl hydrocarbon receptor"
                    ], 
                    "belnodetype": "transcriptionalActivity"
                }, 
                "id": "tscript(p(HGNC:AHR))", 
                "label": "tscript(p(HGNC:AHR))"
            }, 
            {
                "metadata": {
                    "yloc": 858.9998168945312, 
                    "viewx": 0.10048625591104292, 
                    "viewy": 0.5250253297063495, 
                    "xloc": 902.4068603515625, 
                    "synonyms": [
                        "ALDH3", 
                        "ALDHIII", 
                        "aldehyde dehydrogenase isozyme 3", 
                        "aldehyde dehydrogenase type III", 
                        "aldehyde dehydrogenase, dimeric NADP-preferring", 
                        "stomach aldehyde dehydrogenase", 
                        "AL3A1_HUMAN", 
                        "aldehyde dehydrogenase 3 family, member A1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:ALDH3A1)", 
                "label": "p(HGNC:ALDH3A1)"
            }, 
            {
                "metadata": {
                    "yloc": 843.4295043945312, 
                    "viewx": 0.5025989973243559, 
                    "viewy": 0.5143732796816565, 
                    "xloc": 2457.598876953125, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\")", 
                "label": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\")"
            }, 
            {
                "metadata": {
                    "yloc": 1152.583984375, 
                    "viewx": 0.2397254923017424, 
                    "viewy": 0.7258737865667892, 
                    "xloc": 1440.921875, 
                    "synonyms": [
                        "ABC29", 
                        "ABCC", 
                        "GS-X", 
                        "MRP", 
                        "MRP1", 
                        "ATP-binding cassette transporter variant ABCC1delta-ex13", 
                        "ATP-binding cassette transporter variant ABCC1delta-ex13&14", 
                        "ATP-binding cassette transporter variant ABCC1delta-ex25", 
                        "ATP-binding cassette transporter variant ABCC1delta-ex25&26", 
                        "LTC4 transporter", 
                        "leukotriene C(4) transporter", 
                        "multidrug resistance-associated protein 1", 
                        "MRP1_HUMAN", 
                        "ATP-binding cassette, sub-family C (CFTR/MRP), member 1"
                    ], 
                    "belnodetype": "transportActivity"
                }, 
                "id": "tport(p(HGNC:ABCC1))", 
                "label": "tport(p(HGNC:ABCC1))"
            }, 
            {
                "metadata": {
                    "yloc": 971.790283203125, 
                    "viewx": 0.3164385229882803, 
                    "viewy": 0.6021881798050612, 
                    "xloc": 1737.613525390625, 
                    "synonyms": [
                        "GNT1", 
                        "HLUGP", 
                        "HLUGP1", 
                        "UDPGT", 
                        "UDPGT 1-6", 
                        "UGT1", 
                        "UGT1A6S", 
                        "UGT1F", 
                        "UDP glycosyltransferase 1 family, polypeptide A6", 
                        "UDP-glucuronosyltransferase 1 family polypeptide A6s", 
                        "UDP-glucuronosyltransferase 1-6", 
                        "UDP-glucuronosyltransferase 1-F", 
                        "UDP-glucuronosyltransferase 1A6", 
                        "UGT-1F", 
                        "UGT1*6", 
                        "UGT1-06", 
                        "UGT1.6", 
                        "phenol-metabolizing UDP-glucuronosyltransferase", 
                        "UD16_HUMAN", 
                        "UDP glucuronosyltransferase 1 family, polypeptide A6"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:UGT1A6)", 
                "label": "p(HGNC:UGT1A6)"
            }, 
            {
                "metadata": {
                    "yloc": 812.54150390625, 
                    "viewx": 0.5972007450458996, 
                    "viewy": 0.49324200653836436, 
                    "xloc": 2823.47607421875, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(SCHEM:\"Diesel exhaust particles\")", 
                "label": "a(SCHEM:\"Diesel exhaust particles\")"
            }, 
            {
                "metadata": {
                    "yloc": 1167.08251953125, 
                    "viewx": 0.47661489473928276, 
                    "viewy": 0.7357926062288318, 
                    "xloc": 2357.10400390625, 
                    "synonyms": [
                        "AKT", 
                        "CWS6", 
                        "PKB", 
                        "PKB-ALPHA", 
                        "PRKBA", 
                        "RAC", 
                        "RAC-ALPHA", 
                        "PKB alpha", 
                        "RAC-PK-alpha", 
                        "RAC-alpha serine/threonine-protein kinase", 
                        "protein kinase B alpha", 
                        "proto-oncogene c-Akt", 
                        "rac protein kinase alpha", 
                        "AKT1_HUMAN", 
                        "v-akt murine thymoma viral oncogene homolog 1"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:AKT1,pmod(P))", 
                "label": "p(HGNC:AKT1,pmod(P))"
            }, 
            {
                "metadata": {
                    "yloc": 433.1322326660156, 
                    "viewx": 0.8058922385210919, 
                    "viewy": 0.23367839552649092, 
                    "xloc": 3630.601318359375, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(CHEBI:nicotine)", 
                "label": "a(CHEBI:nicotine)"
            }, 
            {
                "metadata": {
                    "yloc": 617.2446899414062, 
                    "viewx": 0.1755294630106158, 
                    "viewy": 0.35963444843593784, 
                    "xloc": 1192.640380859375, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(SCHEM:Indirubin)", 
                "label": "a(SCHEM:Indirubin)"
            }, 
            {
                "metadata": {
                    "yloc": 741.1334228515625, 
                    "viewx": 0.8387683047920644, 
                    "viewy": 0.4443899072910392, 
                    "xloc": 3757.751220703125, 
                    "synonyms": [
                        "CP12", 
                        "P3-450", 
                        "P450(PA)", 
                        "CYPIA2", 
                        "P450 form 4", 
                        "aryl hydrocarbon hydroxylase", 
                        "cytochrome P(3)450", 
                        "cytochrome P450 1A2", 
                        "cytochrome P450 4", 
                        "cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 2", 
                        "cytochrome P450-P3", 
                        "dioxin-inducible P3-450", 
                        "flavoprotein-linked monooxygenase", 
                        "microsomal monooxygenase", 
                        "xenobiotic monooxygenase", 
                        "CP1A2_HUMAN", 
                        "cytochrome P450, family 1, subfamily A, polypeptide 2"
                    ], 
                    "belnodetype": "catalyticActivity"
                }, 
                "id": "cat(p(HGNC:CYP1A2))", 
                "label": "cat(p(HGNC:CYP1A2))"
            }, 
            {
                "metadata": {
                    "yloc": 1021.603759765625, 
                    "viewx": 0.43853793005303576, 
                    "viewy": 0.636266856405009, 
                    "xloc": 2209.83935546875, 
                    "synonyms": [], 
                    "belnodetype": "abundance"
                }, 
                "id": "a(SCHEM:Soot)", 
                "label": "a(SCHEM:Soot)"
            }, 
            {
                "metadata": {
                    "yloc": 972.564453125, 
                    "viewx": 0.15909142987512956, 
                    "viewy": 0.6027178092993585, 
                    "xloc": 1129.0654296875, 
                    "synonyms": [
                        "bHLHe76", 
                        "AH-receptor", 
                        "ah receptor", 
                        "aromatic hydrocarbon receptor", 
                        "class E basic helix-loop-helix protein 76", 
                        "AHR_HUMAN", 
                        "aryl hydrocarbon receptor"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:AHR)", 
                "label": "p(HGNC:AHR)"
            }, 
            {
                "metadata": {
                    "yloc": 1015.71484375, 
                    "viewx": 0.3874960264163977, 
                    "viewy": 0.6322380979591106, 
                    "xloc": 2012.43212890625, 
                    "synonyms": [
                        "GST2", 
                        "GSTA2-2", 
                        "GTA2", 
                        "GTH2", 
                        "GST HA subunit 2", 
                        "GST class-alpha member 2", 
                        "GST-gamma", 
                        "S-(hydroxyalkyl)glutathione lyase A2", 
                        "glutathione S-alkyltransferase A2", 
                        "glutathione S-aralkyltransferase A2", 
                        "glutathione S-aryltransferase A2", 
                        "glutathione S-transferase A2", 
                        "liver GST2", 
                        "GSTA2_HUMAN", 
                        "glutathione S-transferase alpha 2"
                    ], 
                    "belnodetype": "proteinAbundance"
                }, 
                "id": "p(HGNC:GSTA2)", 
                "label": "p(HGNC:GSTA2)"
            }, 
            {
                "metadata": {
                    "yloc": 343.4928894042969, 
                    "viewx": 0.4897766585623384, 
                    "viewy": 0.1723538223296164, 
                    "xloc": 2408.0078125, 
                    "synonyms": [
                        "HIF-1-beta", 
                        "HIF-1beta", 
                        "HIF1-beta", 
                        "HIF1B", 
                        "HIF1BETA", 
                        "TANGO", 
                        "bHLHe2", 
                        "class E basic helix-loop-helix protein 2", 
                        "dioxin receptor, nuclear translocator", 
                        "hypoxia-inducible factor 1, beta subunit", 
                        "ARNT_HUMAN", 
                        "aryl hydrocarbon receptor nuclear translocator", 
                        "bHLHe76", 
                        "AH-receptor", 
                        "ah receptor", 
                        "aromatic hydrocarbon receptor", 
                        "class E basic helix-loop-helix protein 76", 
                        "AHR_HUMAN", 
                        "aryl hydrocarbon receptor"
                    ], 
                    "belnodetype": "transcriptionalActivity"
                }, 
                "id": "tscript(complex(p(HGNC:ARNT),p(HGNC:AHR)))", 
                "label": "tscript(complex(p(HGNC:ARNT),p(HGNC:AHR)))"
            }, 
            {
                "metadata": {
                    "yloc": 1089.9140107157277, 
                    "viewx": 0.9040073859701286, 
                    "viewy": 0.6829996506453192, 
                    "xloc": 4010.0667724609375, 
                    "synonyms": [
                        "CPB6", 
                        "CYP2B", 
                        "CYP2B7", 
                        "CYP2B7P", 
                        "CYPIIB6", 
                        "EFVM", 
                        "IIB1", 
                        "P450", 
                        "1,4-cineole 2-exo-monooxygenase", 
                        "cytochrome P450 2B6", 
                        "cytochrome P450 IIB1", 
                        "cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6", 
                        "CP2B6_HUMAN", 
                        "cytochrome P450, family 2, subfamily B, polypeptide 6"
                    ], 
                    "belnodetype": "catalyticActivity"
                }, 
                "id": "cat(p(HGNC:CYP2B6))", 
                "label": "cat(p(HGNC:CYP2B6))"
            }
        ], 
        "edges": [
            {
                "source": "a(SCHEM:\"Benzo(a)pyrene\")", 
                "relation": "increases", 
                "target": "p(HGNC:NQO1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Benzo(apyrene\") increases the protein abundance of NQO1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Benzo(a)pyrene\") increases p(HGNC:NQO1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Benzo(a)pyrene\") increases p(HGNC:NQO1)", 
                                "eid": "524b352dd3fbfd4c34083a12"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Benzo(a)pyrene\")", 
                "relation": "directlyIncreases", 
                "target": "tscript(p(HGNC:AHR))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Benzo(apyrene\") directly increases the transcriptional activity of the protein abundance of AHR.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Benzo(a)pyrene\") directlyIncreases tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12566446", 
                                "Name": "J Biol Chem 2003 Apr 25 278(17) 15001-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "that in human hepatoma HepG2 cells the UGT1A1 gene is also inducible with aryl hydrocarbon receptor (Ah receptor) ligands such as 2,3,7,8-tetrachlodibenzo-p-dioxin (TCDD), beta-naphthoflavone, and benzo[a]pyrene metabolites.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Benzo(a)pyrene\") directlyIncreases tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083aad"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Benzo(a)pyrene\")", 
                "relation": "increases", 
                "target": "p(HGNC:SULT1A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Benzo(apyrene\") increases the protein abundance of SULT1A1.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "a(SCHEM:Benzo(a)pyrene) increases p(HGNC:SULT1A1)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "22782890", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "Based on expression levels, catalytic efficiency, and the fact that the lung cells only produce M1, it is concluded that the major isoform that can intercept benzo[a]pyrene-7,8-catechol is SULT1A1", 
                            "Cell": "", 
                            "Tissue": "lung", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:NFE2L2))", 
                "relation": "increases", 
                "target": "p(HGNC:ALDH3A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of NFE2L2 increases the protein abundance of ALDH3A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:ALDH3A1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:ALDH3A1)", 
                                "eid": "524b352dd3fbfd4c340839cd"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:NFE2L2))", 
                "relation": "increases", 
                "target": "p(HGNC:NQO1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of NFE2L2 increases the protein abundance of NQO1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:NQO1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:NQO1)", 
                                "eid": "524b352dd3fbfd4c340839dc"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:NFE2L2))", 
                "relation": "increases", 
                "target": "p(HGNC:ABCC1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of NFE2L2 increases the protein abundance of ABCC1.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:ABCC1)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "24672635", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "These studies suggest that the Nrf2 pathway maybe involved in the increases in MRP1 expression that were observed in the present study. More studies are necessary to evaluate the role of Nrf2 and putative AREs in the induction of MRP1 by AITC", 
                            "Cell": "", 
                            "Tissue": "bronchial epithelial cell", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "cat(p(HGNC:CYP1B1))", 
                "relation": "increases", 
                "target": "a(CHEBI:\"reactive oxygen species\")", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The catalytic activity of the protein abundance of CYP1B1 increases the abundance of \"reactive oxygen species\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "cat(p(HGNC:CYP1B1)) increases a(CHEBI:\"reactive oxygen species\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16877260", 
                                "Name": "Drug Metab Rev 2006 38(3) 411-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Generally, induction of CYP1A1, CYP1A2, and CYP1B1 is considered cardiotoxic through generating reactive oxygen species (ROS)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "cat(p(HGNC:CYP1B1)) increases a(CHEBI:\"reactive oxygen species\")", 
                                "eid": "524b352dd3fbfd4c34083b97"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:nicotine)", 
                "relation": "isA", 
                "target": "a(SCHEM:\"Smoke condensate, cigarette\")", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The abundance of nicotine is a abundance of \"Smoke condensate, cigarette\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:nicotine) isA a(SCHEM:\"Smoke condensate, cigarette\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20719243", 
                                "Name": "Regul Toxicol Pharmacol 2010 Dec 58(3) 428-36"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Discussion: The nicotine content of BRI CSC was 2  higher than the nicotine content of FF CSC (2.34 mg/mL and 0.98 mg/mL, respectively)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:nicotine) isA a(SCHEM:\"Smoke condensate, cigarette\")", 
                                "eid": "524b352dd3fbfd4c34083ad6"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Smoke condensate, cigarette\")", 
                "relation": "increases", 
                "target": "cat(p(HGNC:CYP1B1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Smoke condensate, cigarette\" increases the catalytic activity of the protein abundance of CYP1B1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Smoke condensate, cigarette\") increases cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "21376804", 
                                "Name": "Toxicol In Vitro 2011 Jun 25(4) 922-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP1A1/1B1 activity was recorded in NHTBE (D1 ? 0.36 \u00b1 0.15; D2 ? 0.27 \u00b1 0.08; D3 ? 1.65 \u00b1 0.24; RLU/mg protein/min) ", 
                            "Cell": "bronchial epithelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Smoke condensate, cigarette\") increases cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083b82"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Smoke condensate, cigarette\")", 
                "relation": "increases", 
                "target": "cat(p(HGNC:CYP1A1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Smoke condensate, cigarette\" increases the catalytic activity of the protein abundance of CYP1A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Smoke condensate, cigarette\") increases cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "21376804", 
                                "Name": "Toxicol In Vitro 2011 Jun 25(4) 922-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP1A1/1B1 activity was recorded in NHTBE (D1 ? 0.36 \u00b1 0.15; D2 ? 0.27 \u00b1 0.08; D3 ? 1.65 \u00b1 0.24; RLU/mg protein/min) ", 
                            "Cell": "bronchial epithelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Smoke condensate, cigarette\") increases cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083c28"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Smoke condensate, cigarette\")", 
                "relation": "increases", 
                "target": "tport(p(HGNC:ABCG2))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Smoke condensate, cigarette\" increases the transport activity of the protein abundance of ABCG2.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "a(SCHEM:Smoke condensate, cigarette) increases tport(p(HGNC:ABCG2))", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "23144836", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "CSC promotes chemoresistance via Akt-mediated regulation of ABCG2 activity", 
                            "Cell": "", 
                            "Tissue": "lung cancer and head and neck cancer cell lines", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:NR1I3)", 
                "relation": "actsIn", 
                "target": "tscript(p(HGNC:NR1I3))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of NR1I3 acts in transcriptional activity of the protein abundance of NR1I3.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10908304", 
                                "Name": "Mol Pharmacol 2000 Aug 58(2) 361-72"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In this report we show that submicromolar concentrations of dexamethasone enhance pregnane X receptor (PXR) activator-mediated CYP3A4 gene expression in cultured human hepatocytes.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083c1d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16855052", 
                                "Name": "Drug Metab Dispos 2006 Jul 19"
                            }, 
                            "Disease": "", 
                            "SummaryText": "All four CAR activators induced UGT2B1 in liver... UGT1A1, 1A5, 1A6, and 2B12 were induced by at least two CAR activators in liver", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083ba7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8114692", 
                                "Name": "Mol Cell Biol 1994 Mar 14(3) 1544-52"
                            }, 
                            "Disease": "", 
                            "SummaryText": "MB67 (CAR) binds and transactivates the retinoic acid response elements that control expression of the retinoic acid receptor beta 2 and alcohol dehydrogenase 3 genes, both of which consist of a direct repeat hexamers related to the consensus AGGTCA, separated by 5 bp. MB67 binds these elements as a heterodimer with the 9-cis-retinoic acid receptor, RXR", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083b77"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18648086", 
                                "Name": "Toxicol Sci 2008 Nov 106(1) 29-36"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Specifically, PFDA increased Cyp4A14 mRNA expression in wild-type (WT) mice, but much less in PPAR-alpha-null mice. PFDA increased Cyp2B10 mRNA expression in WT mice, but not in CAR-null mice.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c3408397f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15198932", 
                                "Name": "Am J Physiol Endocrinol Metab 2004 Oct 287(4) E731-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "the farnesoid X receptor (FXR), constitutive androstane receptor (CAR), and pregnane X receptor (PXR) were found to regulate DHEA sulfotransferase (Sult2A1), which plays an important role in DHEA sulfation and detoxification of bile acids. Because FXR, PXR, and CAR are suppressed during the APR, we hypothesized that Sult2A1 is downregulated during the APR.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083c53"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18159929", 
                                "Name": "Mol Pharm 5(1) 35-41"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Xenobiotic and drug metabolism and transport are managed by a large number of genes coordinately regulated by at least three nuclear receptors or xenosensors: aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR, NR1I3), and pregnane X receptor (PXR, NR1I2)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c340839ea"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14683479", 
                                "Name": "Curr Drug Metab 2003 Dec 4(6) 515-25"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The constitutive androstane receptor (CAR) appears to be one of the main regulators involved in transcriptional activation of CYP2B genes", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083a09"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14742670", 
                                "Name": "Mol Pharmacol 2004 Feb 65(2) 292-300"
                            }, 
                            "Disease": "", 
                            "SummaryText": "activation of CAR was also associated with an increased expression of the 3'-phosphoadenosine 5'-phosphosulfate synthetase 2 (PAPSS2), Analysis of gene knockout mice revealed that CAR is also indispensable for ligand-dependent activation of SULT and PAPSS2 in vivo.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c340839ad"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10908304", 
                                "Name": "Mol Pharmacol 2000 Aug 58(2) 361-72"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In this report we show that submicromolar concentrations of dexamethasone enhance pregnane X receptor (PXR) activator-mediated CYP3A4 gene expression in cultured human hepatocytes.", 
                            "Cell": "hepatocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083a1a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11729302", 
                                "Name": "Science 2001 Nov 30 294(5548) 1866-70"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nuclear Receptor: CAR Ligand: Xenobiotic, Phenobarbitol CYP Enzyme:  ^CYP2B, ^CYP2C Cytosolic binding protein: ? ABC transporter: ^ABCC3", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083c34"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8603043", 
                                "Name": "J Steroid Biochem Mol Biol 1996 Jan 56(1-6 Spec No) 23-30"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In mammalian cells, coexpression of MIP224 inhibits transactivation by MB67.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083c37"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18159929", 
                                "Name": "Mol Pharm 5(1) 35-41"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Xenobiotic and drug metabolism and transport are managed by a large number of genes coordinately regulated by at least three nuclear receptors or xenosensors: aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR, NR1I3), and pregnane X receptor (PXR, NR1I2)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083bf6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11093784", 
                                "Name": "Mol Pharmacol 2000 Dec 58(6) 1441-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The barbiturate phenobarbital induces the transcription of cytochromes P450 (CYPs) 2B through the constitutive androstane receptor (CAR; NR1I3). CAR is a member of the nuclear receptor family (NR1) mostly expressed in the liver, which heterodimerizes with retinoid X receptor (RXR) and was shown to transactivate both the phenobarbital responsive element module of the human CYP2B6 gene and the CYP3A4 xenobiotic response element.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083aab"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12181440", 
                                "Name": "Mol Pharmacol 2002 Sep 62(3) 638-46"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Our results demonstrate that PXR and CAR regulate overlapping but distinct sets of genes", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083bab"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11502872", 
                                "Name": "Mol Pharmacol 2001 Sep 60(3) 427-31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "PXR was shown to be capable of activating the phenobarbital-responsive enhancer module (PBREM) region of the CYP2B6 gene, a 51-base-pair enhancer element that mediates induction of CYP2B6 expression by CAR", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083baf"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19932133", 
                                "Name": "Prog Lipid Res 2010 Apr 49(2) 171-85"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Primary bile acids (chenodeoxycholic acid and cholic acid) are physiological ligands/activators of farnesoid-X-receptor (FXR), pregnane-X-receptor (PXR) and constitutive androstane receptor (CAR),", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083af2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15919853", 
                                "Name": "Drug Metab Dispos 2005 Sep 33(9) 1276-82"
                            }, 
                            "Disease": "", 
                            "SummaryText": "CAR activators [phenobarbital, 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, and diallyl sulfide] decreased Oatp1a1 mRNA expression.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083b40"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16837569", 
                                "Name": "Drug Metab Dispos 2006 Oct 34(10) 1756-63"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The present study was therefore designed to carefully analyze expression of major drug transporters in primary human hepatocytes exposed to dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) (an AhR activator), rifampicin (RIF) (a PXR activator), phenobarbital (PB) (a CAR activator), and oltipraz (OPZ) (a Nrf2 activator), using mainly reverse transcription-real time polymerase chain reaction assays. ", 
                            "Cell": "hepatocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c3408396d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12815172", 
                                "Name": "Mol Pharmacol 2003 Jul 64(1) 160-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP2B6, CYP2C9, and CYP3A4, is known to be regulated by the constitutive androstane receptor (CAR) and the pregnane X receptor (PXR)", 
                            "Cell": "hepatocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083b74"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12923173", 
                                "Name": "J Biol Chem 2003 Nov 14 278(46) 45062-71"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Hepatic expression of the constitutive androstane receptor (CAR) and its target genes was induced in FXR- and FPXR-null mice fed the CA diet. To test whether up-regulation of CAR represents a means of protection against bile acid toxicity to compensate for the loss of FXR and PXR, animals were pretreated with CAR activators, phenobarbital or 1,4-bis[2-(3,5-dichlorpyridyloxy)]benzene (TCPOBOP), followed by the CA diet. A role for CAR in protection against bile acid toxicity was confirmed by a marked reduction of serum bile acid and bilirubin concentrations, with an elevation of the expression of the hepatic genes involved in bile acid and/or bilirubin metabolism and excretion (CYP2B, CYP3A, MRP2, MRP3, UGT1A, and glutathione S-transferase alpha), following pretreatment with phenobarbital or TCPOBOP. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083c43"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12881517", 
                                "Name": "J Biol Chem 2003 Oct 10 278(41) 39392-401"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We have identified a drug-responsive enhancer in the murine ALAS1 gene. This sequence mediates transcriptional activation by a wide range of compounds including typical cytochrome P450 pan-inducers phenobarbital and metyrapone, as well as specific activators of the pregnane X receptor and the constitutive androstane receptor.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083ae9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18159929", 
                                "Name": "Mol Pharm 5(1) 35-41"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Xenobiotic and drug metabolism and transport are managed by a large number of genes coordinately regulated by at least three nuclear receptors or xenosensors: aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR, NR1I3), and pregnane X receptor (PXR, NR1I2)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083a17"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11752103", 
                                "Name": "J Pharmacol Exp Ther 2002 Jan 300(1) 97-104"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Mrp3 expression was significantly increased by each of the CAR activators and an EpRE activator in liver.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c340839c4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16243957", 
                                "Name": "Drug Metab Dispos 2006 Jan 34(1) 138-44"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Cotransfection with PXR (A) or CAR (B) resulted in a decrease in PXR gene expression.", 
                            "Cell": "hepatocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083a4c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12869636", 
                                "Name": "Mol Pharmacol 2003 Aug 64(2) 316-24"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Analysis of the CYP2C19 promoter revealed a single constitutive androstane receptor (CAR) binding site (CAR-RE; -1891/-1876 bp) and a glucocorticoid-responsive element (GRE; -1750/-1736 bp). Gel-shift assays showed that CAR-RE binds CAR and pregnane X receptor (PXR). Cotransfection with hCAR, mCAR, or hPXR in HepG2 cells up-regulated transcription of CYP2C19 promoter constructs, whereas mutation of the -1891-bp CAR-RE abolished up-regulation. Expression with hCAR also up-regulated endogenous CYP2C19 mRNA content in HepG2 cells. Androstenol repressed the mCAR-mediated constitutive activation of the CYP2C19 promoter in HepG2 cells", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083c1e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12646173", 
                                "Name": "Biochem Biophys Res Commun 2003 Mar 28 303(1) 105-11"
                            }, 
                            "Disease": "", 
                            "SummaryText": "It is intriguing to note two recent reports related to the regulation of CYP2B family genes, in which transcriptional coactivator SRC-1 was reported to enhance the AhR transcriptional activity [27] and also to potentiate the CAR activity for the transcription of the rat CYP2B1 gene", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083a4a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16275121", 
                                "Name": "Trends Endocrinol Metab 2005 Dec 16(10) 478-88"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Small heterodimer partner (SHP; NR0B2), an exceptional member of the mammalian nuclear receptor family, directly modulates the activities of conventional nuclear receptors by acting as an inducible and tissue-specific corepressor. Recent progress in dissecting underlying molecular mechanisms, identifying target factors and target genes, and uncovering physiological functions points to the regulatory involvement of SHP in diverse metabolic and intracellular pathways that awaits future clarification. In this review, we carry out a comprehensive survey of all published data and discuss our current understanding of molecular mechanisms and physiological consequences governing SHP action.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083b00"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11706036", 
                                "Name": "J Biol Chem 2002 Jan 25 277(4) 2908-15"
                            }, 
                            "Disease": "", 
                            "SummaryText": "induction of Mrp2 by phenobarbital, an activator of Car, was comparable in wild-type and Pxr null mice", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083b03"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19542321", 
                                "Name": "Mol Pharmacol 2009 Sep 76(3) 604-11"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Similarly, the activation of Akr1b7 gene expression by the CAR agonist 1,4-bis[2-(3,5-dichlorpyridyloxyl)]-benzene, seen in wild-type mice, was abolished in CAR(-/-) mice. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083b9c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12181440", 
                                "Name": "Mol Pharmacol 2002 Sep 62(3) 638-46"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c34083b25"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15610733", 
                                "Name": "Mol Cell 2004 Dec 22 16(6) 893-905"
                            }, 
                            "Disease": "", 
                            "SummaryText": "many of the xenobiotics that activate CAR ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NR1I3) actsIn tscript(p(HGNC:NR1I3))", 
                                "eid": "524b352dd3fbfd4c340839a7"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:NR3C1))", 
                "relation": "increases", 
                "target": "p(HGNC:CYP3A5)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of NR3C1 increases the protein abundance of CYP3A5.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:NR3C1)) increases p(HGNC:CYP3A5)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:NR3C1)) increases p(HGNC:CYP3A5)", 
                                "eid": "524b352dd3fbfd4c34083ad4"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:CYP1B1)", 
                "relation": "actsIn", 
                "target": "cat(p(HGNC:CYP1B1))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of CYP1B1 acts in catalytic activity of the protein abundance of CYP1B1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15666840", 
                                "Name": "Endocr Res 2004 Nov 30(4) 881-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In 1986 we postulated that this disorder might be due to mutations in P450 oxidoreductase (POR), the flavoprotein that donates electron to these and all other microsomal P450 enzymes,", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083a8e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16092727", 
                                "Name": "Exp Toxicol Pathol 2005 Jul 57 Suppl 1 189-204"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Consistent with these findings, we found increases in EROD activity similar to what has been previously reported (Foster et al., 1998; Hukkanen et al., 2000).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083979"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15667830", 
                                "Name": "Toxicol Appl Pharmacol 2005 Feb 1 202(3) 244-57"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We have shown that BP and DMBA can comparably induce CYP1B1 in the bone marrow and lung of AhRb mice while this form is not detected in the liver. #BP and DMBA are Polycyclic Aromatic Hydrocarbons #", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083a08"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "21376804", 
                                "Name": "Toxicol In Vitro 2011 Jun 25(4) 922-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "TCDD-induced CYP1A1/1B1 activity was observed for NCI-H292 (2.74 \u00b1 0.60 RLU/mg protein/min) and NHTBE cultures in the presence of retinoic acid (D1 \u2013 4.30 \u00b1 1.43; D2 \u2013 4.30 \u00b1 0.65; D3 \u2013 7.35 \u00b1 2.29; RLU/mg protein/min). This activity was inhibited by a-naphthoflavone, a CYP1A1/1B1 inhibitor. the presence of retinoic acid following treatment with TCDD (Fig. 3A and B).", 
                            "Cell": "bronchial epithelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083a70"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8790407", 
                                "Name": "Proc Natl Acad Sci U S A 1996 Sep 3 93(18) 9776-81"
                            }, 
                            "Disease": "", 
                            "SummaryText": "17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083ba9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18073400", 
                                "Name": "Proc Am Thorac Soc 2007 Dec 4(8) 671-4"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The two main CYP enzymes that are up-regulated by cigarette smoke are CYP1A1 and CYP1B1, which are regulated by ER{alpha} (18). Stimulation of estrogen receptor in the lungs increases protein expression of CYP1A1 by twofold (17). The increased CYP expression is also related to increased estradiol-? expression (19). CYPs are also involved in the bioactivation of 17?-estradiol, resulting in a positive feedback loop", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083a25"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17200336", 
                                "Name": "Clin Cancer Res 2007 Jan 1 13(1) 38-45"
                            }, 
                            "Disease": "lung adenocarcinoma", 
                            "SummaryText": "Benzo(a)pyrene consistently induced the highest level of aryl hydrocarbon hydroxylase activity in H1355 cells (Fig. 2B).....The aryl hydrocarbon hydroxylase activity assay was used to measure CYP1A1 and CYP1B1 enzyme activity (24)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083ad7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11740343", 
                                "Name": "Pharmacogenetics 2001 Dec 11(9) 793-801"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Testosterone was a poor substrate and activity with progesterone was 6-fold higher, but estradiol was the preferred substrate, exhibiting a greater metabolite profile with CYP1B1 than with CYP1A2.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c340839e1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20435083", 
                                "Name": "Toxicology 2010 Jun 29 273(1-3) 35-44"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Catalytic activities of CYP1A1, CYP1A2 and CYP1B1, and inducibility of the activities were studied in intact human lung samples (from 23 human subjects) ex vivo. The activities [as measured by ethoxyresorufin O-deethylase (EROD), methoxyresorufin O-demethylase (MROD), and 3-cyano-7-ethoxycoumarin O-deethylase (CECOD)] were present in the lungs and were induced by benzo[a]pyrene (B[a]P) and diesel exhaust particle extract (DEE) but with extensive inter-subject variability. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083a7a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "22187486", 
                                "Name": "Drug Metab Dispos 2012 Mar 40(3) 579-87"
                            }, 
                            "Disease": "lung adenocarcinoma", 
                            "SummaryText": "Exposure of A549, HepG2 hepatic carcinoma cells, and MCF-7 breast carcinoma cells to tetrachlorodibenzo-p-dioxin induced the expression and enzymatic activity of CYP1A1 and CYP1B1,", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083ab1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12010864", 
                                "Name": "Cancer Epidemiol Biomarkers Prev 2002 May 11(5) 489-92"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Cytochrome P450 1B1 catalyzes the conversion of 17-beta-estradiol (E2) to thecatechol estrogen metabolites 2-OH-E2 and 4-OH-E2 that have been postulated to be involved in mammary carcinogenesis.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083bdb"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16877260", 
                                "Name": "Drug Metab Rev 2006 38(3) 411-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Generally, induction of CYP1A1, CYP1A2, and CYP1B1 is considered cardiotoxic through generating reactive oxygen species (ROS)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1B1) actsIn cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083a0b"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "cat(p(HGNC:GSTP1))", 
                "relation": "decreases", 
                "target": "a(SCHEM:\"4-Hydroxy-2-nonenal\")", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The catalytic activity of the protein abundance of GSTP1 decreases the abundance of \"4-Hydroxy-2-nonenal\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "cat(p(HGNC:GSTP1)) decreases a(SCHEM:\"4-Hydroxy-2-nonenal\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12094619", 
                                "Name": "Nutr Cancer 2001 41(1-2) 156-64"
                            }, 
                            "Disease": "colorectal adenoma", 
                            "SummaryText": "We determined the expression of GSTP1 protein (enzyme-linked immunosorbent assay), the major GST in HT29, GSTP1 mRNA (Northern blotting), GST activity, intracellular glutathione, and total protein. Our results show that GSTP1 mRNA, GSTP1 protein, GST activity, and total protein were increased (1.2- to 2.5-fold) and glutathione levels were maintained after 24-72 h of incubation with 4 mM butyrate. Moreover, a marked reduction of HNE-induced genotoxicity was caused by preincubation with butyrate.  In conclusion, butyrate enhances expression of GST and other proteins in both cell lines, which leads to an enhanced chemoprotection, reducing the impact of HNE genotoxicity. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "cat(p(HGNC:GSTP1)) decreases a(SCHEM:\"4-Hydroxy-2-nonenal\")", 
                                "eid": "524b352dd3fbfd4c34083c35"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:ESR1)", 
                "relation": "actsIn", 
                "target": "tscript(p(HGNC:ESR1))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of ESR1 acts in transcriptional activity of the protein abundance of ESR1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15073177", 
                                "Name": "J Biol Chem 2004 Jun 25 279(26) 27781-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "TIP30 overexpression represses ERalpha-mediated c-myc transcription, whereas TIP30 deficiency enhances c-myc transcription in both the absence and presence of estrogen.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a89"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16538531", 
                                "Name": "Breast Cancer Res Treat 2006 Jul 98(2) 191-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Furthermore, we observed that the expression of the truncated BAF57 increased the ability of SRC1e to potentiate transcriptional activation by ERalpha, suggesting that mutations in BAF57 could contribute to the oncogenic transformation in breast cancer cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b4b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11016617", 
                                "Name": "Cancer Res 2000 Sep 15 60(18) 4993-5001"
                            }, 
                            "Disease": "", 
                            "SummaryText": "conducted using human breast cancer cells, BRCA1 protein inhibited ER-a-mediated transcriptional pathways related to cell proliferation. This finding suggests that in addition to maintaining genomic stability during periods of rapid cellular division and multiplication, BRCA1 may also suppress signaling initiated by estrogen-induced activation of ER-a... A loss of BRCA1 function leads to increased proliferation of malignant cells in cell culture (56, 57), and stable transfection of wild-type BRCA1 into these cells inhibits their growth (58). However, activation of BRCA1 seen during puberty and pregnancy does not seem to block proliferation occurring in the breast at these times.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083968"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12372768", 
                                "Name": "Am J Physiol Renal Physiol 2002 Nov 283(5) F934-43"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083969"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12421816", 
                                "Name": "J Biol Chem 2003 Jan 10 278(2) 962-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083afb"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14684617", 
                                "Name": "Endocrinology 2004 Apr 145(4) 1739-49"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c29"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15318926", 
                                "Name": "Breast Cancer Res 2004 6(5) 204-10"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "In preclinical models, co-blockade of the EGFR and ER pathways with gefitinib and either tamoxifen or fulvestrant resulted in restoration of tamoxifen sensitivity and delay of resistance to estrogen deprivation in HER2-overexpressing breast tumors", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bb7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12072388", 
                                "Name": "Endocrinology 2002 Jul 143(7) 2559-70"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Estrogen receptor alpha (ERalpha) was required for this inhibitory activity, because EE inhibition of IL-1beta-stimulated gene expression occurred in ERbeta knockout mice, but not in ERalpha knockout mice", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083965"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10779508", 
                                "Name": "J Biol Chem 2000 Jul 7 275(27) 20837-46"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bc6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12711000", 
                                "Name": "J Steroid Biochem Mol Biol 2003 Feb 84(2-3) 167-70"
                            }, 
                            "Disease": "", 
                            "SummaryText": "caveolin-1 promotes ligand-independent activation of ER", 
                            "Cell": "neuron", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083967"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12612073", 
                                "Name": "Mol Cell Biol 2003 Mar 23(6) 1994-2008"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In breast cancer cells, estrogens activate the Src/Erk pathway through an interaction of the estrogen receptor alpha (ERalpha) with the SH2 domain of c-Src.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083960"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10830317", 
                                "Name": "Endocrinology 2000 Jun 141(6) 2266-74"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bc2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16239258", 
                                "Name": "Mol Endocrinol 2006 Mar 20(3) 631-46"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The growth of both normal and transformed epithelial cells of the female reproductive system is stimulated by estrogens, mainly through the activation of estrogen receptor alpha (ERalpha), which is a ligand-regulated transcription factor.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083963"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15625066", 
                                "Name": "J Biol Chem 2005 Mar 11 280(10) 8819-30"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083aa1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14991571", 
                                "Name": "Int J Cancer 2004 Apr 20 109(4) 507-15"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083aa3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9223281", 
                                "Name": "Proc Natl Acad Sci U S A 1997 Jul 22 94(15) 7879-84"
                            }, 
                            "Disease": "", 
                            "SummaryText": "coactivators, such as ncoa1 and creb are required for efficient steroid receptor transactivation", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083aa2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11073973", 
                                "Name": "Mol Cell Biol 2000 Dec 20(23) 8720-30"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Incubation of COS-1 cells with 8-bromo-cAMP resulted in activation of the MAPK pathway, as determined by Western blotting with antibodies to the phosphorylated (active) form of Erk-1/2, suggesting an indirect pathway to SRC-1 phosphorylation. Elevation of intracellular cyclic AMP (cAMP), a common second messenger for a number of hormones and a direct activator of protein kinase A (PKA), can induce a ligand-independent activation of chicken PR (cPR) (22), AR (44), and the ER (8), as well as enhance steroid-dependent activation of a broader range of receptors, including PR (13, 35), ER (8), GR (45), AR (19, 30), and the mineralocorticoid receptor (41).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bcf"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14996734", 
                                "Name": "Cancer Res 2004 Mar 1 64(5) 1737-43"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In estrogen receptor-positive cells, PCDGF/GP88 was expressed in response to estradiol and shown to mediate its mitogenic effect.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b58"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10537124", 
                                "Name": "Endocrinology 1999 Nov 140(11) 4995-5003"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083aa9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12881205", 
                                "Name": "Am J Physiol Heart Circ Physiol 2003 Nov 285(5) H2150-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bbf"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15774498", 
                                "Name": "Mol Endocrinol 2005 Aug 19(8) 2006-19"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Using chromatin isolated from homogenates of whole uteri fixed immediately after removal from rats at intervals after treatment with E2, we performed ChIP assays using antibodies to rat ER-A or Sp1 and PCR primers encompassing this region of the rat CKB promoter (-678 to -319). ChIP showed that the association of both Sp1 and ER-A with this region increases within 1 h after E2 treatment (Fig. 3).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839af"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12093804", 
                                "Name": "J Biol Chem 2002 Sep 13 277(37) 33571-9"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "TR2 orphan receptor (TR2), a member of the nuclear receptor superfamily without identified ligands, is found to be expressed in the breast cancer cell lines and to function as a repressor to suppress ER-mediated transcriptional activity. Utilizing an interaction blocker, ER-6 (amino acids 312-340), responsible for TR2 interaction, the suppression of ER by TR2 could be reversed, suggesting that this suppression is conferred by the direct protein-protein interaction.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c3408397c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11563984", 
                                "Name": "Biochem J 2001 Oct 1 359(Pt 1) 203-10"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c3408397b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11435445", 
                                "Name": "J Biol Chem 2001 Sep 7 276(36) 33554-60"
                            }, 
                            "Disease": "", 
                            "SummaryText": "FKHR augmented ER alpha transactivation through an estrogen response element. Conversely, ER alpha repressed FKHR-mediated transactivation through an insulin response sequence, and cell cycle arrest induced by FKHRL1 in MCF7 cells was abrogated by estradiol. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839b0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17033697", 
                                "Name": "Biol Proced Online 2006 8 69-76"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Recent gene-array studies, utilizing ERalpha knock-out vs. wild-type mice, have revealed that estrogen regulates numerous uterine genes temporally and most importantly via ERalpha during the phase-II response, including three well characterized genes viz., lactoferrin (Ltf), progesterone receptor (Pgr) and cyclinD1 (Ccnd1). Here, utilizing systematic ChIP studies, we demonstrate endogenous recruitment of ERalpha to above uterine gene promoters following estradiol-17beta (E(2)) injection in mice.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839b1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11850827", 
                                "Name": "Oncogene 2002 Feb 7 21(7) 1097-107"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839b2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15677324", 
                                "Name": "Proc Natl Acad Sci U S A 2005 Feb 1 102(5) 1339-44"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Here, we report the use of chromatin immunoprecipitation (ChIP)-based assays that involve genomic mapping and computational analyses of immunoprecipitated DNA to identify SRC-3-binding target genes in estradiol (E2)-treated MCF-7 breast cancer cells. We identified 18 SRC-3 genomic binding sites and demonstrated estrogen receptor-alpha (ERalpha) binding to all of them.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b0e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19914929", 
                                "Name": "Cardiovasc Res 2010 Mar 1 85(4) 796-805"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Only the ERalpha agonist PPT but not the ERbeta agonist DPN increased eNOS phosphorylation (Figure 4B), suggesting that although both ERs can increase eNOS protein; eNOS phosphorylation/activation is still mediated only through ERalpha.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839b6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8137248", 
                                "Name": "Cancer Res 1994 Mar 15 54(6) 1458-64"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Analysis of the inhibitory mechanisms indicates that RA and Vit D3 receptors can directly or indirectly impair the binding of ER to the estrogen responsive element.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839b7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18451179", 
                                "Name": "Cancer Res 2008 May 1 68(9) 3505-15"
                            }, 
                            "Disease": "carcinoma of breast", 
                            "SummaryText": "Here, we show that CA12 is robustly regulated by estrogen via ER alpha in breast cancer cells, and that this regulation involves a distal estrogen-responsive enhancer region. Upon the addition of estradiol, ER alpha binds directly to this distal enhancer in vivo, resulting in the recruitment of RNA polymerase II and steroid receptor coactivators SRC-2 and SRC-3, and changes in histone acetylation. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a5f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11159847", 
                                "Name": "Endocrinology 2001 Feb 142(2) 751-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c0b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16461929", 
                                "Name": "J Mol Endocrinol 2006 Feb 36(1) 81-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Chromatin immunoprecipitation assays indicated that the estrogen receptor binds directly to the ADM promoter region and RAMP3 intron after estrogen administration.", 
                            "Cell": "", 
                            "Tissue": "uterine stroma", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839ca"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11507039", 
                                "Name": "Cancer Res 2001 Aug 15 61(16) 5985-91"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b6d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11771854", 
                                "Name": "Methods Find Exp Clin Pharmacol 2001 Sep 23(7) 395-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "These findings suggest that BPA reduced hepatic MT synthesis after Cd injection via the estrogen receptor which resulted in increased damage to the liver.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a42"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17369819", 
                                "Name": "Nat Cell Biol 2007 Apr 9(4) 470-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "ICI (ERalpha inhibitor fulvestrant) activates NF-kappaB and AP-1 activities in MCF-7 cells and ER alpha reduces NF-kappaB, AP-1 activities as well as Fra2 (Fosl2), c-jun, RelB {protein} levels in MDA-MB-231 breast cancer cells", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a7c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15351732", 
                                "Name": "Biochem Biophys Res Commun 2004 Oct 8 323(1) 269-74"
                            }, 
                            "Disease": "", 
                            "SummaryText": "These data identify a novel function of XBP-1 and suggest that regulation of large-scale chromatin unfolding by XBP-1 may be responsible for the enhancement of ERalpha transcriptional activity.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a40"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14970864", 
                                "Name": "Br J Cancer 2004 Feb 23 90(4) 853-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Using these cells as well as ERalpha-positive MCF-7 and ZR-75-1 cells, we show that tumour necrosis factor alpha (TNFalpha) and the phosphatidylinositol-3-kinase (PI3-kinase) modulate transrepression function of ERalpha by reducing its stability.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a41"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11103799", 
                                "Name": "Cancer Res 2000 Nov 15 60(22) 6367-75"
                            }, 
                            "Disease": "", 
                            "SummaryText": "a set of 14 estrogen-responsive genes that was differentially expressed in MCF7 cells stimulated by beta-estradiol as compared with unstimulated cells. Tamoxifen repressed the expression of all 14 estrogen-responsive genes. Thirteen of the genes were induced within 6 h of estrogen treatment, indicating that these were early response genes in the ER-regulated pathway. PDZK1 and a new gene, GREB1, demonstrated a significant correlation with ER phenotype in a panel of breast cancer cell lines. %When grown in the presence and absence of beta-estradiol, the changes in the levels of gene expression ranged between approximately 4-fold induction to turning on a previously undetectable gene (on/off).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a47"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11893774", 
                                "Name": "J Lipid Res 2002 Mar 43(3) 383-91"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a45"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11818503", 
                                "Name": "Mol Endocrinol 2002 Feb 16(2) 315-30"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Uba3 directly interacts with ligand-occupied ERalpha and ERbeta Transient transfection of Uba3 in mammalian cells inhibited ER-mediated transactivation in a time-dependent fashion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c3e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12390831", 
                                "Name": "Di Yi Jun Yi Da Xue Xue Bao 2002 Jan 22(1) 13-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The expressions of bFGF and TGFbeta2 mRNA along with smoothelin mRNA were observed with reverse transcriptase-polymerase chain reaction. RESULTS: DHT significantly upregulated bFGF expression, and E2 enhanced TGFbeta2 and smoothelin expressions.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083aac"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16258506", 
                                "Name": "Mod Pathol 2006 Jan 19(1) 9-16"
                            }, 
                            "Disease": "", 
                            "SummaryText": "On the other hand, the presence of nuclear FOXP1 expression was significantly linked with ER-alpha reactivity.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083978"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9751496", 
                                "Name": "Endocrinology 1998 Oct 139(10) 4164-74"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083977"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11544182", 
                                "Name": "Genes Dev 2001 Sep 1 15(17) 2250-62"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c39"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9468485", 
                                "Name": "J Biol Chem 1998 Feb 20 273(8) 4360-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083975"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12771185", 
                                "Name": "J Cell Sci 2003 Jul 15 116(Pt 14) 2929-36"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083974"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15171706", 
                                "Name": "J Mol Endocrinol 2004 Jun 32(3) 649-61"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Northern blot analysis of estradiol-treated MCF-7 cells showed rapid and robust induction of Egr3, and addition of cycloheximide or ICI 182,780 suggested that Egr3 is the bona fide target for the estrogen receptor alpha (ERalpha)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bb3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10218948", 
                                "Name": "Endocrinology 1999 May 140(5) 2004-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083af5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10755407", 
                                "Name": "Br J Cancer 2000 Apr 82(7) 1312-6"
                            }, 
                            "Disease": "carcinoma of breast", 
                            "SummaryText": "Direct activation of oestrogen receptor-alpha by interleukin-6 in primary cultures of breast cancer epithelial cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083af6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15072547", 
                                "Name": "J Mol Endocrinol 2004 Apr 32(2) 397-414"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083af7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12538633", 
                                "Name": "Endocrinology 2003 Feb 144(2) 701-10"
                            }, 
                            "Disease": "", 
                            "SummaryText": "# Ariadne: Additionally, E2 induced expression of the transcription factors E74-like factor 3 (ELF3), STAT5A, and STAT5B. [Expression]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083be1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11507038", 
                                "Name": "Cancer Res 2001 Aug 15 61(16) 5979-84"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "Table 1 Top 50 genes extracted from ANNs  +, higher expression in ER+; -, higher expression in ER-", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083af3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11844790", 
                                "Name": "J Biol Chem 2002 Apr 26 277(17) 14622-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c3408396f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14603248", 
                                "Name": "Oncogene 2003 Nov 6 22(50) 8072-84"
                            }, 
                            "Disease": "osteosarcoma", 
                            "SummaryText": "In this study, we found that the transcriptional activity of human Erg (one of the Ets family-transcription factors) was repressed by several nuclear receptors, including human estrogen receptor ERalpha, nonsteroid receptors and orphan receptors. Conversely, Erg inhibited ERalpha-dependent transcription. These reciprocal functional interactions extended to other nuclear receptors such as thyroid hormone and retinoic acid receptors, as well as to Fli1, an ERG-related ETS factor. We confirmed mutual interference between FLI1 and either RARalpha or TRalpha1 into ROS cells and also observed such interactions between FLI1 and ERalpha, TRbeta1 and RXRalpha (data not shown). In these experiments, FLI1 was as effective as ERG in inhibiting hormone-dependent nuclear receptor-mediated transcription.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083af8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9492071", 
                                "Name": "Endocrinology 1998 Mar 139(3) 1346-53"
                            }, 
                            "Disease": "", 
                            "SummaryText": "rapid, but transient, induction of TIEG steady-state messenger RNA (mRNA) levels by 17beta-estradiol (E2) in estrogen receptor (ER)-positive, human fetal osteoblastic (hFOB/ER) cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bcb"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9291476", 
                                "Name": "Mol Reprod Dev 1997 Oct 48(2) 261-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Treatment with 17b-estradiol raised galectin-1 mRNA level as early as 6 hr and the high level of galectin-1 mRNA remained up to 24 hr (Fig. 2A).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c3408396c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16606610", 
                                "Name": "J Biol Chem 2006 Jun 16 281(24) 16625-31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Upon EE2 treatment, estrogen receptor alpha (ERalpha) repressed the expression of bile acid and cholesterol transporters (bile salt export pump (BSEP), Na(+)/taurocholate cotransporting polypeptide (NTCP), OATP1, OATP2, ABCG5, and ABCG8) in the liver.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839c1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8641283", 
                                "Name": "EMBO J 1996 May 1 15(9) 2174-83"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We show that the N-terminal transcriptional activation function AF-1, but not the C-terminal AF-2, is necessary for the EGF response. Both the EGF-induced hyperphosphorylation and the transcriptional activation of the unliganded ER depend on a phosphorylatable serine residue at position 118. However, its phosphorylation is not sufficient and, hence, there must be other target domains or proteins which fulfill an additional requirement for EGF signaling through the ER. Using dominant-negative Ras and MAP kinase kinase (MAPK kinase) and constitutively active MAPK kinase mutants, we show that EGF activates the ER by signaling through the MAPK pathway suggesting that MAPK directly phosphorylates the critical serine 118. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839c0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12039952", 
                                "Name": "J Biol Chem 2002 Aug 9 277(32) 28624-30"
                            }, 
                            "Disease": "", 
                            "SummaryText": "PRMT2 interacted directly with three ERalpha regions including AF-1, DNA binding domain, and hormone binding domain in a ligand-independent fashion.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c4e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14645498", 
                                "Name": "Mol Endocrinol 2004 Feb 18(2) 291-302"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b65"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12959998", 
                                "Name": "Endocrinology 2003 Nov 144(11) 4923-30"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Both 17 beta-estradiol and progesterone decreased alpha 2A-AR expression and alpha 2A/beta 3-AR protein ratio, but progesterone had higher potency than 17 beta-estradiol, increasing beta-AR levels, mainly beta 3-AR expression, and enhancing lipolysis stimulated by NE.", 
                            "Cell": "brown adipocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b69"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11335712", 
                                "Name": "J Biol Chem 2001 Jul 27 276(30) 27873-80"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839c8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11517191", 
                                "Name": "Endocrinology 2001 Sep 142(9) 4120-30"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a4f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14764652", 
                                "Name": "Mol Endocrinol 2004 May 18(5) 1131-43"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Estrogen-induced transcriptional activities of both ERalpha and ERbeta and mRNA expression of estrogen-responsive genes, including pS2, c-myc, and cyclin D1, were suppressed by PP5 but enhanced by PP5 antisense oligonucleotide.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a4e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10373563", 
                                "Name": "Mol Cell Biol 1999 Jul 19(7) 5143-54"
                            }, 
                            "Disease": "Prostatic Neoplasms", 
                            "SummaryText": "Mitogen-activated protein (MAP) kinases phosphorylate the estrogen receptor and activate transcription from estrogen receptor-regulated genes.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839ba"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12421825", 
                                "Name": "J Biol Chem 2003 Jan 24 278(4) 2701-12"
                            }, 
                            "Disease": "", 
                            "SummaryText": "E2-stimulated ERK required ER in breast cancer and endothelial cells and was substantially prevented by expression of a dominant negative EGFR or by tyrphostin AG1478, a specific inhibitor for EGFR tyrosine kinase activity. Transactivation/phosphorylation of EGFR by E2 was dependent on the rapid liberation of heparin-binding EGF (HB-EGF) from cultured MCF-7 cells and was blocked by antibodies to this ligand for EGFR. Expression of dominant negative mini-genes for Galpha(q) and Galpha(i) blocked E2-induced, EGFR-dependent ERK activation, and Gbetagamma also contributed. G protein activation led to activation of matrix metalloproteinases (MMP)-2 and -9. This resulted from Src-induced MMP activation, implicated using PP2 (Src family kinase inhibitor) or the expression of a dominant negative Src protein.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b7b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15087130", 
                                "Name": "Gene 2004 Apr 14 330 115-22"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a6e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12642867", 
                                "Name": "Oncogene 2003 Mar 20 22(11) 1638-52"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Cotransfection experiments revealed that Stat5aDelta740 completely blocked transcriptional activity of endogenous estrogen receptor in T47D and MCF7 cells, and of both ER alpha and ER beta in COS-7 cells. Stat5aDelta740 was selected for adenoviral delivery, and high-efficiency expression of tyrosine phosphorylated Stat5aDelta740 was achieved in infected cells. Adenoviral-mediated Stat5aDelta740 induced apoptosis in T47D cells but not in caspase-3-negative MCF7 cells. The present study indicates that overexpression of a dominant-negative variant of Stat5 suppresses ER transcriptional activity and induces apoptosis in estrogen-responsive breast cancer tissue culture cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839be"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15028626", 
                                "Name": "Biol Reprod 2004 Jul 71(1) 273-81"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Studies in ERalpha and ERbeta knockout mice confirmed these different pathways, demonstrating that in the endometrium, estrogen-mediated Cx26 [and Cx43] gene induction, but not induction during decidualization, is dependent on functional ERalpha", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839bf"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12782587", 
                                "Name": "Cancer Res 2003 Jun 1 63(11) 2820-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b3e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15821115", 
                                "Name": "J Mol Endocrinol 2005 Apr 34(2) 535-51"
                            }, 
                            "Disease": "", 
                            "SummaryText": "repressed", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c05"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9171238", 
                                "Name": "Mol Endocrinol 1997 Jun 11(6) 747-54"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a57"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15199112", 
                                "Name": "J Natl Cancer Inst 2004 Jun 16 96(12) 926-35"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Molecular cross-talk between the ER and HER2 pathways was increased in the MCF-7/HER-2 cells compared with MCF-7 cells, with cross-phosphorylation and activation of both the ER and the EGFR/HER2 receptors, the signaling molecules AKT and ERK 1,2 mitogen-activated protein kinase (MAPK), and AIB1 itself with both estrogen and tamoxifen treatment. Tamoxifen recruited coactivator complexes (ER, AIB1, CBP, p300) to the ER-regulated pS2 gene promoter in MCF-7/HER2-18 cells and corepressor complexes (NCoR, histone deacetylase 3) in MCF-7 cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083be2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15530441", 
                                "Name": "Biochem Biophys Res Commun 2004 Dec 10 325(2) 639-48"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We have previously identified in uterine cells a novel estrogen-regulated gene called gec1. GEC1 presents 87% identity with GABARAP which, so far, was the only protein found to associate with tubulin and GABA(A) receptor and promotes tubulin assembly and microtubule bundling", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a51"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12237295", 
                                "Name": "J Biol Chem 2002 Nov 22 277(47) 44772-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a50"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12714702", 
                                "Name": "Mol Endocrinol 2003 Jul 17(7) 1296-314"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In this study, we show that a p160 coactivator contributes to the ligand- independent ER activation of a target gene in a cellular model in which ER, coactivator, and target gene are endogenous. Using transfected cells, we further show that the full-length ER can interact physically and functionally with all three p160/SRCs and CBP in the absence of ligand in vivo and that mutation of Ser104/106/118 to Ala residues in ER affects these interactions. In addition, mutation of these residues affects ER coactivation by a subset of coactivators in the presence of E2, albeit to a lesser extent than in the absence of hormone. Further analysis reveals that mutations of both Ser104/106 and Ser118 decrease ligand-independent SRC-1 coactivation of ER activity by two mechanisms. First, there is a seemingly indirect effect on SRC-1 recruitment that, surprisingly, requires other receptor domains in addition to A/B, which is consistent with our finding that SRC-1 enhancement of the ligand- independent interaction between the A/B and DEF regions is regulated by the Ser104/106/118 phosphorylation sites. Secondly, we observe an effect on SRC-1 coactivation of the A/B domain that does not depend on the remainder of the molecule. further show that the full-length ER can interact physically and functionally with all three p160/SRCs and CBP in the absence of ligand in vivo", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c03"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11165043", 
                                "Name": "Mol Cell Endocrinol 2001 Feb 14 172(1-2) 91-103"
                            }, 
                            "Disease": "", 
                            "SummaryText": "A second functional downstream inhibitory DRE (iDRE2) (-130 to -126) has now been identified in the cathepsin D gene promoter and inhibition of E2-induced transactivation involves inhibitory AhR crosstalk with the E2-responsive adenovirus major late promoter element (MLPE) at -124 to -104 in the cathepsin D gene promoter. The MLPE site primarily binds USF1/USF2 and ERalpha, and gel mobility shift and DNA footprinting assays show that the AhR complex decreases binding of these transcription factors to the MLPE.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ba0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15320717", 
                                "Name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24"
                            }, 
                            "Disease": "", 
                            "SummaryText": "SMRT TRAC2 Represses unliganded TR, RAR, ER and PR", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ba1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12810572", 
                                "Name": "Endocrinology 2003 Jul 144(7) 3159-66"
                            }, 
                            "Disease": "", 
                            "SummaryText": "PPT also increased complement component 3, lactoferrin, and glucose-6-phosphate dehydrogenase (G6PDH), and decreased androgen receptor (AR) and progesterone receptor (PR) mRNA levels in uterine tissue, as did estradiol (E(2)).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ba6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11904449", 
                                "Name": "Proc Natl Acad Sci U S A 2002 Mar 19 99(6) 4055-60"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ba4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11139588", 
                                "Name": "J Biol Chem 2001 Mar 30 276(13) 9817-24"
                            }, 
                            "Disease": "", 
                            "SummaryText": "PTEN and a catalytically inactive AKT decreased PI 3-kinase-induced [Estrogen-independent ESR1] activity, suggesting that PI 3-kinase utilizes AKT-dependent and AKT-independent pathways in activating ERalpha . The consensus AKT phosphorylation site Ser-167 of ERalpha is required for phosphorylation and activation by AKT.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ba5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11113208", 
                                "Name": "Mol Cell Biol 2001 Jan 21(1) 343-53"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Strikingly, we observed that CIA not only interacts with RVR and Rev-ErbAalpha in a ligand-independent manner but can also form complexes with estrogen receptor alpha (ERalpha) and ERbeta in vitro and enhances ERalpha transcriptional activity", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bbb"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8180106", 
                                "Name": "J Steroid Biochem Mol Biol 1994 Apr 48(5-6) 453-61"
                            }, 
                            "Disease": "", 
                            "SummaryText": "we conclude that the estrogen receptor is transcriptionally active in MCF-7 cells upon binding of catecholestrogens.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c3408395d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14707290", 
                                "Name": "Mol Cancer Res 2003 Dec 1(14) 1070-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bc5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15351741", 
                                "Name": "Biochem Biophys Res Commun 2004 Oct 8 323(1) 332-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "SRA expression increased ERalpha- and ERbeta-dependent gene expression.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b3b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14506733", 
                                "Name": "Int J Cancer 2003 Nov 10 107(3) 353-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b84"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19035303", 
                                "Name": "Anticancer Res 28(5A) 2733-5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "ER-alpha siRNA transfection significantly reduced ER-alpha expression and MCF-7 cell proliferation. KGF-mediated enhancement of cell proliferation and motile cell morphology were reduced or absent in the siRNA transfected MCF-7 cells", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b56"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16010691", 
                                "Name": "Mol Carcinog 2005 Nov 44(3) 202-11"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Estrogen receptor alpha increases basal and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells...These results suggest that ERalpha regulates the CYP1B1 expression at a transcriptional level, and CYP1A1 expression at a translational level", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c2c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11784056", 
                                "Name": "Dev Biol 2001 Dec 1 240(1) 194-211"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In the adult vagina, E(2) induced expression of involucrin, a CCAAT/enhancer-binding protein beta and cytokeratin 1 via estrogen receptor alpha (ERalpha).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c2a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10395947", 
                                "Name": "Biochim Biophys Acta 1999 Jul 8 1450(3) 364-73"
                            }, 
                            "Disease": "", 
                            "SummaryText": "It was increased in mammary carcinoma MCF-7 cells treated by retinoids and by the anti-estrogen ICI 182,780 but not by 4-hydroxytamoxifen.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b52"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12075357", 
                                "Name": "Nature 2002 Jun 20 417(6891) 871-5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Efp, a target gene product of ER alpha,", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b53"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15891768", 
                                "Name": "EMBO Rep 2005 Jun 6(6) 538-44"
                            }, 
                            "Disease": "", 
                            "SummaryText": "DLC1 facilitated oestrogen-induced ER transactivation and anchorage-independent growth of breast cancer cells. We show that DLC1 interacts with ER, and such interaction is required for the transactivation-promoting activity of DLC1. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c2e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15716114", 
                                "Name": "Gene 2005 Jan 31 345(2) 225-35"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839aa"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9671457", 
                                "Name": "Mol Cell Biol 1998 Aug 18(8) 4471-87"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Here we show that HMG-1 and the highly related HMG-2 stimulate DNA binding by other steroid receptors, including estrogen, androgen, and glucocorticoid receptors", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bbc"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12808020", 
                                "Name": "J Cell Sci 2003 Jul 15 116(Pt 14) 2975-86"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b4c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12538633", 
                                "Name": "Endocrinology 2003 Feb 144(2) 701-10"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a23"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15655247", 
                                "Name": "J Biol Chem 2005 Mar 25 280(12) 11961-72"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In searching for a possible linkage between HA-CD44-mediated IQGAP1 signaling and ERK and ER{alpha} function, we demonstrated that IQGAP1-linked ERK2 isolated from SK-OV-3.ipl cells treated with HA was capable of phosphorylating ER{alpha} in vitro (Fig. 5A, bar b). EGF stimulation of MAPKs such as ERK1 and ERK2 has been shown to phosphorylate ER{alpha} at Ser118 in the N-terminal domain and to enhance transcriptional activity. ER{alpha} phosphorylation in vivo (as detected by anti-phospho-ER{alpha} antibody (Ser118)) was also greatly enhanced in SK-OV-3.ipl cells treated with HA.The level of ERE gene activity was low in untreated cells (bar a) or in cells pretreated with anti-CD44 antibody, followed by HA treatment (bar c). ERE gene activity was greatly enhanced in SK-OV-3.ipl cells treated with intact HA", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b4e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9632709", 
                                "Name": "J Biol Chem 1998 Jun 26 273(26) 16434-41"
                            }, 
                            "Disease": "", 
                            "SummaryText": "This gene, a member of the SNW gene family, encodes a coactivator that enhances transcription from some Pol II promoters. This coactivator can bind to the ligand-binding domain of the vitamin D receptor and to retinoid receptors to enhance vitamin D-, retinoic acid-, estrogen-, and glucocorticoid-mediated gene expression. It can also interact with poly(A)-binding protein 2 to directly control the expression of muscle-specific genes at the transcriptional level. Finally, the protein may be involved in oncogenesis since it interacts with a region of SKI oncoproteins that is required for transforming activity.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a26"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12200431", 
                                "Name": "J Biol Chem 2002 Nov 1 277(44) 41674-85"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In cultured mammalian cells, hOsa1 and hOsa2 stimulate transcription by the glucocorticoid, estrogen, and androgen receptors. The glucocorticoid receptor-mediated activation is not observed with the C-terminal domain or with the hOsa2 polypeptide lacking the ARID DNA binding domain. These results suggest that hOsa1 and hOsa2 participate in promoting transcriptional activation by the steroid hormone receptors.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a27"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12113885", 
                                "Name": "J Soc Gynecol Investig 9(4) 243-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c12"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15289619", 
                                "Name": "Proc Natl Acad Sci U S A 2004 Aug 10 101(32) 11599-604"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Suppression of AIB1 levels leads to ERalpha stabilization in the presence of 17beta-estradiol and, despite increased ERalpha levels, reduced recruitment of ERalpha to endogenous target gene promoters.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c07"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "7481822", 
                                "Name": "Science 1995 Nov 24 270(5240) 1354-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "SRC1 stimulated transactivation of all the steriod receptors tested SRC1 reversed the ability of the estrogen receptor to squelch activation by PR", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c18"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11159832", 
                                "Name": "Endocrinology 2001 Feb 142(2) 613-22"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Npn-2 mRNA expression was decreased by estrogen.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c17"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12552091", 
                                "Name": "Proc Natl Acad Sci U S A 2003 Feb 4 100(3) 1016-21"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The inhibitory effect of E(2) was absent in cells lacking SOCS-2 but not in those lacking SOCS-1 and SOCS-3.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a3b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8823369", 
                                "Name": "J Invest Dermatol 1996 Oct 107(4) 610-4"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The estrogenic effect might be mediated through estrogen receptor and the putative estrogen response element at the 5' region of both SS-A/Ro genes.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c13"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12576474", 
                                "Name": "J Biol Chem 2003 Apr 25 278(17) 15192-200"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Upon examining the molecular mechanisms, we found that Smad4, a common signal transducer in the bone morphogenetic protein (BMP)/transforming growth factor-beta (TGF-beta) signaling pathway, functions as a transcription corepressor for human estrogen receptor alpha (ERalpha).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a3f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10829018", 
                                "Name": "J Biol Chem 2000 Aug 18 275(33) 25781-90"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Site-directed mutation of an nuclear factor-kappaB (NF-kappaB) site at -671 or of Sp-1 sites at -189 and -172 residing in those regions resulted in an abrogation of the AGE/TNF-alpha- or E(2)-mediated transcriptional activation. Electrophoretic mobility shift assays revealed that ECV304 cell nuclear extracts contained factors which retarded the NF-kappaB and Sp-1 elements, and that the DNA-protein complexes were supershifted by anti-p65/p50 NF-kappaB and anti-Sp-1/estrogen receptor alpha antibodies, respectively.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a3d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15294957", 
                                "Name": "J Immunol 2004 Aug 15 173(4) 2435-42"
                            }, 
                            "Disease": "", 
                            "SummaryText": "RNA levels for TCR{beta}, IFN-{gamma}, TNF-alpha, and lymphotoxin-alpha were strongly up-regulated within the spinal cord of ERalpha-{Delta}2-/- mice and their WT littermate controls. Interestingly, while E2 treatment abolished the expression of these transcripts to nearly basal levels in ERalpha-{Delta}2+/+ mice, it had no effect in ERalpha-{Delta}2-/- mice for both doses of E2 tested.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c2b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12873981", 
                                "Name": "Cancer Res 2003 Jul 15 63(14) 3899-903"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The SNCG-stimulated ER-alpha signaling was demonstrated in three different cell systems including ER-alpha-positive and SNCG-negative MCF-7 cells, ER-alpha-positive and SNCG-positive T47D cells, and SNCG-negative and ER-alpha-negative MDA-MB-435 cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b7f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12915398", 
                                "Name": "Am J Physiol Endocrinol Metab 2003 Dec 285(6) E1237-45"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bf4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15300201", 
                                "Name": "Surgery 2004 Aug 136(2) 346-54"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "Overexpression of NCOA-1, NCOA-2, and NCOA-3 enhanced E2-mediated gene expression by 3.17 +/- 0.51-, 2.33 +/- 0.8-, and 3.65 +/- 0.65-fold, respectively, and enhanced cell survival by suppressing tumor necrosis factor alpha (TNF-alpha)-induced cell death", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b72"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12612073", 
                                "Name": "Mol Cell Biol 2003 Mar 23(6) 1994-2008"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "In breast cancer cells, estrogens activate the Src/Erk pathway through an interaction of the estrogen receptor alpha (ERalpha) with the SH2 domain of c-Src.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bd4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12697671", 
                                "Name": "Endocrinology 2003 May 144(5) 1675-85"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083be7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11356664", 
                                "Name": "Endocrinology 2001 Jun 142(6) 2205-12"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a83"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12223122", 
                                "Name": "Breast Cancer Res 2002 4(5) 187-90"
                            }, 
                            "Disease": "", 
                            "SummaryText": "PRA but not PRB, in the presence of either progesterone or antiprogestins, lessened the ability of estrogen to induce an estrogen-responsive reporter", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b0c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15254226", 
                                "Name": "Mol Cell Biol 2004 Aug 24(15) 6581-91"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a38"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12659671", 
                                "Name": "Neoplasia 5(1) 63-73"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a32"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "2456904", 
                                "Name": "DNA 1988 Jun 7(5) 347-54"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We show that mRNAs for alpha 2(I), alpha 1(III), and alpha 2(V) collagens are regulated by estradiol in the immature rat uterus. Clones for alpha 2(I) and alpha 1(III) collagen were induced in a cDNA library prepared from estradiol-stimulated rat uterine mRNA.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a31"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16688764", 
                                "Name": "J Cell Physiol 2006 Aug 208(2) 255-66"
                            }, 
                            "Disease": "", 
                            "SummaryText": "These results provide in vivo evidence supporting the hypothesis that loss of Pten and subsequent Akt activation result in the activation of several", 
                            "Cell": "", 
                            "Tissue": "endometrium", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a30"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12775722", 
                                "Name": "J Biol Chem 2003 Aug 15 278(33) 30605-13"
                            }, 
                            "Disease": "", 
                            "SummaryText": "swi/snf activity has been shown to be essential for ERalpha activity", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c10"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17991765", 
                                "Name": "Mol Endocrinol 2008 Feb 22(2) 304-16"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We cotransfected siRNA against ARNT or the scrambled sequence together with the 3xERE-TATA-luciferase reporter construct and expression plasmids for either ER or ER. siRNA reduction of the intracellular levels of ARNT resulted in a clear reduction in ER and ER transcriptional activity.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c22"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9407129", 
                                "Name": "J Biol Chem 1997 Dec 26 272(52) 33360-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839a8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15350356", 
                                "Name": "Gynecol Oncol 2004 Sep 94(3) 661-70"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b5b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17627304", 
                                "Name": "J Clin Invest 2007 Aug 1 117(8) 2205-2215"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Inducible Src stimulated ligand-activated ERalpha transcriptional activity and reduced ERalpha t(1/2).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c24"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12511606", 
                                "Name": "Mol Endocrinol 2003 Jan 17(1) 56-66"
                            }, 
                            "Disease": "", 
                            "SummaryText": "E2 activation of mouse BMP-2 gene transcription requires ERalpha or ERbeta acting via a variant estrogen-responsive element binding site in the promoter, with ERalpha being the more efficacious regulator.", 
                            "Cell": "", 
                            "Tissue": "mesenchyme", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b5a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15304487", 
                                "Name": "J Biol Chem 2004 Sep 24 279(39) 40255-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "estrogen receptor (ER) alpha- and beta-catenin precipitated within the same immunocomplexes, reciprocally enhanced the transactivation of cognate reporter genes, and were reciprocally recruited to cognate response elements in the promoters of endogenous target genes.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839a1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19952273", 
                                "Name": "Endocrinology 2010 Jan 151(1) 174-84"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Our data show that ERalpha, and not ERbeta, mediates E2-induced reduction of the inflammatory response. By real-time PCR and immunohistochemistry assays, we demonstrate ERalpha expression in the resident and infiltrated inflammatory cells of the lung, in which ERbeta could not be detected. In these cells, E2-mediated reduction in the expression of inflammatory mediators was also due to ERalpha.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839a0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10755407", 
                                "Name": "Br J Cancer 2000 Apr 82(7) 1312-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839a3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12790780", 
                                "Name": "Endocr Relat Cancer 2003 Jun 10(2) 179-86"
                            }, 
                            "Disease": "", 
                            "SummaryText": "increase in cyclin D1 mRNA (Altucci et al. 1996, Prall et al. 1997), indicating that cyclin D1 is directly regulated by ER. However, the cyclin D1 promoter region does not contain a classical ERE. Instead, induction by ER\u00c3\u017d\u00c2\u00b1 has been mapped to a cAMP response element (CRE) close to the transcription start site (Sabbah et al. 1999, Castro-Rivera et al. 2001) and a more distal Sp1 site bound by both ER\u00c3\u017d\u00c2\u00b1 and Sp1 in chromatin immunoprecipitation assays", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a2c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9501191", 
                                "Name": "Proc Natl Acad Sci U S A 1998 Mar 17 95(6) 2920-5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Several lines of evidence indicate that the nuclear receptor corepressor (N-CoR) complex imposes ligand dependence on transcriptional activation by the retinoic acid receptor and mediates the inhibitory effects of estrogen receptor antagonists, such as tamoxifen, suppressing a constitutive N-terminal, Creb-binding protein/coactivator complex-dependent activation domain.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b45"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15691879", 
                                "Name": "J Mol Endocrinol 2005 Feb 34(1) 77-89"
                            }, 
                            "Disease": "", 
                            "SummaryText": "mobility shift and chromatin immunoprecipitation assays confirmed that both ERalpha and Sp1 were required for hormone-induced transactivation, which involved both ERalpha and Sp1 directly binding to DNA. Taken together, these findings suggest that ERalpha and Sp1 play a role in activation of the human LRP16 gene promoter.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839a6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12915738", 
                                "Name": "Physiol Genomics 2003 Oct 17 15(2) 127-41"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Several chaperonin transcripts [i.e., Hspa8, Hspa4, and Hspa5 (also known as BiP); clusters J and L] were also induced consistent with previous reports (17, 58), as well as numerous translation initiation factors [i.e., Eif2a, Eif2s2, Eif4a1, Itgb4bp (also known as Eif6), Eif1a, and Eif2b1].", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a7f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "22761658", 
                                "Name": "PLoS One 2012 7(6) e37705"
                            }, 
                            "Disease": "", 
                            "SummaryText": "TCC treatment to female hUGT1*28 mice resulted in the induction of Cyp1b1 (Figure 5C). These results clearly link TCC exposure to activation of ER? target genes, Cyp1b1/CYP1B1 and Cyp2b10/CYP2B6 in both cultured human breast cancer cells and in vivo estrogen-sensitive tissues.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bf8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11244506", 
                                "Name": "Oncogene 2001 Jan 4 20(1) 77-87"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "The BRCA1 gene was previously found to inhibit the transcriptional activity of the estrogen receptor [ER-alpha] in human breast and prostate cancer cell lines. The BRCA1 protein was found to associate with ER-alpha in vivo and to bind to ER-alpha in vitro, by an estrogen-independent interaction that mapped to the amino-terminal region of BRCA1 (ca. amino acid 1-300) and the conserved carboxyl-terminal activation function [AF-2] domain of ER-alpha.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b2c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12223121", 
                                "Name": "Breast Cancer Res 2002 4(5) 182-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Uba3 was recently demonstrated as a corepressor of the ER, the androgen receptor and the PR in mammalian transfection assays", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083abf"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11108261", 
                                "Name": "Endocrinology 2000 Dec 141(12) 4503-11"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ad9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18565642", 
                                "Name": "Mol Cell Endocrinol 2008 Sep 10 291(1-2) 87-94"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Aryl hydrocarbon receptor repressor (AhRR) suppressed, in a ligand independent manner, the ability of estrogen receptor alpha (ERalpha) to enhance the transcription of heterologous estrogen-responsive reporter plasmids in transient transfection assays", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bff"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15557322", 
                                "Name": "J Biol Chem 2005 Jan 28 280(4) 2708-13"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Vitamin D receptor (16), estrogen receptor {alpha} (17), Smad (18), Cbfa (19), and Ets-1 (20) have been shown to regulate OPN expression in osteoclasts, whereas metastasis-associated transcription factor (21), Tcf-1, Ets-1, Ets-2, polyomavirus enhancer A-binding protein-3, c-Jun (22) and acute myeloid leukemia-1 (23) are involved in OPN expression in cancer cells.", 
                            "Cell": "osteoclast", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bfd"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10462534", 
                                "Name": "Mol Pharmacol 1999 Sep 56(3) 473-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a06"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9751502", 
                                "Name": "Endocrinology 1998 Oct 139(10) 4213-21"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b2f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15345672", 
                                "Name": "Endocrinology 2004 Dec 145(12) 5485-92"
                            }, 
                            "Disease": "", 
                            "SummaryText": "E2 rapidly decreased the expression of Txnip, but increased the levels of cytosolic Txn1 and Txnrd1 as well as mitochondrial Txn2. Using the ER antagonist, ICI 182,780, and mice lacking functional estrogen receptor alpha (ERalpha), we demonstrate that these E2-mediated changes require ERalpha, but not ERbeta", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a04"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15762987", 
                                "Name": "BMC Genomics 2005 Mar 11 6(1) 37"
                            }, 
                            "Disease": "", 
                            "SummaryText": "BACKGROUND: Estrogens are known to regulate the proliferation of breast cancer cells and to modify their phenotypic properties. Identification of estrogen-regulated genes in human breast tumors is an essential step toward understanding the molecular mechanisms of estrogen action in cancer. To this end we generated and compared the Serial Analysis of Gene Expression (SAGE) profiles of 26 human breast carcinomas based on their estrogen receptor alpha (ER) status. Thus, producing a breast cancer SAGE database of almost 2.5 million tags, representing over 50,000 transcripts. RESULTS: We identified 520 transcripts differentially expressed between ERalpha-positive (+) and ERalpha-negative (-) primary breast tumors (Fold change >or= 2; p < 0.05). Furthermore, we identified 220 high-affinity Estrogen Responsive Elements (EREs) distributed on the promoter regions of 163 out of the 473 up-modulated genes in ERalpha (+) breast tumors. In brief, we observed predominantly up-regulation of cell growth related genes, DNA binding and transcription factor activity related genes based on Gene Ontology (GO) biological functional annotation. GO terms over-representation analysis showed a statistically significant enrichment of various transcript families including: metal ion binding related transcripts (p = 0.011), calcium ion binding related transcripts (p = 0.033) and steroid hormone receptor activity related transcripts (p = 0.031). SAGE data associated with ERalpha status was compared with reported information from breast cancer DNA microarrays studies. A significant proportion of ERalpha associated gene expression changes was validated by this cross-platform comparison. However, our SAGE study also identified novel sets of genes as highly expressed in ERalpha (+) invasive breast tumors not previously reported. These observations were further validated in an independent set of human breast tumors by means of real time RT-PCR. CONCLUSION: The integration of the breast cancer comparative transcriptome analysis based on ERalpha status coupled to the genome-wide identification of high-affinity EREs and GO over-representation analysis, provide useful information for validation and discovery of signaling networks related to estrogen response in this malignancy.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ad1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15158369", 
                                "Name": "Life Sci 2004 Jun 18 75(5) 599-609"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a02"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16807234", 
                                "Name": "J Biol Chem 2006 Sep 8 281(36) 26587-26601"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "WT.BRCA1 selectively binds OPN-activating transcription factors estrogen receptor alpha, AP-1, and PEA3, inhibits OPN promoter transactivation, and suppresses OPN mRNA and protein", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b6a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10342864", 
                                "Name": "Endocrinology 1999 Jun 140(6) 2733-44"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a00"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12790780", 
                                "Name": "Endocr Relat Cancer 2003 Jun 10(2) 179-86"
                            }, 
                            "Disease": "carcinoma of breast", 
                            "SummaryText": "In rat uteri (Murphy et al. 1987) and breast cancer cell lines (Dubik et al. 1987), the rapid and direct regulation of c-myc by estrogen, apparently via an atypical ERE (Dubik ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a86"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15070958", 
                                "Name": "J Clin Endocrinol Metab 2004 Apr 89(4) 1869-78"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Using estrogen receptor subtype-specific ligands, we found that this effect of estrogen was caused through the estrogen receptor subtype alpha", 
                            "Cell": "Adipocytes", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c4a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12829444", 
                                "Name": "Am J Physiol Regul Integr Comp Physiol 2003 Oct 285(4) R754-61"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Semiquantitative RT-PCR was used to confirm and quantitate the decrease in biglycan gene expression in response to estrogen (-37%), genistein (-15%), and daidzein (-10%).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839f8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12554767", 
                                "Name": "Mol Endocrinol 2003 May 17(5) 818-30"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Taken together, our data suggest that estradiol, bound to membrane ERalpha, interacts with and activates an ErbB dimer containing ErbB2, inducing activation of PI 3-K/Akt", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839f9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8195142", 
                                "Name": "J Biol Chem 1994 May 27 269(21) 15046-53"
                            }, 
                            "Disease": "", 
                            "SummaryText": "DNase I footprinting showed that the COUP-TF I protein bound to the 5'-flanking region of the oxytocin gene at the site of the distal composite hormone response element, which mediates the responses to estrogen, retinoic acid, and thyroid hormone. Electrophoretic mobility shift assay using this composite hormone response element as probe showed that COUP-TF I and the estrogen receptor competed for binding but did not form a heterodimer. The binding by COUP-TF I was stronger than the binding of the estrogen receptor.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839f4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14610283", 
                                "Name": "Proc Natl Acad Sci U S A 2003 Nov 25 100(24) 14451-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a82"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12659870", 
                                "Name": "Biochem Biophys Res Commun 2003 Apr 4 303(2) 660-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "However when cotransfected with ER alpha and stimulated with 17 beta-estradiol (E2) the enhancer was activated. Interestingly, expression of ER alpha in Cos7 cells and E2 treatment was sufficient to induce expression of the endogenous SK3 gene. Only Sp1 and Sp3 specifically bound to the enhancer from Cos7 and L6 nuclear extracts, however, ER alpha increased Sp1s affinity for the enhancer.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839f6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14707134", 
                                "Name": "J Biol Chem 2004 Mar 19 279(12) 10848-54"
                            }, 
                            "Disease": "", 
                            "SummaryText": "expression of human CNOT6(hCCR4) or CNOT7(hCAF1) potentiates ligand-dependent activation by the estrogen receptor [alpha]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b30"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9632141", 
                                "Name": "Oncogene 1998 May 16(20) 2647-56"
                            }, 
                            "Disease": "", 
                            "SummaryText": "FGF treatment also results in the phosphorylation of STAT1.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839f3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16282588", 
                                "Name": "Nucleic Acids Res 2005 33(19) 6393-404"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We have shown previously that the base excision repair enzyme thymine DNA glycosylase (TDG) acts as a potent coactivator for estrogen receptor-alpha.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a99"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11914591", 
                                "Name": "Neuroendocrinology 2002 Mar 75(3) 193-200"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083991"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15564439", 
                                "Name": "Exp Biol Med (Maywood) 2004 Dec 229(11) 1127-35"
                            }, 
                            "Disease": "", 
                            "SummaryText": "This action happens principally through decreasing activity of lipoprotein lipase (LPL), an enzyme that regulates lipid uptake by adipocytes. Ovariectomy increases LPL and lipid deposition within the adipocyte and administering physiological doses of E2 reverses this deposition (29). Recently, work on a 3T3 adipocyte cell line transfected with estrogen receptor showed that the LPL gene has a negatively controlled estrogen response element (30).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b95"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16497810", 
                                "Name": "Endocrinology 2006 Jun 147(6) 3027-39"
                            }, 
                            "Disease": "carcinoma of neuron", 
                            "SummaryText": "three inhibitors of GSK3, dose-dependently blocked ERalpha-mediated transcription. In contrast, overexpression of wild-type GSK3, but not of a mutant inactive form, increased ER-dependent gene expression.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a95"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14960313", 
                                "Name": "FEBS Lett 2004 Feb 13 559(1-3) 89-95"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We have previously shown that HMGA1 enhances the transcriptional activity of promoters containing the estrogen response element (ERE) and increases binding of the estrogen receptor (ER) to ERE. \\\"The functional interaction between HMGA1 and the estrogen receptor requires either the N- or the C-terminal domain of the receptor.\\\"", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a97"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15467735", 
                                "Name": "Oncogene 2004 Nov 18 23(54) 8826-33"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Estrogen treatment of T47D cells caused increased expression of E2F-1, and this expression was inhibited by cotreatment with all-trans retinoic acid.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a96"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15579445", 
                                "Name": "Am J Pathol 2004 Dec 165(6) 2019-31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Estrogen has been postulated to be involved in inhibition of vascular smooth muscle cell (VSMC) proliferation mainly via estrogen receptor (ER), but the detailed mechanism has remained primarily unknown. Therefore, in this study, microarray analysis was used in two types of cultured human VSMCs: one positive for ER alpha, and the other for ER beta, which were treated by estrogens to detect the estrogen-responsive genes. We also used quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) to evaluate mRNA levels of selective target gene (TG) in these cells. We further studied whether the TG product was involved in inhibition of proliferation using small interfering RNA (siRNA) of the TG transfection. We subsequently used quantitative RT-PCR and in situ hybridization analysis to evaluate the expression of these gene products in human aorta. E4F1, a possible inducer of cell growth arrest, was markedly increased only in ER alpha-positive VSMCs by estrogens in both microarray and RT-PCR analyses. Blocking of E4F1 using siRNA suppressed estrogenic inhibition of ER alpha-positive VSMC proliferation. E4F1 mRNA was abundant in premenopausal female aorta with mild atherosclerotic changes. E4F1 is therefore considered one of the estrogen-responsive genes involving ER alpha-mediated inhibition of VSMC proliferation and may play an important role in estrogen-related atheroprotection of human aorta.", 
                            "Cell": "", 
                            "Tissue": "vascular smooth muscle", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083aee"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11380688", 
                                "Name": "Immunology 2001 May 103(1) 17-25"
                            }, 
                            "Disease": "", 
                            "SummaryText": "As male ER-\u00c3????\u00c3???\u00c3??\u00c3?\u00c2\u00b1\u00c3???\u00c3??\u00c3?\u00c2\u00a2?? mice are known to have lower IGF-1 levels in serum,33,34 we propose that their smaller spleens are caused by suppressed activity in the GH/IGF-1 axis. In order to test directly the hypothetical importance of IGF-1 in oestrogen-mediated effects on male immune organ development, replacement studies with IGF-1 in ERKO mice are currently underway in our laboratory.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a74"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12021387", 
                                "Name": "Mol Pharmacol 2002 Jun 61(6) 1273-83"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In summary, the data suggest that the effect of estrogen is mediated through a cross-talk between the estrogen-responsive element and the AP1 response element and that ERalpha plays a crucial role in mediating the effect of both estrogen and PMA.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b35"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9178752", 
                                "Name": "Mol Endocrinol 1997 Jun 11(7) 928-37"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Cotransfection of the reporter genes with truncated versions of the ER shows that the two non-ligand activators of ER require different regions of the receptor to produce their effects on transcription. EGF acts primarily by means of transactivation domain AF-1, whereas cAMP acts via transactivation domain AF-2 of the ER. A point mutation that removes a major site of inducible phosphorylation within the AF-1 domain of the ER abolishes the response to EGF, but the response to estradiol and cAMP is retained. Specific inhibition of cAMP-activated protein kinase (protein kinase A) prevents the response to elevated cAMP but does not affect EGF or estradiol responses. Overexpression of the protein kinase A catalytic subunit in HeLa cells results in an amplified response to estradiol, similar to that induced by cholera toxin with 3-isobutyl-1-methyl-xanthine. Comparable experiments performed using COS-1 cells produce similar results but also reveal cell type- and promoter-specific aspects of the activation mechanisms. Apparently, the ER may be activated by three different signal molecules, estradiol, EGF, and cAMP, each using a mechanism that is distinguishable from that of the others.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b89"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10872826", 
                                "Name": "Biochem Biophys Res Commun 2000 May 27 272(1) 193-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Gadd45 family proteins interact with several nuclear hormone receptors including RXR alpha, RAR alpha, ER alpha, PPAR alpha, PPAR beta, and PPAR gamma2 in vitro. Interaction between Gadd45 family proteins and nuclear hormone receptors resulted in modest activation of transactivating function of nuclear hormone receptors in reporter systems.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ab2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14993442", 
                                "Name": "Mol Interv 2003 Aug 3(5) 281-92"
                            }, 
                            "Disease": "", 
                            "SummaryText": "When coexpressed, ERbeta exhibits an inhibitory action on ERalpha -mediated gene expression and in many instances opposes the actions of ERalpha", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ab3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12093804", 
                                "Name": "J Biol Chem 2002 Sep 13 277(37) 33571-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "TR2 orphan receptor (TR2), a member of the nuclear receptor superfamily without identified ligands, is found to be expressed in the breast cancer cell lines and to function as a repressor to suppress ER-mediated transcriptional activity. Utilizing an interaction blocker, ER-6 (amino acids 312-340), responsible for TR2 interaction, the suppression of ER by TR2 could be reversed, suggesting that this suppression is conferred by the direct protein-protein interaction.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ab5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12684053", 
                                "Name": "Biochem Biophys Res Commun 2003 Apr 18 303(4) 1129-34"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ab6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15564439", 
                                "Name": "Exp Biol Med (Maywood) 2004 Dec 229(11) 1127-35"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Fatty acid-b oxidation might also be increased, which might contribute to the decrease in adipose tissue deposition induced by E2 (33).", 
                            "Cell": "Adipocytes", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a11"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15988012", 
                                "Name": "Mol Cell Biol 2005 Jul 25(14) 5965-72"
                            }, 
                            "Disease": "", 
                            "SummaryText": "GAC63 enhanced transcriptional activation by NRs in a hormone-dependent and GRIP1-dependent manner in transient transfection assays and cooperated synergistically and selectively with other NR coactivators, including GRIP1 and CARM1, to enhance estrogen receptor function.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c3d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15300201", 
                                "Name": "Surgery 2004 Aug 136(2) 346-54"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Overexpression of NCOA-1, NCOA-2, and NCOA-3 enhanced E2-mediated gene expression by 3.17 +/- 0.51-, 2.33 +/- 0.8-, and 3.65 +/- 0.65-fold, respectively, and enhanced cell survival by suppressing tumor necrosis factor alpha (TNF-alpha)-induced cell death Overexpression of NCOA-1 and NCOA-3 exerted potent survival effects in breast carcinoma cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c3b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14680484", 
                                "Name": "Breast Cancer Res 2004 6(1) 39-52"
                            }, 
                            "Disease": "", 
                            "SummaryText": "and the p160 family, a wide spectrum In addition to the chromatin remodeling complexes of coactivators has been found to interact with ER. These include DRIP205/ TRAP220/PBP, a component of the DRIP/TRAP mediator complex [39-41], PGC-1, a tissue- and promoter-specific PPARgamma-coactivator-1 [42,43], SNURF, a small nuclear C(3)HC(4) finger protein [44], PELP1, a proline-, glutamic acid-, leucine-rich protein 1 [45], and NCoA-7 (ERAP140), a structurally distinct coactivator [46].", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839fd"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12145209", 
                                "Name": "EMBO J 2002 Aug 1 21(15) 4094-103"
                            }, 
                            "Disease": "", 
                            "SummaryText": "BRG1, a catalytic subunit in the mammalian SWI/SNF complex, is required for transcriptional activation by the estrogen receptor, but the mechanisms by which the complex is recruited to estrogen target genes are unknown. Here, we have identified an interaction between the estrogen receptor and BAF57, a subunit present only in mammalian SWI/SNF complexes, which is stimulated by estrogen and requires both a functional hormone-binding domain and the DNA-binding region of the receptor.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839fe"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11073980", 
                                "Name": "Mol Cell Biol 2000 Dec 20(23) 8793-802"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ae0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14587863", 
                                "Name": "J Mammary Gland Biol Neoplasia 2003 Jan 8(1) 45-73"
                            }, 
                            "Disease": "", 
                            "SummaryText": "ER expression alters the transcriptional regulation of PPARG - targeted gene expression and reduces both basal and stimulated PPARG-mediated reporter activity, suggesting a cross-talk between PPARG andERsignaling in breast cancer cells (89). Activation of PPARG by PGJ2 results in a significant inhibition of ErbB-2 and ErbB-3 tyrosine phosphorylation caused by neuregulin 1 (NRG1) and neuregulin 2 (NRG2) in MCF-7 cells (90)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839fb"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12659870", 
                                "Name": "Biochem Biophys Res Commun 2003 Apr 4 303(2) 660-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b3c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18824559", 
                                "Name": "Endocr Relat Cancer 2008 Dec 15(4) 985-1002"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Unexpectedly, while inhibition of AKT had no effect on ESR1 transactivation in the MCF-7 and TamR-1 cell lines, inhibition of MAPK3/1 significantly decreased activity by 30% in each cell line in the absence of tamoxifen.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bf3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11457856", 
                                "Name": "J Biol Chem 2001 Sep 21 276(38) 35444-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We also found that both the AF1 and AF2 domains of ER-alpha are  responsible for specific transactivation of the IGF-I promoter by ER-alpha.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c40"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11782371", 
                                "Name": "Cancer Res 2002 Jan 1 62(1) 141-51"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We previously reported that expression of the breast cancer susceptibility gene BRCA1 strongly inhibits the transcriptional activity of the estrogen receptor (ER-alpha) in human breast and prostate cancer cell lines but only weakly inhibits ER-alpha activity in cervical cancer cells (S. Fan et al., Science (Wash. DC), 284: 1354-1356, 1999). We now report that the ability of BRCA1 to repress ER-alpha activity correlates with its ability to induce down-regulation of the cellular levels of the transcriptional coactivator p300 in breast and prostate, but not in cervical cancer cells. On the other hand, BRCA1 failed to alter the expression of the CREB binding protein (CBP), the structural and functional homologue of p300, in any of these cell types. Ectopic expression of either p300 or CBP \\\"rescued\\\" (i.e., reversed) the BRCA1 inhibition of ER-alpha activity, whereas two other nuclear receptor coactivators, the p300/CBP-associated factor (PCAF) and the glucocorticoid receptor-interacting protein-1 (GRIP1), failed to rescue the ER-alpha activity. The rescue function mapped to the cysteine-histidine rich domain CH3, a region of p300/CBP that we found to interact directly with the conserved COOH-terminal activation domain (AF-2) of ER-alpha. p300 and ER-alpha were also found to interact in vivo and to colocalize within the nucleus in breast cancer cells. These findings suggest that the cofactors p300 and CBP modulate the ability of the BRCA1 protein to inhibit ER-alpha signaling. They further suggest that the BRCA1 inhibition of ER-alpha activity may be attributable, at least in part, to the down-regulation of p300.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bf7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10068081", 
                                "Name": "Breast Cancer Res Treat 1998 51(3) 227-38"
                            }, 
                            "Disease": "", 
                            "SummaryText": "After binding of ligand, either estrogens or antiestrogens, to the ER, the receptor dimerizes with another receptor-monomer to somehow activate the complex and to facilitate the binding of the receptor dimer to the EREs of target genes... ERalpha and ERbeta can heterodimerize, and ERbeta appears to have different functional properties Other nuclear proteins can interact with the ER dimer to modify the expression of certain genes...Some of these receptor-interacting proteins function as co-activators to amplify transcription activation from the ER, while others function as co-repressors. Molecules that have been identified to act as ER co-activators include SRC-1 and SRC-2, CBP/p300, TIF-2,TRIP-1, and AIB-1 ...AIB(also called SRC-3 or Rac3) is amplififed and/or overexpressed in a large percentage of human breast cancer specimens, suggesting that it may have an important role in breast cancer development N-CoR and SMRT function as co-repressors and bind to the ER either in the absence of estrogen or in the presence of tamoxifen progression", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b28"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16153720", 
                                "Name": "Biochim Biophys Acta 2005 Oct 15 1731(1) 23-31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Transfection and gel shift experiments showed that a sequence located at +36/+50 in the first exon permitted induction of expression of this gene by estradiol acting via ERalpha. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a0f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16427018", 
                                "Name": "Mol Cell 2006 Jan 20 21(2) 295-305"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In concert with these results, we show that MUC1 stimulates ERalpha-mediated transcription and contributes to E2-mediated growth and survival of breast cancer cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bf9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "1680817", 
                                "Name": "Int J Cancer 1991 Oct 21 49(4) 616-23"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Upon hormone withdrawal, erbB2 mRNA and protein increased, while pS2 mRNA declined to an undetectable level and cell proliferation slowed down. The anti-estrogens toremifene and tamoxifen inhibited estrogen induction of pS2 expression, down-regulation of erbB2 expression and proliferation of the ZR-75-I cells in a concentration-dependent manner.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a0e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11581164", 
                                "Name": "Genes Dev 2001 Oct 1 15(19) 2598-612"
                            }, 
                            "Disease": "", 
                            "SummaryText": "CITED1 enhances estrogen-induced expression of the transforming growth factor-alpha mRNA transcript in MCF-7?cells.......CITED1 is recruited to the TGF-alpha promoter in an estrogen-dependent manner", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083adf"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10713182", 
                                "Name": "Mol Cell Biol 2000 Apr 20(7) 2604-18"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a0c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15072553", 
                                "Name": "J Mol Endocrinol 2004 Apr 32(2) 481-96"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Importantly, mACTN2 not only served as a primary coactivator for androgen receptor, estrogen receptor and thyroid receptor activities, but also acted synergistically with GRIP1 to enhance these nuclear receptor (NR) functions.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083add"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11145955", 
                                "Name": "J Biol Chem 2001 Apr 13 276(15) 11590-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b86"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12138116", 
                                "Name": "J Biol Chem 2002 Oct 11 277(41) 38772-80"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bda"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10499531", 
                                "Name": "Endocrinology 1999 Oct 140(10) 4725-31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ac9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14749358", 
                                "Name": "Endocrinology 2004 May 145(5) 2433-44"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b1b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11487586", 
                                "Name": "J Biol Chem 2001 Oct 5 276(40) 37280-3"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bd7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "7592654", 
                                "Name": "J Biol Chem 1995 Oct 13 270(41) 24406-13"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ac2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15716114", 
                                "Name": "Gene 2005 Jan 31 345(2) 225-35"
                            }, 
                            "Disease": "", 
                            "SummaryText": "complex between hormone-activated ERalpha and C/EBPdelta inhibits transcription by each factor", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ac7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12163132", 
                                "Name": "J Steroid Biochem Mol Biol 2002 Jul 81(3) 203-16"
                            }, 
                            "Disease": "", 
                            "SummaryText": "data indicate that the transcript levels of interleukin 1 receptor antagonist (IL-1ra), beta 2-microglobulin, annexin XI and the LXR(alpha) receptor significantly increased and that Ly-GDI transcript levels significantly decreased after estrogen withdrawal;", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839ee"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15318926", 
                                "Name": "Breast Cancer Res 2004 6(5) 204-10"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In preclinical models, co-blockade of the EGFR and ER pathways with gefitinib and either tamoxifen or fulvestrant resulted in restoration of tamoxifen sensitivity and delay of resistance to estrogen deprivation in HER2-overexpressing breast tumors", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a65"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15802376", 
                                "Name": "Mol Endocrinol 2005 Jun 19(6) 1555-68"
                            }, 
                            "Disease": "", 
                            "SummaryText": "4HT and Estrogen induced genes in U2OS-Esr1 expressing cell lines. Fold change >2.0 with a p-value of 0.05 or less from supplemental data", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839ef"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12810571", 
                                "Name": "Endocrinology 2003 Jul 144(7) 3148-58"
                            }, 
                            "Disease": "", 
                            "SummaryText": "This article describes the structural and functional characterization of Ini (AF495522), a novel highly conserved zinc-finger protein that had been identified by screening an estrogen-induced rat myometrial expression library. Ini localizes to the nucleus of HeLa cells and binds to the proximal connexin43 (cx43) promoter, as demonstrated by EMSA. In addition, transient transfection experiments performed with estrogen receptor alpha (ERalpha) cDNA show that overexpression of Ini enhances, in a dose-dependent fashion, the up-regulation of the cx43 gene by estrogen. On binding to the cx43 promoter, Ini stimulates the transcriptional activating function (AF)-1, but not the AF-2, of the ERalpha. This makes Ini one of the few known coactivators specific for AF-1. Because estrogen up-regulates Ini mRNA in the myometrium, it is likely that Ini's physiological role in this tissue is to modulate the response of the cx43 gene to estrogen. Transfection studies with an Ini antisense construct seem to indicate that Ini plays an additional role in the cellular response to estrogen affecting both AF-1 and AF-2 activities of the ERalpha. This broader effect may be associated with cell cycle progression that in yeast has been shown to require Ini.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b0a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12873981", 
                                "Name": "Cancer Res 2003 Jul 15 63(14) 3899-903"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "Augmentation of SNCG expression stimulated transcriptional activity of ER-alpha, whereas compromising endogenous SNCG expression suppressed ER-alpha signaling.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bef"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12088876", 
                                "Name": "Mol Cell Endocrinol 2002 Jun 28 192(1-2) 147-56"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Northern blot analysis demonstrated an enhanced inhibition of ERalpha mRNA expression and an enhanced induction of pancreatic spasmolytic polypeptide (pS2) by melatonin in MT(1)-transfected MCF-7 cells relative to vector-transfected MCF-7 cells", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083988"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12897156", 
                                "Name": "Mol Cell Biol 2003 Aug 23(16) 5867-81"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Using the chromatin immunoprecipitation assay, we demonstrate an E2-dependent recruitment of ERalpha to the Mdm2 promoter, suggesting a role of ER in the regulation of Mdm2 protein expression and hence the enhanced GR degradation in the presence of estrogen agonists. Our study shows that cross talk between the GR and ER involves multiple signaling pathways, indicative of the mechanistic diversity within steroid receptor-regulated transcription.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083989"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12400015", 
                                "Name": "Oncogene 2002 Oct 31 21(50) 7730-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Furthermore, ER-alpha induced activation of VEGF gene transcription, using human VEGF promoter-luciferase reporter constructs.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083986"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10619402", 
                                "Name": "Mol Cell Endocrinol 1999 Nov 25 157(1-2) 105-19"
                            }, 
                            "Disease": "", 
                            "SummaryText": "co-treatment with TCDD suppressed the E2-stimulated luciferase activity.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083987"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15496419", 
                                "Name": "J Biol Chem 2004 Dec 24 279(52) 54230-40"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Thus, our results demonstrate that ADA3 directly binds to human estrogen receptor and enhances the transcription of ER-responsive genes", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083984"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11244506", 
                                "Name": "Oncogene 2001 Jan 4 20(1) 77-87"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The BRCA1 protein was found to associate with ER-alpha in vivo and to bind to ER-alpha in vitro, by an estrogen-independent interaction that mapped to the amino-terminal region of BRCA1 (ca. amino acid 1-300) and the conserved carboxyl-terminal activation function [AF-2] domain of ER-alpha", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b24"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9605408", 
                                "Name": "J Steroid Biochem Mol Biol 1998 Feb 64(3-4) 137-45"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a69"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11353774", 
                                "Name": "J Biol Chem 2001 Jul 27 276(30) 27907-12"
                            }, 
                            "Disease": "", 
                            "SummaryText": "FKHR differentially regulates the transactivation mediated by different NRs. Transient transfection of FKHR into mammalian cells dramatically represses transcription mediated by the ER, glucocorticoid receptor, and progesterone receptor.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083981"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15319356", 
                                "Name": "Endocrinology 2004 Dec 145(12) 5525-31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In summary, estrogen, via ERalpha, up-regulated hepatic expression of SOCS-2 and -3, probably through transcriptional activation", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839d3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11916237", 
                                "Name": "Clin Cancer Res 2001 Dec 7(12 Suppl) 4436s-4442s; discussion 4411s-4412s"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Small molecule inhibitors of the HER2 kinase or MAP extracellular signal-regulated kinase 1/2 or dominant-negative MAP extracellular signal-regulated kinase 1/2 constructs restored the inhibitory effect of tamoxifen on both ER-mediated transcription and tumor cell proliferation.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a7e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12529333", 
                                "Name": "J Biol Chem 2003 Apr 4 278(14) 12335-43"
                            }, 
                            "Disease": "", 
                            "SummaryText": "estrogen receptor alpha (ERalpha)-driven transcription is also enhanced by SUMO-1", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c3408399e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11773441", 
                                "Name": "Mol Endocrinol 2002 Jan 16(1) 85-99"
                            }, 
                            "Disease": "", 
                            "SummaryText": "AR and ERalpha transcriptional activities were inhibited by PAK6 in transient transfections with episomal and integrated reporter genes.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839d4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14695198", 
                                "Name": "Cancer Res 2003 Dec 15 63(24) 8821-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c3408399f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12177049", 
                                "Name": "J Biol Chem 2002 Oct 25 277(43) 41230-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bde"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9212049", 
                                "Name": "Mol Endocrinol 1997 Jul 11(8) 1009-19"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The effect of high-mobility group (HMG) protein HMG-1 and purified recombinant TATA-binding protein-associated factor TAF(II)30 on ER-ERE binding and transcription initiation were assessed by electrophoretic mobility shift assay and in vitro transcription from an ERE-containing template (pERE2LovTATA), respectively. We find that purified, recombinant ER fails to bind to ERE in spite of high ligand-binding activity and electrophoretic and immunological properties identical to ER in MCF-7 breast cancer cells. HMG-1 interacts with ER and promotes ER-ERE binding in a concentration- and time-dependent manner.We find that TAF(II)30 has no effect on ER-ERE binding either alone or in combination with ER and HMG-1. Although HMG-1 promotes ER-ERE binding, it fails to stimulate transcription initiation either in the presence or absence of hormone. In contrast, TAF(II)30, while not affecting ER-ERE binding, stimulates transcription initiation 20-fold in the presence of HMG-1.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839d9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15033914", 
                                "Name": "Endocrinology 2004 Jul 145(7) 3473-86"
                            }, 
                            "Disease": "", 
                            "SummaryText": "TABLE 3. Estrogen-stimulated genes regulated selectively through one ER subtype ERa selective", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b8a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15273280", 
                                "Name": "Mol Hum Reprod 2004 Sep 10(9) 641-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b8c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15169784", 
                                "Name": "J Biol Chem 2004 Jul 30 279(31) 32709-15"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b34"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16608856", 
                                "Name": "J Biol Chem 2006 Jun 16 281(24) 16272-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We show that cyclin G2 is a primary ER target gene in MCF-7 breast cancer cells that is rapidly and robustly down-regulated by estrogen. Promoter analysis reveals a responsive region containing a half-estrogen response element and GC-rich region that interact with ER and Sp1 proteins.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a64"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18073400", 
                                "Name": "Proc Am Thorac Soc 2007 Dec 4(8) 671-4"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The two main CYP enzymes that are up-regulated by cigarette smoke are CYP1A1 and CYP1B1, which are regulated by ER{alpha} (18). Stimulation of estrogen receptor in the lungs increases protein expression of CYP1A1 by twofold (17). The increased CYP expression is also related to increased estradiol-? expression (19). CYPs are also involved in the bioactivation of 17?-estradiol, resulting in a positive feedback loop", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a63"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15367686", 
                                "Name": "Mol Cell Biol 2004 Oct 24(19) 8681-90"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "Moreover, expression of ERalpha is associated with a higher degree of differentiation of tumors and lower speed of tumor cell proliferation, which is consistent with the fact that ERalpha-expressing cells are usually negative for proliferating cell nuclear antigen and Ki67 expression, two markers of proliferation.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c52"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11060289", 
                                "Name": "J Biol Chem 2001 Feb 2 276(5) 3231-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bd0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11739747", 
                                "Name": "Mol Cell Biol 2002 Jan 22(1) 357-69"
                            }, 
                            "Disease": "", 
                            "SummaryText": "GT198 potently stimulated transcription mediated by estrogen receptor alpha and beta, thyroid hormone receptor beta1, androgen receptor, glucocorticoid receptor, and progesterone receptor.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bd3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16645043", 
                                "Name": "Mol Endocrinol 2006 Sep 20(9) 2020-35"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We demonstrate that MTA2 expression is correlated with ERalpha protein expression in invasive breast tumors. We show that the MTA2 family member can bind to ERalpha and repress its activity in human breast cancer cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b02"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11751622", 
                                "Name": "Endocrinology 2002 Jan 143(1) 304-12"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083bd5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17991765", 
                                "Name": "Mol Endocrinol 2008 Feb 22(2) 304-16"
                            }, 
                            "Disease": "", 
                            "SummaryText": "we coexposed cells to E2 and either dioxin or a hypoxic environment and studied the effects on ER signaling. As expected, the H-ERE cells responded to E2 with a robust increase of reporter gene expression (Fig. 1A). Coexposure with TCDD or hypoxia, however, resulted in a significant down-regulation of reporter gene activity,", 
                            "Cell": "Epithelial Cells", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083acf"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16009131", 
                                "Name": "Cell 2005 Jul 15 122(1) 33-43"
                            }, 
                            "Disease": "", 
                            "SummaryText": "direct ER binding requires the presence of Forkhead factor binding in close proximity. Furthermore, knockdown of FoxA1 expression blocks the association of ER with chromatin and estrogen-induced gene expression demonstrating the necessity of FoxA1 in mediating an estrogen response in breast cancer cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083ace"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16275121", 
                                "Name": "Trends Endocrinol Metab 2005 Dec 16(10) 478-88"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Small heterodimer partner (SHP; NR0B2), an exceptional member of the mammalian nuclear receptor family, directly modulates the activities of conventional nuclear receptors by acting as an inducible and tissue-specific corepressor. Recent progress in dissecting underlying molecular mechanisms, identifying target factors and target genes, and uncovering physiological functions points to the regulatory involvement of SHP in diverse metabolic and intracellular pathways that awaits future clarification. In this review, we carry out a comprehensive survey of all published data and discuss our current understanding of molecular mechanisms and physiological consequences governing SHP action.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083c54"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12635173", 
                                "Name": "Nat Rev Cancer 2002 Feb 2(2) 101-12"
                            }, 
                            "Disease": "", 
                            "SummaryText": "in a substantial proportion of patients with primary breast cancer, and in all patients with ER positive metastatic disease, resistance eventually develops to all strategies that are designed to limit ER activation by oestrogen. ER binds as a dimer to small palindromic DNA motifs - known as oestrogen response elements (EREs) - in the promoters of these genes, through the action of two ZINC FINGERS 29. AF1 and AF2 activate transcription independently and/or synergistically. There is evidence that AF1 and AF2 activities are influenced by the promoter and cell type 32. Three related co-activators, collectively known as the p160 co-activators, stimulate ER activity following ligand stimulation, through direct interaction with AF2 (reviewed in REFS 45,46).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b43"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "7491495", 
                                "Name": "Science 1995 Dec 1 270(5241) 1491-4"
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Ser118 is phosphorylated by mitogen-activated protein kinase (MAPK) in vitro and in cells treated with epidermal growth factor (EGF) and insulin-like growth factor (IGF) in vivo", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839db"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16847062", 
                                "Name": "J Biol Chem 2006 Sep 8 281(36) 26683-92"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Microarray experiments identified cyclin-dependent kinase inhibitor 1A as a nonclassical pathwayresponsive gene, and transient expression experiments using the cyclin-dependent kinase inhibitor 1A promoter confirmed transcriptional responses to the ERalpha (E207A/G208A) mutant.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083992"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16684779", 
                                "Name": "J Biol Chem 2006 Jul 14 281(28) 19092-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We found that KIBRA-DLC1 complex is recruited to ER-responsive promoters. We also found that KIBRA-DLC1 interaction is mandatory for the recruitment and transactivation functions of ER or DLC1 to the target chromatin. Finally we found that KIBRA interacts with histone H3 via its glutamic acid-rich region and that such interaction might play a mechanistic role in conferring an optimal ER transactivation function as well as the proliferation of ligand-stimulated breast cancer cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083995"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15126349", 
                                "Name": "Cancer Res 2004 May 1 64(9) 3119-25"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "treatment with 10 nM E2 for 12 h induced CYP1B1 mRNA expression in estrogen receptor (ER)-positive MCF-7 cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083994"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14625289", 
                                "Name": "J Biol Chem 2004 Mar 5 279(10) 9255-63"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839dd"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12943740", 
                                "Name": "J Steroid Biochem Mol Biol 2003 Jul 86(1) 1-14"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083998"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "21690342", 
                                "Name": "Proc Natl Acad Sci U S A 2011 Jun 20"
                            }, 
                            "Disease": "carcinoma of breast", 
                            "SummaryText": "HOXB7 is an ERalpha-responsive gene", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839eb"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17369357", 
                                "Name": "Proc Natl Acad Sci U S A 2007 Mar 27 104(13) 5455-60"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Epidermal growth factor receptor (EGFR) signaling has long been implicated downstream of ERalpha signaling", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b80"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11432835", 
                                "Name": "EMBO J 2001 Jul 2 20(13) 3484-94"
                            }, 
                            "Disease": "", 
                            "SummaryText": "docking of p90 ribosomal S6 kinase 2 (Rsk2) to the hormone-binding domain (HBD) of estrogen receptor alpha (ERalpha) induces a conformational change that enhances the transcriptional activation function contained in the HBD A constitutively active mutant of Rsk2 specifically enhances ERalpha-mediated transcription by phosphorylation of Ser167 in ERalpha", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b08"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8923463", 
                                "Name": "Mol Endocrinol 1996 Nov 10(11) 1371-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839e5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14715875", 
                                "Name": "J Clin Endocrinol Metab 2004 Jan 89(1) 375-83"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In both cell lines (MCF-7 and T47D) and in primary breast cancer cell cultures, beta-estradiol up-regulated ER-beta and coregulator protein expression and increased ER-alpha/ER-beta interaction with the estrogen response element (ERE)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839e4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12842887", 
                                "Name": "J Biol Chem 2003 Sep 19 278(38) 36418-29"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839e6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11782371", 
                                "Name": "Cancer Res 2002 Jan 1 62(1) 141-51"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "We previously reported that expression of the breast cancer susceptibility gene BRCA1 strongly inhibits the transcriptional activity of the estrogen receptor (ER-alpha) in human breast and prostate cancer cell lines but only weakly inhibits ER-alpha activity in cervical cancer cells (S. Fan et al., Science (Wash. DC), 284: 1354-1356, 1999).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b01"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15331580", 
                                "Name": "Endocrinology 2004 Dec 145(12) 5439-47"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Cyclin D1 enhances transcription of estrogen response element-responsive genes, independent of CDK-binding activity. Unliganded ER{alpha} binds to cyclin D1 in vivo and in vitro. ER{alpha} activation by cyclin D1 is not inhibited by antiestrogens (99).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839e0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11493692", 
                                "Name": "Proc Natl Acad Sci U S A 2001 Aug 14 98(17) 9587-92"
                            }, 
                            "Disease": "", 
                            "SummaryText": "that BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor alpha (ERalpha), a principal determinant of the growth, differentiation, and normal functional status of breasts and ovaries. Ectopic expression in Brca1-deficient cells of wild-type BRCA1, but not clinically validated BRCA1 missense mutants, restored ligand-independent repression of ERalpha in a manner dependent upon apparent histone deacetylase activity. In estrogen-dependent human breast cancer cells, chromatin immunoprecipitation analysis revealed the association of BRCA1 with ERalpha at endogenous estrogen-response elements before, but not after estrogen stimulation.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a6c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10379897", 
                                "Name": "Mol Endocrinol 1999 Jun 13(6) 993-1004"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In transient transfection experiments, we observed that overexpression of estrogen receptor (ER) alpha or beta induced endogenous rab11 mRNA in a hormone-dependent manner. ER bound to an antagonist, ICI 182,780, failed to activate this gene expression.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c3408398e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10403573", 
                                "Name": "Endocrine 1999 Feb 10(1) 67-76"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c340839e8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15319356", 
                                "Name": "Endocrinology 2004 Dec 145(12) 5525-31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Short-term treatment (at 24 h) increased the mRNA level of SOCS-3 but not SOCS-2. In cultured hepatoma cells, estrogen increased SOCS-2 and -3 mRNA levels by 2-fold in a time- and dose-dependent manner", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ESR1) actsIn tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b9e"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Diesel exhaust particles\")", 
                "relation": "increases", 
                "target": "cat(p(HGNC:CYP1A1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Diesel exhaust particles\" increases the catalytic activity of the protein abundance of CYP1A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Diesel exhaust particles\") increases cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20435083", 
                                "Name": "Toxicology 2010 Jun 29 273(1-3) 35-44"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Catalytic activities of CYP1A1, CYP1A2 and CYP1B1, and inducibility of the activities were studied in intact human lung samples (from 23 human subjects) ex vivo. The activities [as measured by ethoxyresorufin O-deethylase (EROD), methoxyresorufin O-demethylase (MROD), and 3-cyano-7-ethoxycoumarin O-deethylase (CECOD)] were present in the lungs and were induced by benzo[a]pyrene (B[a]P) and diesel exhaust particle extract (DEE) but with extensive inter-subject variability. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Diesel exhaust particles\") increases cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083a14"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Diesel exhaust particles\")", 
                "relation": "increases", 
                "target": "a(CHEBI:\"reactive oxygen species\")", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Diesel exhaust particles\" increases the abundance of \"reactive oxygen species\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Diesel exhaust particles\") increases a(CHEBI:\"reactive oxygen species\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12730081", 
                                "Name": "Am J Physiol Lung Cell Mol Physiol 2003 Sep 285(3) L671-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Using fluorescent probes, we detected ROS production in bronchial and nasal epithelial cells exposed to native DEP", 
                            "Cell": "bronchial epithelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Diesel exhaust particles\") increases a(CHEBI:\"reactive oxygen species\")", 
                                "eid": "524b352dd3fbfd4c34083a39"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Diesel exhaust particles\") increases a(CHEBI:\"reactive oxygen species\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8384149", 
                                "Name": "Free Radic Biol Med 1993 Jan 14(1) 37-47"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We found that DEP could produce O2.- and hydrsuperoxide oxyl radical (.OH) in vitro without any biological activating systems. From these results, it was suggested that most parts of DEP toxicity in lungs are due to active oxygen radicals such as O2.- and .OH.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Diesel exhaust particles\") increases a(CHEBI:\"reactive oxygen species\")", 
                                "eid": "524b352dd3fbfd4c34083a49"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Diesel exhaust particles\") increases a(CHEBI:\"reactive oxygen species\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12730081", 
                                "Name": "Am J Physiol Lung Cell Mol Physiol 2003 Sep 285(3) L671-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Using fluorescent probes, we detected ROS production in bronchial and nasal epithelial cells exposed to native DEP", 
                            "Cell": "Epithelial Cells", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Diesel exhaust particles\") increases a(CHEBI:\"reactive oxygen species\")", 
                                "eid": "524b352dd3fbfd4c3408395c"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Diesel exhaust particles\")", 
                "relation": "increases", 
                "target": "tscript(p(HGNC:NFE2L2))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Diesel exhaust particles\" increases the transcriptional activity of the protein abundance of NFE2L2.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Diesel exhaust particles\") increases tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12730081", 
                                "Name": "Am J Physiol Lung Cell Mol Physiol 2003 Sep 285(3) L671-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Indeed, DEP induced the translocation of Nrf2 to the nucleus and increased protein nuclear binding to the antioxidant responsive element.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Diesel exhaust particles\") increases tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083adc"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Diesel exhaust particles\") increases tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18614404", 
                                "Name": "Clin Immunol 2008 Sep 128(3) 366-73"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf2(-/-) mice exposed to low-dose DEP showed significantly increased airway hyperresponsiveness and counts of lymphocytes and eosinophils, together with increased concentrations of IL-12 and IL-13, and thymus and activation-regulated chemokine (TARC), in BAL fluid than wild-type mice. In contrast, expression of antioxidant enzyme genes was significantly higher in wild-type mice than in Nrf2(-/-) mice.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Diesel exhaust particles\") increases tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a4d"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Diesel exhaust particles\")", 
                "relation": "increases", 
                "target": "cat(p(HGNC:CYP1B1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Diesel exhaust particles\" increases the catalytic activity of the protein abundance of CYP1B1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Diesel exhaust particles\") increases cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20435083", 
                                "Name": "Toxicology 2010 Jun 29 273(1-3) 35-44"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Catalytic activities of CYP1A1, CYP1A2 and CYP1B1, and inducibility of the activities were studied in intact human lung samples (from 23 human subjects) ex vivo. The activities [as measured by ethoxyresorufin O-deethylase (EROD), methoxyresorufin O-demethylase (MROD), and 3-cyano-7-ethoxycoumarin O-deethylase (CECOD)] were present in the lungs and were induced by benzo[a]pyrene (B[a]P) and diesel exhaust particle extract (DEE) but with extensive inter-subject variability. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Diesel exhaust particles\") increases cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083b1f"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Diesel exhaust particles\")", 
                "relation": "increases", 
                "target": "cat(p(HGNC:CYP1A2))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Diesel exhaust particles\" increases the catalytic activity of the protein abundance of CYP1A2.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Diesel exhaust particles\") increases cat(p(HGNC:CYP1A2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20435083", 
                                "Name": "Toxicology 2010 Jun 29 273(1-3) 35-44"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Catalytic activities of CYP1A1, CYP1A2 and CYP1B1, and inducibility of the activities were studied in intact human lung samples (from 23 human subjects) ex vivo. The activities [as measured by ethoxyresorufin O-deethylase (EROD), methoxyresorufin O-demethylase (MROD), and 3-cyano-7-ethoxycoumarin O-deethylase (CECOD)] were present in the lungs and were induced by benzo[a]pyrene (B[a]P) and diesel exhaust particle extract (DEE) but with extensive inter-subject variability. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Diesel exhaust particles\") increases cat(p(HGNC:CYP1A2))", 
                                "eid": "524b352dd3fbfd4c34083bb6"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Diesel exhaust particles\")", 
                "relation": "increases", 
                "target": "tscript(p(HGNC:AHR))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Diesel exhaust particles\" increases the transcriptional activity of the protein abundance of AHR.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Diesel exhaust particles\") increases tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18497156", 
                                "Name": "Environ Sci Technol 2008 Apr 15 42(8) 2992-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Diesel exhaust contains numerous toxic substances that show different modes of action such as triggering aryl hydrocarbon receptor (AhR)-mediated pathways", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Diesel exhaust particles\") increases tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083bdc"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Diesel exhaust particles\") increases tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17827877", 
                                "Name": "J Reprod Dev 2007 Dec 53(6) 1191-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Diesel exhaust particles (DEPs) contain polycyclic aromatic hydrocarbons (PAH) that bind to aryl hydrocarbon receptors (AhRs) and decrease sperm production. These data suggest that DEP toxicity may affect the male reproductive system in an AhR-dependent manner.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Diesel exhaust particles\") increases tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083c2d"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:NR1I3))", 
                "relation": "increases", 
                "target": "p(HGNC:CYP1A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of NR1I3 increases the protein abundance of CYP1A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:NR1I3)) increases p(HGNC:CYP1A1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:NR1I3)) increases p(HGNC:CYP1A1)", 
                                "eid": "524b352dd3fbfd4c34083acc"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:GSTP1)", 
                "relation": "actsIn", 
                "target": "cat(p(HGNC:GSTP1))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of GSTP1 acts in catalytic activity of the protein abundance of GSTP1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12023900", 
                                "Name": "Biochem J 2002 Jun 1 364(Pt 2) 563-70"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The fifth intron of the GST-P1 gene contains the androgen-responsive region. Multiple androgen receptor binding sites are clustered within a 500 bp region of this intron. The whole fragment contains a minimum of seven androgen receptor binding sites, which collectively display strong androgen-dependent enhancer activity.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                                "eid": "524b352dd3fbfd4c34083bd8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11279197", 
                                "Name": "J Biol Chem 2001 Jun 15 276(24) 20999-1003"
                            }, 
                            "Disease": "", 
                            "SummaryText": "title := \\\"Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus.\\\"", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                                "eid": "524b352dd3fbfd4c34083beb"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14676828", 
                                "Name": "Oncogene 2004 Apr 1 23(14) 2442-53"
                            }, 
                            "Disease": "", 
                            "SummaryText": "ER beta-mediated regulation of GST-Pi and GCSh point towards an % important role for ER beta in cellular protection against oxidative stress. A % protective role is supported by our observation of inhibition of % estrogen-induced DNA damage upon upregulation of GST-Pi and GCSh expression", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                                "eid": "524b352dd3fbfd4c34083962"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15604283", 
                                "Name": "Cancer Res 2004 Dec 15 64(24) 9131-8"
                            }, 
                            "Disease": "Carcinoma of brain", 
                            "SummaryText": "We report here that the human glutathione S-transferase P1 (GSTP1) protein, involved in phase II metabolism of many carcinogens and anticancer agents and in the regulation of c-Jun NH(2)-terminal kinase-mediated cell signaling, undergoes phosphorylation by the Ser/Thr protein kinases, cAMP-dependent protein kinase (PKA) and protein kinase C (PKC), resulting in a significant enhancement of its metabolic activity. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                                "eid": "524b352dd3fbfd4c340839a9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11408560", 
                                "Name": "J Pharmacol Exp Ther 2001 Jul 298(1) 339-45"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Both early passage and immortalized MEF cells from GSTpi(-/-) animals expressed significantly elevated activity of extracellular signal-regulated kinases ERK1/ERK2, kinases linked to cell proliferation pathways", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                                "eid": "524b352dd3fbfd4c34083c4d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12094619", 
                                "Name": "Nutr Cancer 2001 41(1-2) 156-64"
                            }, 
                            "Disease": "colorectal adenoma", 
                            "SummaryText": "We determined the expression of GSTP1 protein (enzyme-linked immunosorbent assay), the major GST in HT29, GSTP1 mRNA (Northern blotting), GST activity, intracellular glutathione, and total protein. Our results show that GSTP1 mRNA, GSTP1 protein, GST activity, and total protein were increased (1.2- to 2.5-fold) and glutathione levels were maintained after 24-72 h of incubation with 4 mM butyrate. Moreover, a marked reduction of HNE-induced genotoxicity was caused by preincubation with butyrate.  In conclusion, butyrate enhances expression of GST and other proteins in both cell lines, which leads to an enhanced chemoprotection, reducing the impact of HNE genotoxicity. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                                "eid": "524b352dd3fbfd4c34083a3c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15604283", 
                                "Name": "Cancer Res 2004 Dec 15 64(24) 9131-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We report here that the human glutathione S-transferase P1 (GSTP1) protein, involved in phase II metabolism of many carcinogens and anticancer agents and in the regulation of c-Jun NH(2)-terminal kinase-mediated cell signaling, undergoes phosphorylation by the Ser/Thr protein kinases, cAMP-dependent protein kinase (PKA) and protein kinase C (PKC), resulting in a significant enhancement of its metabolic activity. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                                "eid": "524b352dd3fbfd4c34083bbe"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10353259", 
                                "Name": "Biochem Pharmacol 1999 Jun 15 57(12) 1383-90"
                            }, 
                            "Disease": "", 
                            "SummaryText": "PGA2 appeared to inhibit GSTP1-1 mainly by binding to the cysteine 47 moiety of the enzyme", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                                "eid": "524b352dd3fbfd4c34083b31"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11668494", 
                                "Name": "Int J Cancer 2001 Oct 15 94(2) 171-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "% A conjugate of doxorubicin and glutathione via glutaraldehyde (GSH-DXR) % inhibited glutathione S-transferase (GST) activity of rat hepatoma AH66 % cells, and treatment of the cells with GSH-DXR induced caspase-3 activation % and DNA fragmentation. Caspase-3 activation and DNA fragmentation were induced % following the suppression of GST-P expression by treatment with GSH-DXR.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:GSTP1) actsIn cat(p(HGNC:GSTP1))", 
                                "eid": "524b352dd3fbfd4c34083c11"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:NFE2L2)", 
                "relation": "actsIn", 
                "target": "tscript(p(HGNC:NFE2L2))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of NFE2L2 acts in transcriptional activity of the protein abundance of NFE2L2.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20452971", 
                                "Name": "J Biol Chem 2010 Jul 9 285(28) 21349-58"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Mutagenesis and transfection experiments identified an antioxidant response element in the forward and reverse strands of the proximal Cul3 and Rbx1 promoters, respectively, that Nrf2 binds and regulates expression and antioxidant induction of the Cul3-Rbx1 genes. In addition, short interfering RNA inhibition and overexpression of Nrf2 led to a respective decrease and increase in Cul3-Rbx1 gene expression. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083be6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17192422", 
                                "Name": "J Lipid Res 2007 Mar 48(3) 709-15"
                            }, 
                            "Disease": "", 
                            "SummaryText": "OKL38 stimulation by OxPAPC was reduced by 86%in cells treated with Nrf2 siRNA (Fig. 6C). Thus, Nrf2 is necessary for OKL38 stimulation by OxPAPC.", 
                            "Cell": "Endothelial Cells", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bc9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18316592", 
                                "Name": "Cancer Res 2008 Mar 1 68(5) 1303-9"
                            }, 
                            "Disease": "lung adenocarcinoma", 
                            "SummaryText": "We found that cell lines expressing lower levels of KEAP1 (H1437 and II-18) and KEAP1 mutant cells (A549) showed greater resistance to cisplatin than SQ-19 cells with normal KEAP1 (Fig. 4D), indicating that constitutive activation of Nrf2 enhances resistance to chemotherapy reagents.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bc4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19454702", 
                                "Name": "J Immunol 2009 Jun 1 182(11) 7048-57"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Transfection studies with luciferase reporter gene constructs indicate that increased HO-1 gene expression via inhibition of p38 was mediated by the transcription factor Nrf2, which is a central regulator of the cellular oxidative stress response. Accordingly, inhibitors of p38 induced binding of nuclear proteins to a Nrf2 target sequence of the HO-1 promoter, but did not affect HO-1 protein expression and promoter activity in Nrf2(-/-) MEF.", 
                            "Cell": "Monocytes", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083966"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18996472", 
                                "Name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In addition, 4-hydroxy-2-nonenal, a lipid peroxidation product of OxLDL, was one of the most effective activators of Nrf2 [137].", 
                            "Cell": "Macrophages", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c4b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17360324", 
                                "Name": "Proc Natl Acad Sci U S A 2007 Mar 20 104(12) 5205-10"
                            }, 
                            "Disease": "neuroblastoma", 
                            "SummaryText": "Overexpression of SQSTM1 and DPP3 in IMR-32 cells stimulated NF-E2-related factor 2 (NRF2) nuclear translocation and led to increased levels of NAD(P)H:quinone oxidoreductase 1, a protein which is transcriptionally regulated by the ARE.....SQSTM1 and DPP3 were unable to activate the ARE in cells transfected with siRNAs against NRF2", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083aa0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12145307", 
                                "Name": "J Biol Chem 2002 Sep 27 277(39) 36544-52"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Collectively, these data support the conclusion that Keap1 dimerization is required for Nrf2 sequestration and transcriptional repression. Furthermore, exposure to inducing agents disrupts the Keap1 dimerization function and results in Nrf2 release.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083aa4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16172382", 
                                "Name": "Proc Natl Acad Sci U S A 2005 Sep 27 102(39) 14010-5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The abrogation of shear-induced COX-2 expression by PI3-K activity and/or stimulation of the Nrf2/ARE pathway suggests the existence of PI3-K/Nrf2/ARE negative feedback loops that potentially interfere with c-Jun N-terminal kinase 2 activity upstream of COX-2", 
                            "Cell": "chondrocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083aa8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12506115", 
                                "Name": "J Biol Chem 2003 Mar 7 278(10) 8135-45"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Regulation of both basal and inducible expression of cytoprotective genes is mediated in part by the antioxidant response element (ARE)3, a cis-acting sequence found in the 5?-flanking region of genes encoding many phase 2 enzymes including mouse glutathione Stransferase (GST) A1, human NAD(P)H quinone oxidoreductase (NQO1) and human ?- glutamylcysteine ligase as well as murine Nrf2 itself (5-8).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839d2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18996472", 
                                "Name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Table 1 Transcription factors activated by OxLDL", 
                            "Cell": "Myocytes, Smooth Muscle", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839b4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18996472", 
                                "Name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37"
                            }, 
                            "Disease": "", 
                            "SummaryText": "This factor is activated by oxidants such as hydrogen peroxide [125], hypochlorous acid [126], or nitric oxide [127] and by environmental toxic metals such as chromium [128].", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839b5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17673673", 
                                "Name": "Circ Res 2007 Sep 28 101(7) 723-33"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We next infected HUVECs with a dominant-negative form of Akt and found that it blocked the Nrf2 activation and HO-1 expression (Figure 7B).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b76"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12391262", 
                                "Name": "Mol Pharmacol 2002 Nov 62(5) 1001-10"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Expression of phase II detoxifying genes is regulated by NF-E2-related factor 2 (Nrf2)-mediated antioxidant response element (ARE) activation. We showed previously that phosphatidylinositol 3 (PI3)-kinase plays an essential role in ARE-mediated rGSTA2 induction by oxidative stress. In view of the fact that the signaling pathway of PI3-kinase controls microfilaments and translocation of actin-associated proteins, the current study was designed to investigate the PI3-kinase-mediated nuclear translocation of Nrf2 and the interaction of Nrf2 with actin. tert-Butylhydroquinone (t-BHQ) caused Nrf2 to translocate into the nucleus in H4IIE cells, which was prevented by pretreatment of the cells with PI3-kinase inhibitors (wortmannin/LY294002). t-BHQ relocalized Nrf2 in concert with changes in actin microfilament architecture, as visualized by superposition of immunochemically stained Nrf2 and fluorescent phalloidin-stained actin. Furthermore, t-BHQ increased the level of nuclear actin, coimmunoprecipitated with Nrf2, which returned to that of control by pretreatment of the cells with PI3-kinase inhibitors. Cytochalasin B, an actin disruptor, alone stimulated actin-mediated nuclear translocation of Nrf2 and induced rGSTA2. In contrast, phalloidin, an agent that prevents actin filaments from depolymerization, inhibited Nrf2 translocation and rGSTA2 induction by t-BHQ. Subcellular fractionation and immunoblot analyses allowed us to detect both 57- and 100-kDa Nrf2. Immunoblot and immunoprecipitation assays showed that the 100-kDa protein comprised both Nrf2 and actin. The present study demonstrates that the PI3-kinase signaling pathway regulates rearrangement of actin microfilaments in response to oxidative stress and that depolymerization of actin causes a complex of Nrf2 bound with actin to translocate into nucleus.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a5d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19646463", 
                                "Name": "Toxicol Appl Pharmacol 2009 Jul 29"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Activation of Nrf2-ARE responses by a polyphenol epigallocatechin-3-gallate treatment reduced bleomycin-induced lung injury and inflammation in rats (Sriram et al., 2008).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b2e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12730081", 
                                "Name": "Am J Physiol Lung Cell Mol Physiol 2003 Sep 285(3) L671-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Indeed, DEP induced the translocation of Nrf2 to the nucleus and increased protein nuclear binding to the antioxidant responsive element.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c0c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16200199", 
                                "Name": "J Clin Invest 2005 Oct 115(10) 2656-64"
                            }, 
                            "Disease": "", 
                            "SummaryText": "From Figure 1", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839cc"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18614404", 
                                "Name": "Clin Immunol 2008 Sep 128(3) 366-73"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf2(-/-) mice exposed to low-dose DEP showed significantly increased airway hyperresponsiveness and counts of lymphocytes and eosinophils, together with increased concentrations of IL-12 and IL-13, and thymus and activation-regulated chemokine (TARC), in BAL fluid than wild-type mice. In contrast, expression of antioxidant enzyme genes was significantly higher in wild-type mice than in Nrf2(-/-) mice.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b6b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15292179", 
                                "Name": "J Biol Chem 2004 Oct 1 279(40) 42302-12"
                            }, 
                            "Disease": "", 
                            "SummaryText": "To determine whether the nuclear Nrf2 is capable of binding to DNA, we used an EMSA approach with a 32P-labeled ARE probe (Fig. 2). When incubated with the nuclear extracts from control and hyperoxia-exposed C10 cells, the ARE probe formed two major protein complexes, designated I and II. The formation of these complexes was enhanced in cells exposed to hyperoxic conditions (lane 2, Fig. 2B).In particular, a significant difference was observed at 3 h post-exposure. Similar results were obtained with the nuclear extracts from A549 cells (data not shown).", 
                            "Cell": "Epithelial Cells", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a44"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14978030", 
                                "Name": "J Biol Chem 2004 May 7 279(19) 20108-17"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The accumulation of unfolded proteins elicits a cellular response that triggers both pro-survival and pro-apoptotic signaling events. PERK-dependent activation of NF-E2-related factor-2 (Nrf2) is critical for survival signaling during this response", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b17"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17278884", 
                                "Name": "Cell Stress Chaperones 2006 11(4) 356-63"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In conclusion, expression of Nrf2-dependent genes is increased during cholestasis.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083aaa"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18973804", 
                                "Name": "Free Radic Biol Med 2009 Jan 15 46(2) 146-53"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Cotransfection with Nrf2 stimulated the Prdx6 promoter in an ARE-dependent manner, whereas it was negatively regulated by Nrf3. siRNA targeting Nrf2 down-regulated reporter gene expression, whereas siRNA targeting the Nrf2 repressor, Keap1, up-regulated it. Binding of Nrf2 to the ARE sequence in chromatin was confirmed by PCR after chromatin immunoprecipitation. These data demonstrate that the ARE within the Prdx6 promoter is a key regulator of basal transcription of the Prdx6 gene and of its inducibility under conditions of oxidative stress.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083aae"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20185790", 
                                "Name": "Arterioscler Thromb Vasc Biol 2010 May 30(5) 1007-13"
                            }, 
                            "Disease": "", 
                            "SummaryText": "OxPLs induced upregulation of ATF4 mRNA and protein in several types of endothelial cells and that these effects were suppressed by short interfering RNA (siRNA) against NRF2.... Chromatin immunoprecipitation revealed OxPL-dependent binding of NRF2 to a putative antioxidant response element site in the ATF4 gene promoter. ", 
                            "Cell": "Endothelial Cells", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083be0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8962164", 
                                "Name": "Proc Natl Acad Sci U S A 1996 Dec 10 93(25) 14960-5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "These results indicated that hARE-mediated expression of the NQO1 gene and its induction by xenobiotics and antioxidants are mediated by Nrf1 and Nrf2. The hARE-mediated basal expression, however, is repressed by overexpression of c-Fos and Fra1", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bb9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9872330", 
                                "Name": "Oncogene 1998 Dec 17 17(24) 3145-56"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Jun, Jun-B and Jun-D) proteins to upregulate ARE-mediated expression and coordinated induction of detoxifying enzymes in response to antioxidants and xenobiotics.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083aaf"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11909699", 
                                "Name": "Free Radic Biol Med 2002 Apr 1 32(7) 650-62"
                            }, 
                            "Disease": "", 
                            "SummaryText": "# Pubmed:gene: Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of gamma-glutamylcysteine synthetase. # Ariadne: These results also support the hypothesis that indomethacin-induced transcriptional activation of GCLC involves the redox-dependent release of KIAA0132 from Nrf2 followed by the nuclear translocation of Nrf2. [MolTransport]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bb4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11274184", 
                                "Name": "J Biol Chem 2001 Jun 15 276(24) 20858-65"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf2 regulates expression of genes encoding enzymes with antioxidant (e.g. heme oxygenase-1 (HO-1)) or xenobiotic detoxification (e.g. NAD(P)H:quinone oxidoreductase, glutathione S-transferase) functions via the stress- or antioxidant-response elements (StRE/ARE)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bb2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16870687", 
                                "Name": "Toxicol Sci 2006 Oct 93(2) 422-31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Generally, we observed the upregulation of a specific subset of antioxidant and phase II\u2013related genes known to be widely controlled by nuclear factor-E2\u2013related factor 2 (Nrf2) (for review, see Kobayashi and Yamamoto, 2005Go), thus confirming recent mechanistic investigations showing that Nrf2 activation is a major protective cellular feature in the context of CS exposure in vitro (Kn\u00f6rr-Wittmann et al., 2005Go) and in vivo (Rangasamy et al., 2004Go).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bb1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18996472", 
                                "Name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The transcription factor Nrf2 was originally described as a transcription factor controlling expression of the ?-globin gene in erythrocytes.", 
                            "Cell": "erythrocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083af4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18467642", 
                                "Name": "Arterioscler Thromb Vasc Biol 2008 May 8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We report that KLF2 substantially enhances antioxidant activity of Nrf2 by increasing its nuclear localization and activation. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bce"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18585365", 
                                "Name": "Arch Biochem Biophys 2008 Sep 1 477(1) 139-45"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Similarly, Nrf2 activators induced CD36 expression in bone marrow-derived macrophages in a Nrf2-dependent manner.", 
                            "Cell": "Macrophages", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b12"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17015834", 
                                "Name": "Proc Natl Acad Sci U S A 2006 Oct 10 103(41) 15091-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Overexpressed Nrf2 robustly activated ARE-regulated luciferase (Fig. 3B, lanes 1 vs. lane 2). Cells with siCTL produced a basal level of luciferase, whereas tBHQ induced luciferase expression as expected (36) (Fig. 3B, lanes 3 and 4). In the presence of siDJ-1#1 or siDJ-1#2, luciferase activity was reduced (Fig. 3B, lanes 5 and 7), and it was no longer stimulated by tBHQ treatment (lanes 6 and 8).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c3408396b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15375163", 
                                "Name": "J Biol Chem 2004 Dec 10 279(50) 52390-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "oxidant-inducible Nrf2", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b63"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18048326", 
                                "Name": "Proc Natl Acad Sci U S A 2007 Dec 4 104(49) 19589-94"
                            }, 
                            "Disease": "", 
                            "SummaryText": "ATRA did not block the nuclear accumulation of Nrf2 but reduced the binding of Nrf2 to the ARE enhancer as a consequence of forming a complex with RARalpha.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b61"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11013233", 
                                "Name": "J Biol Chem 2000 Dec 22 275(51) 40134-41"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The various AREs bind to a complex of nuclear proteins from cells of different origins (15-23, 25). Analysis of ARE-nuclear protein complexes have identified several nuclear transcription factors including c-Jun, Jun-B, Jun-D, c-Fos, Fra1, Nrf1, Nrf2, YABP, ARE-BP1, MafK, Ah (aromatic hydrocarbon) receptor, and the estrogen receptor (15-32). Among these transcription factors, Nrf1 and Nrf2 have been shown to heterodimerize with c-Jun and up-regulate the ARE-mediated expression and induction of NQO1 in response to antioxidants and xenobiotics (26, 31). ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b67"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18036733", 
                                "Name": "Cancer Lett 2008 Feb 18 260(1-2) 96-108"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf2-deficient murine embryonic fibroblasts showed increased cell death, cytotoxicity, and apoptosis in response to cisplatin treatment compared to wild-type cells. Cisplatin-resistant human ovarian cancer SK-OV cells, which are retaining 25-fold higher levels of GSH than murine fibroblasts, could be sensitized by inhibition of Nrf2.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839c9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16585964", 
                                "Name": "J Clin Invest 2006 Apr 116(4) 984-95"
                            }, 
                            "Disease": "", 
                            "SummaryText": "At 30 minutes after LPS challenge, gene expression for cytokines such as TNF-alpha, TNFSF9, IL-1alpha, IL-6, IL1F9, IL-10, IL-12b, IL-23p19, CSF1, and CSF2 was significantly higher in lungs of Nrf2-/- compared with Nrf2+/+ mice. Among all cytokines, the expression of IL-6 was highest. Members of C-C family (CCL12 [MCP5], CCL17 [TARC], CCL2 [MCP1], CCL3 [MIP1alpha], CCL4 [MIP1b], and CCL6 and CCL8 [MCP2]) and C-X-C chemokines (MIP2, MIG, KC, ITAC, IP-10, and CXCL13) were greatly upregulated in LPS-challenged Nrf2-/- lungs relative to Nrf2+/+ (Figure 4 and Supplemental Table 1).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b68"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20122946", 
                                "Name": "Toxicol Appl Pharmacol 2010 Apr 1 244(1) 57-65"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively regulates the basal and inducible expression of a large battery of cytoprotective genes. These gene products include proteins that catalyze reduction reactions (NAD(P)H:quinone oxidoreductase 1, Nqo1), conjugation reactions (glutathione-S-transferases, Gsts and UDP-glucuronosyltransferases, Ugts), as well as the efflux of potentially toxic xenobiotics and xenobiotic conjugates (multidrug resistance-associated proteins, Mrps)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b3d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16958665", 
                                "Name": "J Gastroenterol Hepatol 2006 Oct 21 Suppl 3 S22-5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "E47 cells showed increased Nrf2 mRNA and protein expression. Upregulation of GCLC and HO-1 in E47 cells is dependent on Nrf2.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839bb"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12023900", 
                                "Name": "Biochem J 2002 Jun 1 364(Pt 2) 563-70"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf2 directly activated the GST-P1 gene promoter, up to the \u00ae95 deletion position.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b7c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14673141", 
                                "Name": "Mol Cell Biol 2004 Jan 24(1) 36-45"
                            }, 
                            "Disease": "", 
                            "SummaryText": "in mouse peritoneal macrophages 15d-PGJ(2) can activate Nrf2 by forming adducts with Keap1, resulting in an Nrf2-dependent induction of heme oxygenase 1 and peroxiredoxin I (PrxI) gene expression.", 
                            "Cell": "Macrophages", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a59"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14565943", 
                                "Name": "Am J Physiol Lung Cell Mol Physiol 2004 Feb 286(2) L427-36"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Overexpression of Fra-1 downregulated c-Jun and Nrf2 enhanced AP-1- and ARE-mediated reporter gene expression, respectively....In contrast, it markedly stimulated ARE-dependent reporter expression (Fig. 7B). Overexpression of Fra-1 significantly and dose-dependently suppressed basal (Fig. 6B) and c-Jun enhanced (Fig. 6C) TRE-driven reporter expression. Similarly, Fra-1 suppressed basal and Nrf2-enhanced ARE-mediated reporter expression (Fig.  7C). Together, these results indicate that fra-1  induction by DEP may play a role in modulation of c-Jun- and Nrf2-dependent gene expression in alveolar epithelial cells.", 
                            "Cell": "Epithelial Cells", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a55"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20300512", 
                                "Name": "PLoS One 2010 5(3) e9631"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The NQO1 promoter contains an antioxidant response element (ARE), the target sequence for Nrf2, and is known to be Nrf2-inducible. We therefore evaluated protein levels of NQO1 in cytoplasmic extracts of p47phox-/- and WT macrophages following zymosan stimulation as an indirect readout of Nrf2 activation. Consistent with Nrf2 nuclear translocation, NQO1 expression was induced by zymosan in WT, but not in p47phox-/-, macrophages (Figure 6C).", 
                            "Cell": "Macrophages", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c06"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20351055", 
                                "Name": "Toxicol Sci 2010 Jul 116(1) 151-63"
                            }, 
                            "Disease": "", 
                            "SummaryText": "These data suggest that cinnamaldehyde promotes GCLC and GCLM expression through the activation of the Nrf2 pathway.", 
                            "Cell": "Endothelial Cells", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a56"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15292179", 
                                "Name": "J Biol Chem 2004 Oct 1 279(40) 42302-12"
                            }, 
                            "Disease": "", 
                            "SummaryText": "hyperoxia caused the translocation of Nrf2 from the cytoplasm to the nucleus within 30-60 min of exposure", 
                            "Cell": "", 
                            "Tissue": "Epithelium", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c00"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16234432", 
                                "Name": "FASEB J 2005 Dec 19(14) 2085-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Gel shift analysis confirmed the increased binding of an Nrf2 containing protein complex to the ets-1 ARE after H2O2 treatment. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c01"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20452972", 
                                "Name": "J Biol Chem 2010 Jul 16 285(29) 22576-91"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Herein, we have mapped an antioxidant response element (ARE) in the p62 promoter that is responsible for its induction by oxidative stress via NRF2. Chromatin immunoprecipitation and gel mobility-shift assays verified that NRF2 binds to this cis-element in vivo and in vitro.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ba8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17015256", 
                                "Name": "Free Radic Res 2006 Aug 40(8) 775-87"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Sulforaphane induces via activation of the Nrf2/Keap1 system phase 2 enzymes that protect against carcinogens and oxidants.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c3408395f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15629866", 
                                "Name": "Free Radic Biol Med 2005 Feb 1 38(3) 375-87"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Smad3E suppressed Nrf2-mediated activation of the GCLC reporter. We demonstrate that TGF-beta increased ATF3 protein levels, as did transient overexpression of Smad3E. Ectopic expression of ATF3 was sufficient to suppress the GCLC reporter activity, as well as endogenous GCLC expression", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083be3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17413030", 
                                "Name": "Am J Respir Cell Mol Biol 2007 Jul 37(1) 3-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Moreover, despite their elevated levels of ROS, Nrf2(-/-) type II cells were viable and, like their wild-type counterparts, exhibited normal differentiation characteristics.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b54"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19931411", 
                                "Name": "Int J Biochem Cell Biol 2010 Feb 42(2) 297-305"
                            }, 
                            "Disease": "", 
                            "SummaryText": "eckol treated cells exhibited significantly elevated Nrf2 binding to the ARE sequence as assessed by the gel shift assay (Fig. 2D)....As illustrated in Fig. 2E, eckol increased the transcriptional activity of Nrf2.", 
                            "Cell": "Fibroblasts", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c2f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15870071", 
                                "Name": "J Biol Chem 2005 Jul 8 280(27) 25571-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "FGF-1 induced the expression of HO-1 in cultured rat spinal cord astrocytes, which was dependent on FGF receptor activation and prevented by cycloheximide. FGF-1 also induced Nrf2 mRNA and protein levels and prompted its nuclear translocation. HO-1 induction was abolished by transfection of astrocytes with a dominant-negative mutant Nrf2, indicating that FGF-1 regulates HO-1 expression through Nrf2. FGF-1 also modified the expression of other antioxidant genes regulated by Nrf2", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b7a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18316592", 
                                "Name": "Cancer Res 2008 Mar 1 68(5) 1303-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We found that cell lines expressing lower levels of KEAP1 (H1437 and II-18) and KEAP1 mutant cells (A549) showed greater resistance to cisplatin than SQ-19 cells with normal KEAP1 (Fig. 4D), indicating that constitutive activation of Nrf2 enhances resistance to chemotherapy reagents.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a20"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19345732", 
                                "Name": "Free Radic Biol Med 2009 Jun 15 46(12) 1650-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In HBE1 cells, silencing of Nrf2 with siRNA inhibited induction of MRP3 by HNE. ", 
                            "Cell": "bronchial epithelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839ac"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16828809", 
                                "Name": "Life Sci 2006 Jun 20"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Phenethyl isothiocyanate (PEITC) is a promising chemopreventive agent that exerts its effects by induction of phase II enzymes via activation of Nrf2.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839ab"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19520915", 
                                "Name": "Am J Respir Cell Mol Biol 2009 Jun 11"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Interestingly, COPD patients? lungs have decreased expression of Nrf2 target genes, which correlate with increased lung damage and COPD severity (21). ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c19"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12947090", 
                                "Name": "J Biol Chem 2003 Nov 7 278(45) 44675-82"
                            }, 
                            "Disease": "", 
                            "SummaryText": "# Ariadne: Both require PKC-mediated phosphorylation of  Nrf2, leading to either release of Nrf2 from INrf2 ( Hypothesis I ) or escape  of Nrf2 from INrf2 ( Hypothesis II ). [ProtModification]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b71"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12370194", 
                                "Name": "J Biol Chem 2003 Jan 10 278(2) 703-11"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In addition, expression of NQO1 or Nrf2 inhibited tumor necrosis factor-alpha-induced activation of VCAM-1 (vascular cell adhesion molecule-1) gene expression in EC", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bae"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19646463", 
                                "Name": "Toxicol Appl Pharmacol 2009 Jul 29"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In vitro exposure to acrolein, an electrophilic carcinogen in cigarette smoke, stimulated Nrf2 activation and transcriptional induction of phase 2 enzymes (NQO1, GCL) in type II lung cells (Tirumalai et al., 2002).", 
                            "Cell": "Alveolar type II cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c30"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15292179", 
                                "Name": "J Biol Chem 2004 Oct 1 279(40) 42302-12"
                            }, 
                            "Disease": "", 
                            "SummaryText": "To determine whether the nuclear Nrf2 is capable of binding to DNA, we used an EMSA approach with a 32P-labeled ARE probe (Fig. 2). When incubated with the nuclear extracts from control and hyperoxia-exposed C10 cells, the ARE probe formed two major protein complexes, designated I and II. The formation of these complexes was enhanced in cells exposed to hyperoxic conditions (lane 2, Fig. 2B).In particular, a significant difference was observed at 3 h post-exposure. Similar results were obtained with the nuclear extracts from A549 cells (data not shown).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a33"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15520857", 
                                "Name": "J Clin Invest 2004 Nov 114(9) 1248-59"
                            }, 
                            "Disease": "", 
                            "SummaryText": "(EMSA) was used to determine the activation and DNA binding activity of Nrf2 in the lungs in response to acute exposure of the mice to CS (5 hours) ....Supershift analysis with anti-Nrf2 antibody also showed the binding of Nrf2 to the ARE consensus sequence, suggesting the activation of Nrf2 in the lungs of Nrf2+/+ mice in response to CS exposure (Figure 6A).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a37"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "21569840", 
                                "Name": "Free Radic Biol Med 2011 Jul 1 51(1) 97-106"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Knockdown of Nrf2 significantly decreased NQO1 mRNA and protein levels in cells with or without BaP treatment. NQO1 promoter activity was abrogated by mutation of the Nrf2-binding site in this promoter.", 
                            "Cell": "", 
                            "Tissue": "Endothelium", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c1b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18273910", 
                                "Name": "J Biochem Mol Toxicol 2008 Feb 22(1) 63-76"
                            }, 
                            "Disease": "neuroblastoma", 
                            "SummaryText": "The findings demonstrated that phosphorylation of Nrf2 at the TA domains by CK2 is an integral component of Nrf2 activation necessary for the nuclear localization and transcription activation function of Nrf2 in neuroblastoma cells.  \t ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c1a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19273391", 
                                "Name": "Front Biosci 2009 14 4809-14"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In a rat hepatoma cell line, peroxynitrite induced PI3K activation and PKB/Akt phosphorylation, leading to the activation of Nrf2/ARE transcription factor and the upregulated expression of the detoxifying enzyme glutathione-Stransferase (41). A similar conclusion was reached by Li et al, who demonstrated a peroxynitrite-dependent phosphorylation of Akt triggering the activation of Nrf2/ARE, and the subsequent upregulation of the antioxidant and cytoprotective enzyme heme-oxygenase-1 in neural cells, resulting in the limitation of peroxynitrite-mediated apoptosis (42).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b5f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15004004", 
                                "Name": "Genes Dev 2004 Feb 15 18(4) 357-68"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c26"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17707332", 
                                "Name": "Arch Biochem Biophys 2007 Sep 15 465(2) 336-46"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Also, several Nrf2 target genes involved in phase 2 drug metabolism and oxidative stress were increased. Examples include Gpx2 (chgf 2), Ho-1 (chgf 1.4), ferritin (chgf 1.1), Mt1 (chgf 6), and Mt2 (chgf 2). Moreover, Gadd45 was upregulated as described by Gebel et al. (chgf 0.8), indicating DNA damage.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b5c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16181113", 
                                "Name": "Curr Neurovasc Res 2005 Jul 2(3) 189-96"
                            }, 
                            "Disease": "", 
                            "SummaryText": "HO-1 expression is controlled by a stress-responsive transcription factor, Nrf2, which is a labile protein that is subject to proteasomal degradation. ", 
                            "Cell": "astrocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c25"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19797762", 
                                "Name": "Am J Respir Crit Care Med 2009 Dec 15 180(12) 1196-207"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Compared with wild-type mice, emphysematous lungs of CS-exposed Nrf2-deficient mice exhibited markedly lower proteasomal activity and elevated markers of ER stress", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b41"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20224069", 
                                "Name": "Am J Respir Crit Care Med 2010 Jul 15 182(2) 170-82"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Deletion or site-directed mutagenesis of a potential ARE spanning -784/-764 sequence significantly attenuated hyperoxia-increased Pparg promoter activity in airway epithelial cells overexpressing Nrf2, indicating that the -784/-764 ARE is critical for Nrf2-regulated PPARgamma expression. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a2b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15655294", 
                                "Name": "J Pharmacol Sci 2005 Jan 97(1) 43-51"
                            }, 
                            "Disease": "", 
                            "SummaryText": "beta-Naphthoflavone, an Nrf2 activator, elevated the level of AR mRNA in HepG2 cells...and increased the promoter activity of the mouse AR (AKR1B3) gene", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a2d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15546873", 
                                "Name": "J Biol Chem 2005 Jan 14 280(2) 872-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Luciferase reporter assays indicated that ER stress stimulated HO-1 promoter activity via the antioxidant response element. Moreover, ER stress induced the nuclear import of Nrf2 and the binding of Nrf2 to the HO-1 antioxidant response element.", 
                            "Cell": "", 
                            "Tissue": "vascular smooth muscle", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a2e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19027064", 
                                "Name": "Free Radic Biol Med 2009 Feb 1 46(3) 376-86"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Western blot analysis of lung proteins showed that Srx1 proteinwas present constitutively, and its level increased significantly on exposure to CS in Nrf2+/+ mice. By contrast, expression of Srx1 protein was low in Nrf2?/? mice and did not change significantly with CS exposure (Figs. 1B and C).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a2f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "21490276", 
                                "Name": "Sci Transl Med 2011 Apr 13 3(78) 78ra32"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf2 increased phagocytic ability of macrophages by direct transcriptional up-regulation of the scavenger receptor MARCO.", 
                            "Cell": "Macrophages", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083abb"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17823375", 
                                "Name": "Circ Res 2007 Oct 26 101(9) 919-27"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In human umbilical vein endothelial cells, exogenous CO activated Nrf2 through the phosphorylation of protein kinase R-like endoplasmic reticulum kinase (PERK), resulting in HO-1 expression.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083abe"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12646564", 
                                "Name": "J Biol Chem 2003 Jun 20 278(25) 22243-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a9a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11287661", 
                                "Name": "Proc Natl Acad Sci U S A 2001 Apr 10 98(8) 4611-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In contrast, the glutathione level in the Nrf2(-/-) mice was not compensated and remained low. This was because of the decrease in the gene expression of gcs(H) and gcs(L) as well as gss in the livers of the Nrf2(-/-) mice. In addition, the expression of ugt1a6 and gstpi that detoxify APAP by conjugation was also decreased.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a9f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14985508", 
                                "Name": "Proc Natl Acad Sci U S A 2004 Mar 9 101(10) 3381-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "nuclear factor erythroid2-related factor 2 (Nrf2) governs basal and inducible GCLC and GCLM expression by means of the antioxidant response element (ARE)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ad8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18316592", 
                                "Name": "Cancer Res 2008 Mar 1 68(5) 1303-9"
                            }, 
                            "Disease": "Carcinoma, Non-Small-Cell Lung", 
                            "SummaryText": "We found that cell lines expressing lower levels of KEAP1 (H1437 and II-18) and KEAP1 mutant cells (A549) showed greater resistance to cisplatin than SQ-19 cells with normal KEAP1 (Fig. 4D), indicating that constitutive activation of Nrf2 enhances resistance to chemotherapy reagents.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ad3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19273391", 
                                "Name": "Front Biosci 2009 14 4809-14"
                            }, 
                            "Disease": "Neoplasm", 
                            "SummaryText": "In a rat hepatoma cell line, peroxynitrite induced PI3K activation and PKB/Akt phosphorylation, leading to the activation of Nrf2/ARE transcription factor and the upregulated expression of the detoxifying enzyme glutathione-Stransferase (41). A similar conclusion was reached by Li et al, who demonstrated a peroxynitrite-dependent phosphorylation of Akt triggering the activation of Nrf2/ARE, and the subsequent upregulation of the antioxidant and cytoprotective enzyme heme-oxygenase-1 in neural cells, resulting in the limitation of peroxynitrite-mediated apoptosis (42).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ad0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16794261", 
                                "Name": "Am J Respir Cell Mol Biol 2006 Jun 22"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf2 knockout decreased expression of Gpx2. An ARE sequence located in the 5' promoter-flanking region of exon 1 of Gpx2 was identified and is highly conserved between mouse, rat, and human. Mutation of this ARE core sequence completely abolished the activity of promoter-reporter gene construct. The binding of Nrf2 to the GPX2 antioxidant response element was confirmed by chromatin immunoprecipation, electrophoretic mobility shift assays and site directed mutagenesis", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a03"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16804021", 
                                "Name": "Ann N Y Acad Sci 2006 May 1067 420-4"
                            }, 
                            "Disease": "", 
                            "SummaryText": "regulation of the proteasome by its inhibitor MG-132. Here, we demonstrate that the stimulation of the proteasome by low levels of MG-132 can be abrogated by small interfering RNAs (siRNAs) targeted against Nrf2.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ad5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15816842", 
                                "Name": "J Invest Dermatol 2005 Apr 124(4) 825-32"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Whereas disruption of nrf2 increased the number of apoptotic cells following UVA irradiation by 1.7-fold, disruption of keap1 decreased the apoptotic cell number by half as compared with wild-type controls.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a87"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14517290", 
                                "Name": "Mol Cell Biol 2003 Oct 23(20) 7198-209"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf2 is maintained in the cytoplasm via association with Keap1.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a84"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17925401", 
                                "Name": "J Biol Chem 2007 Dec 14 282(50) 36412-20"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Mutagenesis, transfection, and chromatin immunoprecipitation assays identified an antioxidant-response element in the reverse strand of the proximal INrf2 promoter that binds to Nrf2 and regulates expression and antioxidant induction of the INrf2 gene. In addition, short interfering RNA inhibition or overexpression of Nrf2 led to a respective decrease and increase in INrf2 gene expression.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a85"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19646463", 
                                "Name": "Toxicol Appl Pharmacol 2009 Jul 29"
                            }, 
                            "Disease": "Neoplasm", 
                            "SummaryText": "NRF2 (or Nrf2) activation also stimulated growth of lung cancer-derived cell lines expressing KEAP1 at low levels in KEAP1 mutant cell lines and in Keap1-null mouse embryonic fibroblasts under homeostatic conditions (Singh et al., 2006).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b39"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14998373", 
                                "Name": "Biochem J 2004 Jun 15 380(Pt 3) 695-703"
                            }, 
                            "Disease": "", 
                            "SummaryText": "nuclear factor erythroid 2-related factor 2, a tBHQ-activated CNC bZip (cap 'n' collar basic leucine zipper) protein", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a80"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18550526", 
                                "Name": "J Biol Chem 2008 Aug 15 283(33) 22363-70"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Conversely, following treatment with 25 um arsenite, NFE2L2 is highly bound at both elements, and BACH1 binding is lost. ", 
                            "Cell": "Keratinocytes", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a1f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20133372", 
                                "Name": "Toxicol Sci 2010 May 115(1) 238-52"
                            }, 
                            "Disease": "", 
                            "SummaryText": "from full text - Another potential candidate of partial Nrf 2 regulation observed in this study is aldh3a1 (subcluster 1.2), a key component of aldehyde detoxification. Exhibiting an (Nrf2-independent) expression profile characteristic for phase 1 genes, which is also supported by a previous promoter analysis (Xie et al., 1996), this gene was found to be constitutively upregulated > 12-fold in lung tissue of unexposed mice exhibiting a Clara cell\u2013specific conditional knock out in the keap1 gene (Jon Maher and Keiko Taguchi, unpublished observation). Thus, we conclude that aldh3a1 is targeted by both the Ah receptor and the Nrf2 pathway, supporting the concept that drug-processing genes may be activated by an AhR-Nrf2 signaling axis (Yeager et al., 2009).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b37"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12600891", 
                                "Name": "Circ Res 2003 Mar 7 92(4) 386-93"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Supershift analyses revealed that oxLDL stimulates binding of the transcription factors Nrf1, Nrf2, and c-jun to the AREs", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c38"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20185790", 
                                "Name": "Arterioscler Thromb Vasc Biol 2010 May 30(5) 1007-13"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Chromatin immunoprecipitation demonstrated OxPAPC-induced binding of NRF2 protein to a DNA region (-363/-183) containing this site (Figure 4A).", 
                            "Cell": "umbilical vein endothelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083aeb"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16357179", 
                                "Name": "Cancer Res 2005 Dec 15 65(24) 11676-88"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Cultures treated with MGd or zinc acetate alone elicited transcriptional responses characterized by induction of metal response element-binding transcription factor-1 (MTF-1)-regulated and hypoxia-inducible transcription factor-1 (HIF-1)-regulated genes. Cultures cotreated with MGd and zinc acetate displayed further increases in the levels of MTF-1- and HIF-1-regulated transcripts as well as additional transcripts regulated by NF-E2-related transcription factor 2", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a90"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11683914", 
                                "Name": "Genes Cells 2001 Oct 6(10) 857-68"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf2 contains two transcription activation domains, Neh4 and Neh5, which act synergistically to attain maximum a activation of reporter gene expression. Neh4 and Neh5 both individually and cooperatively bind to CBP", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a93"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15890065", 
                                "Name": "Biochem J 2005 Sep 1 390(Pt 2) 521-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The transcriptional start site is located 80 nt upstream of the translation start site. The human GSS promoter efficiently drove luciferase expression in Chang cells. Overexpression of either Nrf1 or Nrf2 induced the GSS promoter activity by 130 and 168% respectively. Two regions homologous to the NFE2 motif are demonstrated to be important for basal expression of human GSS, as mutation of these sites reduced the promoter activity by 66%", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a92"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15520196", 
                                "Name": "Cancer Res 2004 Nov 1 64(21) 7893-909"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Finally, BRCA1 stimulated antioxidant response element-driven transcriptional activity and enhanced the activity of the antioxidant response transcription factor nuclear factor erythroid-derived 2 like 2 [also called NRF2 (NFE2L2)]. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a94"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14673141", 
                                "Name": "Mol Cell Biol 2004 Jan 24(1) 36-45"
                            }, 
                            "Disease": "", 
                            "SummaryText": "in mouse peritoneal macrophages 15d-PGJ(2) can activate Nrf2 by forming adducts with Keap1, resulting in an Nrf2-dependent induction of heme oxygenase 1 and peroxiredoxin I (PrxI) gene expression.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ab8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15870285", 
                                "Name": "Mol Cell Biol 2005 May 25(10) 4150-65"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The small interference RNA (siRNA) against SMRT abolished SMRT repression of the gene induction by C/EBPbeta or Nrf2. The plasmid transfection and siRNA experiments directly evidenced the functional role of SMRT in GSTA2 repression.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ab0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17928287", 
                                "Name": "J Biol Chem 2007 Dec 21 282(51) 36837-44"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The binding of TCF11/MafG to the iNOS promoter could be enhanced by phorbol 12-myristate 13-acetate and suppressed by the protein kinase C inhibitor staurosporine. Moreover, the induction of TCF11/MafG binding by TGF-beta and Smad6-short could be blocked by staurosporine, and the effect of TGF-beta was blocked by the selective protein kinase C inhibitor calphostin C. ", 
                            "Cell": "", 
                            "Tissue": "Muscle, Smooth", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ab4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19027064", 
                                "Name": "Free Radic Biol Med 2009 Feb 1 46(3) 376-86"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The reporter assay using pTAL-Luc-derived constructs showed that only ARE1 (pTALARE1) demonstrates substantially higher reporter activity in control A549 cells compared with A549-Nrf2shRNA cells (Fig. 5C).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a8f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18996472", 
                                "Name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Table 1 Transcription factors activated by OxLDL", 
                            "Cell": "Macrophages", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c44"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10821856", 
                                "Name": "J Biol Chem 2000 May 26 275(21) 16023-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Using peritoneal macrophages from Nrf2-deficient mice, we show here that Nrf2 also controls the expression of a group of electrophile- and oxidative stress-inducible proteins and activities, which includes heme oxygenase-1, A170, peroxiredoxin MSP23, and cystine membrane transport (system x(c)(-)) activity.", 
                            "Cell": "Macrophages", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c45"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18079489", 
                                "Name": "Am J Respir Cell Mol Biol 2008 May 38(5) 541-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In the present study, lungs from the chronic smokers demonstrated up-regulation of the Nrf2-regulated antioxidant enzyme, mitochondrial thioredoxin-dependent peroxide reductase (12).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c46"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18162601", 
                                "Name": "Am J Physiol Lung Cell Mol Physiol 2008 Mar 294(3) L478-88"
                            }, 
                            "Disease": "Neoplasm", 
                            "SummaryText": "treatment with CSE resulted in no nuclear translocation of Nrf2, resveratrol induced significant nuclear accumulation of Nrf2, and resveratrol plus CSE induced significant nuclear translocation of Nrf2", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a19"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16855052", 
                                "Name": "Drug Metab Dispos 2006 Jul 19"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf2 activators increased UGT2B3 and 2B12 in both liver and duodenum, and UGT1A6, 1A7, and 2B1 in liver only, and Ugt1a2 and ugt1a3 in duodenum. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a18"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20122946", 
                                "Name": "Toxicol Appl Pharmacol 2010 Apr 1 244(1) 57-65"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively regulates the basal and inducible expression of a large battery of cytoprotective genes. These gene products include proteins that catalyze reduction reactions (NAD(P)H:quinone oxidoreductase 1, Nqo1), conjugation reactions (glutathione-S-transferases, Gsts and UDP-glucuronosyltransferases, Ugts), as well as the efflux of potentially toxic xenobiotics and xenobiotic conjugates (multidrug resistance-associated proteins, Mrps)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ae7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17263920", 
                                "Name": "Redox Rep 2007 12(1) 101-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We demonstrated that submicromolar concentrations of HNE (as little as 0.3 muM) could increase the expression of both GCLC and GCLM. We also found that the induction of GCL expression was abrogated by siRNA for Nrf2.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ae1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15988009", 
                                "Name": "Mol Cell Biol 2005 Jul 25(14) 5933-46"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The basal protein and mRNA levels and nuclear binding activities of c-Jun, c-Fos, p50, and p65 were lower in F1 (Nrf1/Nfe2l1 null) and F2 (Nrf2/Nfe2l2 null) cells and exhibited a blunted response to TBH. ", 
                            "Cell": "Fibroblasts", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839fa"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16432161", 
                                "Name": "Mol Cancer Ther 2006 Jan 5(1) 39-51"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Genes that were induced or suppressed >2-fold by curcumin treatments at 3 hours and 12 hours compared with vehicle in wild-type mice but not in Nfe2l2 knockout mice using Affymetrix mouse genome 430 2.0 array in the liver and small intestine.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ae2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17709388", 
                                "Name": "Mol Cell Biol 2007 Oct 27(20) 7188-97"
                            }, 
                            "Disease": "", 
                            "SummaryText": "A pharmacological activator of NRF2 signaling, CDDO-IM {1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole}, induced Ahr, Cyp1a1, and Cyp1b1 transcription in Nrf2+/+ MEFs but not in Nrf2-/- MEFs. ", 
                            "Cell": "Fibroblasts", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bf1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14747657", 
                                "Name": "Proc Natl Acad Sci U S A 2004 Feb 10 101(6) 1461-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Using chromatin immunoprecipitation assays in NIH 3T3 cells, we show that heme, an inducer of ho-1, promotes displacement of Bach1 from the MafK-occupied ho-1 enhancers, which is followed by Nrf2 binding to these elements. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bf0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19646463", 
                                "Name": "Toxicol Appl Pharmacol 2009 Jul 29"
                            }, 
                            "Disease": "", 
                            "SummaryText": "role of Keap1 has been ascertained by investigations of Keap1?/? mice in which constitutive transactivation of Nrf2 and overproduction of its target genes lead to esophagus and forestomach hyperkeratosis (Wakabayashi et al., 2003).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b29"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11287661", 
                                "Name": "Proc Natl Acad Sci U S A 2001 Apr 10 98(8) 4611-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In contrast, the glutathione level in the Nrf2(-/-) mice was not compensated and remained low. This was because of the decrease in the gene expression of gcs(H) and gcs(L) as well as gss in the livers of the Nrf2(-/-) mice. In addition, the expression of ugt1a6 and gstpi that detoxify APAP by conjugation was also decreased.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083adb"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12435735", 
                                "Name": "J Biol Chem 2003 Jan 24 278(4) 2361-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "lectrophoretic mobility shift assays demonstrate that the ferritin H EpRE/ARE binds Nrf2. Transfection of chimeric ferritin H reporter genes with Nrf2 expression vectors and Nrf2 dominant-negative mutants indicate that Nrf2 functions at the EpRE/ARE to mediate transcriptional activation of ferritin H. Induction of ferritin H and L was not seen in Nrf2 knockout cells,", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ada"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16354693", 
                                "Name": "Mol Cell Biol 2006 Jan 26(1) 221-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "oxidative and electrophilic stresses induce the nuclear accumulation of Nrf2 by affecting the Keap1-mediated rapid turnover of Nrf2", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b21"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18841140", 
                                "Name": "Nat Med 2008 Oct 14(10) 1024-5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In studies of transformed human airway epithelial cells in culture, the authors observed that cigarette smoke induces the UPR and activates the NF-E2\u2013related factor 2 (Nrf2) transcription factor.", 
                            "Cell": "Endothelial Cells", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c1c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19028565", 
                                "Name": "Free Radic Biol Med 2009 Feb 15 46(4) 443-53"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Reporter analysis, site-directed mutagenesis, and chromatin immunoprecipitation assays demonstrated binding of Nrf2 to two AREs distal to the transcription start site     (in combination with Nrf2 KO lowering GSR mRNA above)", 
                            "Cell": "Fibroblasts", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ac3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19608619", 
                                "Name": "Carcinogenesis 2009 Sep 30(9) 1571-80"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Whole-genome microarray revealed that knockdown of KEAP1 resulted in 23 messenger RNAs (mRNAs) being up-regulated > or = 2.0-fold. mRNA for aldo-keto reductase (AKR) 1B10, AKR1C1, AKR1C2 and AKR1C3 were induced to the greatest extent, showing increases of between 12- and 16-fold, whereas mRNA for glutamate-cysteine ligase catalytic and modifier subunits, NAD(P)H:quinone oxidoreductase-1 and haem oxygenase-1 (HMOX1) were induced between 2.0- and 4.8-fold", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083ac0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15993334", 
                                "Name": "Free Radic Biol Med 2005 Aug 1 39(3) 355-64"
                            }, 
                            "Disease": "", 
                            "SummaryText": "HNE caused a small but rapid increase in nuclear Nrf2 that was seen as early as 1 h postincubation and reached significance 3 h postincubation (Fig. 9).", 
                            "Cell": "Epithelial Cells", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bdd"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12968018", 
                                "Name": "J Biol Chem 2003 Nov 28 278(48) 48021-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf1 and Nrf2 Regulate a Similar Subset of Antioxidant Genes: Expression of Gclm was reduced to the same extent in both Nrf1 and Nrf2 mutant cells. NQO1 was down-regulated to a similar extent in both single mutant cells, whereas mRNA levels of heme-oxygenase-1 (HO-1), ferritin-H (FtH), and metallothionein-1 (MT-1) was lower in nrf2\u2013/\u2013 cells compared with nrf1\u2013/\u2013 cells (Fig. 6a). In all cases, however, expression in double knockout cells was abolished compared with single knockout cells, indicating a dependence on both Nrf1 and Nrf2", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a66"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18601945", 
                                "Name": "Mol Aspects Med 30(1-2) 42-59"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Similar to GCL subunits, Nrf2 also is a positive regulator of GGT expression (Zhang et al., 2006).", 
                            "Cell": "Epithelial Cells", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c50"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19602432", 
                                "Name": "Toxicol In Vitro 2009 Oct 23(7) 1326-32"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Subsequently, to understand the mechanism of nanoparticles-induced oxidative stress, the involvement of oxidative stress-responding transcription factors, such as, nuclear factor-kappaB (NF-kappaB) and nuclear factor-E2-related factor-2 (Nrf-2), as well as the mitogen-activated protein (MAP) kinase signal transduction pathway were investigated. From the overall results, silica nanoparticles exerted toxicity via oxidative stress, which lead to the induction of HO-1 via the Nrf-2-ERK MAP kinase signaling pathway", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a61"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15050748", 
                                "Name": "Exp Hematol 2004 Apr 32(4) 375-81"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In contrast, addition of ascorbic acid to KCL22/SR cells resulted in a decrease in Nrf2-DNA binding and decreases in levels of gamma-GCSl mRNA and GSH.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b90"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16837569", 
                                "Name": "Drug Metab Dispos 2006 Oct 34(10) 1756-63"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The present study was therefore designed to carefully analyze expression of major drug transporters in primary human hepatocytes exposed to dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) (an AhR activator), rifampicin (RIF) (a PXR activator), phenobarbital (PB) (a CAR activator), and oltipraz (OPZ) (a Nrf2 activator), using mainly reverse transcription-real time polymerase chain reaction assays. ", 
                            "Cell": "hepatocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b91"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15919853", 
                                "Name": "Drug Metab Dispos 2005 Sep 33(9) 1276-82"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf2 activators (oltipraz, ethoxyquin, and butylated hydroxyanisole) down-regulated Oatp1a1 but up-regulated Oatp2b1", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083982"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18585411", 
                                "Name": "Biochim Biophys Acta 2008 Oct 1783(10) 1847-56"
                            }, 
                            "Disease": "", 
                            "SummaryText": "When MafG was co-expressed with Nrf2 in HeLa cells, MafG exerted a bi-directional transcription regulatory effect. At low concentrations, MafG amplified Nrf2 induced ARE-Luciferase activities in a dose-dependent manner (Fig. 5A). At higher concentrations, the amplification effect of MafG was attenuated and even reversed (Fig. 5A). This observation is consistent with previous reports [48, 49], probably due to the reason that overexpressing MafG may favor the formation of MafG/MafG homodimer.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b07"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16951197", 
                                "Name": "Cancer Res 2006 Sep 1 66(17) 8804-13"
                            }, 
                            "Disease": "", 
                            "SummaryText": "stimulation of p38 MAPK isoforms phosphorylated purified Nrf2 protein and caused an increase in the interaction between Nrf2 and Keap1 in vitro and the suppression of Nrf2 translocation into the nucleus.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c3408399a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20298567", 
                                "Name": "Respir Res 2010 11 31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "the expression levels of GST-P1, GCLC, and NQO1 mRNAs were significantly lower in the lungs of Nrf2-/- mice than in those of WT mice at both 1 and 3 days after bleomycin administration (Figures 5B-5D). The expression levels of HO-1 and Prx-I mRNAs were also significantly lower in the lungs of Nrf2-/- mice than in those of WT mice 3 days after bleomycin administration (Figures 5E and 5F). ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c3408399c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14612418", 
                                "Name": "Mol Cell Biol 2003 Dec 23(23) 8786-94"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We show herein that expression of most subunits of 20S and 19S proteasomes, which collectively assemble the 26S proteasome, was enhanced up to threefold in livers of mice following treatment with dithiolethiones, which act as indirect antioxidants. Subunit protein levels and proteasome activity were coordinately increased. No induction was seen in mice where the transcription factor Nrf2 was disrupted. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a7d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11439354", 
                                "Name": "Oncogene 2001 Jun 28 20(29) 3906-17"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Antioxidant response element (ARE) and nuclear transcription factor Nrf2 are known to regulate expression and coordinated induction of NQO1 and other detoxifying enzyme genes in response to antioxidants and xenobiotics.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839d6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19262504", 
                                "Name": "Mucosal Immunol 2009 May 2(3) 206-19"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Interestingly, the deletion of the antioxidant gene transcription factor, nuclear erythroid 2 p45- related factor-2 (Nrf2), in DCs leads to oxidative stress in DCs", 
                            "Cell": "dendritic cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c3408399d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10559251", 
                                "Name": "J Biol Chem 1999 Nov 19 274(47) 33627-36"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Increased expression was associated with an increase in the binding of Nrf2 to electrophile response elements (EpRE) in the promoters of these genes. Nrf2 overexpression increased the activity of GCS(h) and GCS(l) promoter/reporter transgenes.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b14"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20347035", 
                                "Name": "Free Radic Biol Med 2010 Jun 15 48(12) 1626-35"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Overexpression of NOX1 resulted in induction of Nrf2 as demonstrated by Nrf2 Western blot and ARE reporter gene assay (Fig. 3D, right).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b15"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14565864", 
                                "Name": "DNA Cell Biol 2003 Aug 22(8) 479-87"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Ecotopic expression of NF-E2 related factors showed that Nrf2, but not Nrf1, Nrf3, or Bach1, activated TXAS promoter in a dose-dependent manner. Furthermore, chromatin immunoprecipitation assay using the stably transfected A549 cells demonstrated that Nrf2 bound the TXAS NF-E2 site in vivo.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b8e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20934988", 
                                "Name": "J Lipid Res 2010 Oct 8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Here we show that upregulation of NRF2 by OxPLs depends on the activity of protein kinase CK2. Inactivation of CK2 by chemical inhibitors or gene silencing resulted in diminished accumulation of NRF2 and its downstream genes GCLM, HO-1 and NQO1 in response to OxPLs. Furthermore, inhibition of CK2 suppressed NRF2-dependent induction of ATF4 and its downstream gene VEGF. ", 
                            "Cell": "Endothelial Cells", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b18"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15521073", 
                                "Name": "J Cell Physiol 2005 Jun 203(3) 529-37"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Overexpression of NF-E2-related factor-2 (Nrf2) augmented the TrxR1 promoter activity. In contrast, overexpression of the dominant negative mutant of Nrf2 suppressed cadmium-induced activation of TrxR1 promoter through the ARE. Chromatin immunoprecipitation (ChIP) assays showed that anti-Nrf2 antibody precipitated ARE from the chromatin of the cadmium-treated cells. These results indicated that cadmium-induced TrxR1 gene expression is mediated by the activation of Nrf2 transcription factor and its binding to ARE in the TrxR1 gene promoter. ", 
                            "Cell": "", 
                            "Tissue": "Endothelium, Vascular", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b8f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19086807", 
                                "Name": "Antioxid Redox Signal 2009 May 11(5) 937-48"
                            }, 
                            "Disease": "", 
                            "SummaryText": "This hyperoxia-induced expression of Srx was not evident in mice deficient in the transcription factor Nrf2, indicating an essential role for an Nrf2 signaling pathway in this effect", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c27"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19457866", 
                                "Name": "J Biol Chem 2009 Jul 10 284(28) 18882-92"
                            }, 
                            "Disease": "", 
                            "SummaryText": "LSS increased Nrf2 activation by 4-fold, whereas atorvastatin alone (0.6 uM) had no effect, nor did it increase activation in EC pre-conditioned with LSS.", 
                            "Cell": "umbilical vein endothelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839e3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12360409", 
                                "Name": "Oncogene 2002 Oct 3 21(44) 6829-34"
                            }, 
                            "Disease": "", 
                            "SummaryText": "INrf2 tethering of the transcription factor Nrf2 in the cytosol prevents Nrf2 activation of antioxidant response element (ARE) mediated gene expression.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bd1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15988009", 
                                "Name": "Mol Cell Biol 2005 Jul 25(14) 5933-46"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Lower c-Jun and p65 expression also occurs in Nrf2 (NFE2L2) null livers.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083acb"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20122946", 
                                "Name": "Toxicol Appl Pharmacol 2010 Apr 1 244(1) 57-65"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively regulates the basal and inducible expression of a large battery of cytoprotective genes. These gene products include proteins that catalyze reduction reactions (NAD(P)H:quinone oxidoreductase 1, Nqo1), conjugation reactions (glutathione-S-transferases, Gsts and UDP-glucuronosyltransferases, Ugts), as well as the efflux of potentially toxic xenobiotics and xenobiotic conjugates (multidrug resistance-associated proteins, Mrps)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083c51"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12370194", 
                                "Name": "J Biol Chem 2003 Jan 10 278(2) 703-11"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In addition, expression of NQO1 or Nrf2 inhibited tumor necrosis factor-alpha-induced activation of VCAM-1 (vascular cell adhesion molecule-1) gene expression in EC", 
                            "Cell": "", 
                            "Tissue": "Endothelium", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083bd6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12869663", 
                                "Name": "Pharmacol Rev 2003 Sep 55(3) 551-71"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Bach1 competes with activators, including Nrf2, for the binding to Maf recognition element (MARE). HREs share a nucleotide sequence with the MARE, which is important in development and differentiation (Motohashi et al., 1997; Ogawa et al., 2001). Therefore, stress response genes bearing MARE may be up-regulated via the MARE-binding transcription factors with increased levels of heme (Ogawa et al., 2001). ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b9b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20309604", 
                                "Name": "Cell Mol Life Sci 2010 Jul 67(13) 2297-309"
                            }, 
                            "Disease": "", 
                            "SummaryText": "A conserved antioxidant response element (ARE) in the CFTR minimal promoter, which binds Nrf2, has been identified. Surprisingly, Nrf2 exerts an unexpected repressive role on the CFTR gene promoter activity.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a77"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18316592", 
                                "Name": "Cancer Res 2008 Mar 1 68(5) 1303-9"
                            }, 
                            "Disease": "Lung Neoplasms", 
                            "SummaryText": "Keap1 or individual Keap1 mutants were cotransfected into NIH3T3 cells with an Nrf2 expression plasmid and a luciferase reporter pRBGP2 (16). Luciferase activity was repressed significantly when WT Keap1 or the H200P mutant was transfected simultaneously (Fig. 2C, lanes 3 and 4).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839da"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17468336", 
                                "Name": "Am J Physiol Heart Circ Physiol 2007 Jul 293(1) H770-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Furthermore, LNO(2) triggered nuclear factor-erythroid 2-related factor 2 (Nrf2) nuclear translocation and activation of the antioxidant-responsive element-driven transcriptional activity via impairing Kelch-like ECH-associating protein 1 (Keap1)-mediated negative control of Nrf2 activity in VSMCs. LNO(2) upregulated the expression of Nrf2 protein levels, but not mRNA levels, in VSMCs. A forced activation of Nrf2 led to an upregulation of p27(kip1) and growth inhibition of VSMCs. ", 
                            "Cell": "Myocytes, Smooth Muscle", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c340839df"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15917255", 
                                "Name": "J Biol Chem 2005 Jul 22 280(29) 27244-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "chromatin immunoprecipitation analysis revealed that Nrf2 binding to the NQO1 ARE was significantly diminished in the case of O-flow compared with that of L-flow", 
                            "Cell": "Endothelial Cells", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a72"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10747902", 
                                "Name": "J Biol Chem 2000 May 19 275(20) 15466-73"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In the present study, we have examined the binding specificities of Nrf2/MafK heterodimers to the ARE derived from the rat GST A2 and QR genes using gel mobility shift and DNase I protection assays. Furthermore, we utilized co-transfection assays to explore the role these transcription factors play in basal and inducible expression of the rat GST A2 and QR genes. We found that Nrf2/small Maf heterodimers bind with high affinity to the rat QR ARE but with low affinity to the rat GST A2 ARE. Our data suggest that Nrf2 is involved in regulating basal level expression of the rat GST A2 and QR genes; however, small Maf acts as a transcriptional repressor rather than activator of ARE-mediated transcription. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083999"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12556532", 
                                "Name": "J Biol Chem 2003 Apr 4 278(14) 12029-38"
                            }, 
                            "Disease": "", 
                            "SummaryText": "TABLE II Identification of inducible Nrf2-dependent genes in primary cortical astrocytes", 
                            "Cell": "astrocyte", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a78"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19608619", 
                                "Name": "Carcinogenesis 2009 Sep 30(9) 1571-80"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In the oesophagus of Keap1-/- mice, the expression of keratin 6 is greatly increased in an NRF2-dependent manner (44).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b05"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18633191", 
                                "Name": "Hypertens Res 2008 Apr 31(4) 783-92"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Heterodimers of the small Maf proteins and NF-E2\u2013 related factor 2 (Nrf2), which belongs to the basic leucin zipper (bZip) family of transcriptional factors, activate HO-1 through binding to MAREs (16\u201319). In contrast, heterodimers of small Maf and Bach1 or Bach2 repress MAREdependent transcription (20).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b4a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19028565", 
                                "Name": "Free Radic Biol Med 2009 Feb 15 46(4) 443-53"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) is the primary transcription factor protecting cells from oxidative stress", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a6f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15574414", 
                                "Name": "J Biol Chem 2005 Feb 11 280(6) 4483-90"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The Nrf2/MafG heterodimer bound the Ic-ARE and activated transcription, whereas DEM failed to activate mafG in nrf2-null mutant cells. Chromatin immunoprecipitation further revealed that both Nrf2 and small Maf proteins associate with the Ic-ARE in vivo. These results demonstrate that mafG is itself an ARE-dependent gene that is regulated by an Nrf2/small Maf heterodimer and suggest the presence of an autoregulatory feedback pathway for mafG transcriptional regulation.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b06"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18372916", 
                                "Name": "Oncogene 2008 Jul 17 27(31) 4353-62"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Nrf2 is a transcription factor that is activated by increased ROS, which induces the transcription of several antioxidant and detoxification enzymes including several classes of GST", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b47"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11804867", 
                                "Name": "Am J Respir Cell Mol Biol 2002 Feb 26(2) 175-82"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Hyperoxia-induced mRNA levels of NAD(P)H:quinone oxidoreductase 1 (NQO1), glutathione-S-transferase (GST)-Ya and -Yc subunits, UDP glycosyl transferase (UGT), glutathione peroxidase-2 (GPx2), and heme oxygenase-1 (HO-1) were significantly lower in Nrf2-/- mice compared with Nrf2+/+ mice.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a6b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16962933", 
                                "Name": "Free Radic Biol Med 2006 Oct 1 41(7) 1079-91"
                            }, 
                            "Disease": "", 
                            "SummaryText": "dominant-negative Nrf2 abolished the SIN-1-induced increase in Nrf2-ARE binding and subsequent upregulation of HO-1 expression,", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c3408398f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16274879", 
                                "Name": "Free Radic Biol Med 2005 Dec 1 39(11) 1438-48"
                            }, 
                            "Disease": "", 
                            "SummaryText": "CS-dependent hmox1 promoter activation is mainly, but not exclusively, controlled by Nrf2.  Nuclear localization of Nrf2 coincides with increased DNA binding of a putative Nrf2/MafK heterodimer to its cognate cis-regulatory site. Studies on the regulatory elements of the oxidative stress-inducible gene heme oxygenase-1 (hmox1) using various hmox1 promoter/luciferase reporter constructs revealed that the strong CS-dependent expression of this gene is primarily governed by the distal enhancers 1 (\\\"E1\\\") and 2 (\\\"E2\\\"), which both contain three canonical ARE-like stress-responsive elements (StREs). Notably, depletion of Nrf2 levels caused by RNA interference or deletion of E1 or E2 sites significantly compromised CS-induced hmox1 promoter activation, based on the distinct Nrf2 sensitivity exhibited by E1 and E2. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c3408398d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17189831", 
                                "Name": "Free Radic Biol Med 2007 Jan 15 42(2) 260-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Small interfering RNA (SiRNA) against Nrf2 significantly attenuated the expression of Nrf2-regulated genes such as HO-1, SQSTM1, NQO1, glutamate-cysteine ligase modifier subunit (GCLM), and ferritin heavy chain. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083a1c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12804587", 
                                "Name": "Biochem Biophys Res Commun 2003 Jun 27 306(2) 469-75"
                            }, 
                            "Disease": "", 
                            "SummaryText": "SSAT is transcriptionally regulated through the interaction of two trans-acting transcription factors, NF-E2-related factor 2 (Nrf-2), and polyamine modulated factor-1 (PMF-1)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b09"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16723490", 
                                "Name": "Invest Ophthalmol Vis Sci 2006 Jun 47(6) 2709-15"
                            }, 
                            "Disease": "", 
                            "SummaryText": "zinc upregulated the mRNA level of GCL and activated the ARE-Nrf2 pathway", 
                            "Cell": "retinal epithelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b9d"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:Cotinine)", 
                "relation": "increases", 
                "target": "p(HGNC:AKT1,pmod(P))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of Cotinine increases the protein abundance of AKT1 which is phosphorylated.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:Cotinine) increases p(HGNC:AKT1,pmod(P))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:Cotinine) increases p(HGNC:AKT1,pmod(P))", 
                                "eid": "524b352dd3fbfd4c34083985"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:Cotinine)", 
                "relation": "increases", 
                "target": "bp(GO:\"xenobiotic metabolic process\")", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of Cotinine increases the biological process of GO:\"xenobiotic metabolic process\".", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "a(SCHEM:Cotinine) increases bp(GO:xenobiotic metabolic process)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "21465741", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "Even subjects with the lowest levels of nicotine and cotinine had enhanced activity of biological pathways involved in the metabolism of xenobiotics by cytochrome P450 and arachidonic acid", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:CYP1A2)", 
                "relation": "actsIn", 
                "target": "cat(p(HGNC:CYP1A2))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of CYP1A2 acts in catalytic activity of the protein abundance of CYP1A2.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "1302044", 
                                "Name": "Pharmacogenetics 1992 Apr 2(2) 73-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP1A2 alone was responsible for caffeine 3-demethylation and paraxanthine 7-demethylation; in addition, 1A2 catalysed virtually all reactions related to caffeine and its metabolites.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                                "eid": "524b352dd3fbfd4c340839c3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16405939", 
                                "Name": "Toxicol Appl Pharmacol 2006 Jun 15 213(3) 198-206"
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP1A2, NAT2 phenotype and number of cigarettes smoked (NCIG) accounted for 47% of the variability in 3-ABP adducts, whereas 32% variability in 4-ABP adducts was accounted by CYP1A2 and NCIG. The ratio of 4-ABP Hb adducts in adult S:NS was approximately 5:1, whereas 3-ABP Hb adducts levels were BLOQ in some S, exhibited large interindividual variability ( approximately 91% compared to 57% for 4-ABP Hb) and poor dose response relationship. Therefore, 4-ABP Hb adduct levels may be a more useful biomarker of aminobiphenyl exposure from cigarette smoke.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                                "eid": "524b352dd3fbfd4c34083b62"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15666840", 
                                "Name": "Endocr Res 2004 Nov 30(4) 881-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In 1986 we postulated that this disorder might be due to mutations in P450 oxidoreductase (POR), the flavoprotein that donates electron to these and all other microsomal P450 enzymes,", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                                "eid": "524b352dd3fbfd4c34083a15"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14980704", 
                                "Name": "Free Radic Biol Med 2004 Mar 1 36(5) 605-17"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The CYP1A2 inhibitor furafylline in vitro exacerbated microsomal H(2)O(2) production proportional to the degree of CYP1A2 inhibition,", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                                "eid": "524b352dd3fbfd4c34083a34"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12927920", 
                                "Name": "J Hepatol 2003 Sep 39(3) 349-56"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Treatment of the LPS-sensitive mice with intraperitoneal indomethacin (5 mg/kg per day, 3 days) significantly decreased enzyme activities for CYP3A11, CYP2D9 and CYP1A2 but not CYP2E1.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                                "eid": "524b352dd3fbfd4c34083a6d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12785736", 
                                "Name": "Arch Pharm Res 2003 May 26(5) 394-404"
                            }, 
                            "Disease": "", 
                            "SummaryText": "When mice were treated intraperitoneally with 3, 10 and 30 mg/kg of individual PAHs for 3 consecutive days, the activities of ethoxyresorufin- and methoxyresorufin-O-dealkylases were significantly and differentially induced in both liver and lung. Moreover, other CYP isozyme-associated monooxygenase activities were also induced significantly in liver and lung with characteristic induction profiles. It was found that the activities of CYP 1A-selective EROD and MROD were significantly induced in both liver and lung tissues of treated mice (Figs. 2 to 5).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                                "eid": "524b352dd3fbfd4c34083c21"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11346483", 
                                "Name": "Food Chem Toxicol 2001 Jun 39(6) 541-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In vitro incubation of rat liver microsomes with each of the compounds--C[curcumin], dmC, bdmC, PITC and PEITC-...Significantly lower concentrations of curcumin(s) than isothiocyanates achieved 50% inhibition of activity of CYP 1A1 and 1A2", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                                "eid": "524b352dd3fbfd4c34083a1d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20435083", 
                                "Name": "Toxicology 2010 Jun 29 273(1-3) 35-44"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Catalytic activities of CYP1A1, CYP1A2 and CYP1B1, and inducibility of the activities were studied in intact human lung samples (from 23 human subjects) ex vivo. The activities [as measured by ethoxyresorufin O-deethylase (EROD), methoxyresorufin O-demethylase (MROD), and 3-cyano-7-ethoxycoumarin O-deethylase (CECOD)] were present in the lungs and were induced by benzo[a]pyrene (B[a]P) and diesel exhaust particle extract (DEE) but with extensive inter-subject variability. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                                "eid": "524b352dd3fbfd4c34083bb0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16877260", 
                                "Name": "Drug Metab Rev 2006 38(3) 411-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Generally, induction of CYP1A1, CYP1A2, and CYP1B1 is considered cardiotoxic through generating reactive oxygen species (ROS)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A2) actsIn cat(p(HGNC:CYP1A2))", 
                                "eid": "524b352dd3fbfd4c34083b8b"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:CYP2B6)", 
                "relation": "actsIn", 
                "target": "cat(p(HGNC:CYP2B6))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of CYP2B6 acts in catalytic activity of the protein abundance of CYP2B6.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2B6) actsIn cat(p(HGNC:CYP2B6))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16092727", 
                                "Name": "Exp Toxicol Pathol 2005 Jul 57 Suppl 1 189-204"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Phenobarbital also produced a very weak induction of CYP2B6 both at mRNA and activity level (Fig. 6). ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2B6) actsIn cat(p(HGNC:CYP2B6))", 
                                "eid": "524b352dd3fbfd4c34083afd"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2B6) actsIn cat(p(HGNC:CYP2B6))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16550168", 
                                "Name": "Oncogene 2006 Mar 13 25(11) 1679-91"
                            }, 
                            "Disease": "", 
                            "SummaryText": "cyclophosphamide metabolized by CYP2D6, CYP2C19 and CYP2B6", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2B6) actsIn cat(p(HGNC:CYP2B6))", 
                                "eid": "524b352dd3fbfd4c34083a1b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2B6) actsIn cat(p(HGNC:CYP2B6))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17433521", 
                                "Name": "Toxicology 2007 Jun 3 235(1-2) 83-91"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Curcumin showed a competitive type of inhibition towards CYP1A2, CYP3A4 and CYP2B6. Curcumin inhibited CYP1A2 (IC(50), 40.0 microM), CYP3A4 (IC(50), 16.3 microM), CYP2D6 (IC(50), 50.3 microM), CYP2C9 (IC(50), 4.3 microM) and CYP2B6 (IC(50), 24.5 microM). ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2B6) actsIn cat(p(HGNC:CYP2B6))", 
                                "eid": "524b352dd3fbfd4c34083af9"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "cat(p(HGNC:CYP1A1))", 
                "relation": "increases", 
                "target": "a(CHEBI:\"reactive oxygen species\")", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The catalytic activity of the protein abundance of CYP1A1 increases the abundance of \"reactive oxygen species\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "cat(p(HGNC:CYP1A1)) increases a(CHEBI:\"reactive oxygen species\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16877260", 
                                "Name": "Drug Metab Rev 2006 38(3) 411-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Generally, induction of CYP1A1, CYP1A2, and CYP1B1 is considered cardiotoxic through generating reactive oxygen species (ROS)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "cat(p(HGNC:CYP1A1)) increases a(CHEBI:\"reactive oxygen species\")", 
                                "eid": "524b352dd3fbfd4c34083c36"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:CYP2E1)", 
                "relation": "actsIn", 
                "target": "cat(p(HGNC:CYP2E1))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of CYP2E1 acts in catalytic activity of the protein abundance of CYP2E1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11888901", 
                                "Name": "Cancer Res 2002 Mar 1 62(5) 1330-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "albumin adducts of benzene oxide and 1,4-benzoquinone form adduct levels were less than proportional to benzene exposure, suggesting saturable CYP2E1 metabolism of benzene", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083b70"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "21483585", 
                                "Name": "Libyan J Med 2010 5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The hepatotoxic effect of CCl4 is thought to be initiated as a result of its reductive dehalogenation by cytochrome P450 2E1 to the highly reactive trichloromethyl radical (\u2022CCl3), which is subsequently converted into a trichloromethyl peroxyl radical (\u2022OOCCl3) in the presence of oxygen ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083a67"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16624972", 
                                "Name": "J Pharmacol Exp Ther 2006 Jul 318(1) 360-72"
                            }, 
                            "Disease": "", 
                            "SummaryText": "PI3-kinase/AKT may serve as a survival pathway against CYP2E1-dependent toxicity.E47 cells (HepG2 cells transfected with human CYP2E1 cDNA) exposed to 25 microM iron-nitrilotriacetate+5 microM arachidonic acid (AA+Fe) developed higher toxicity than C34 cells (HepG2 cells transfected with empty plasmid). Toxicity was associated with increased oxidative stress and activation of calcium-dependent hydrolases calpain and phospholipase A2.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083be9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12154027", 
                                "Name": "Cancer Res 2002 Aug 1 62(15) 4256-62"
                            }, 
                            "Disease": "", 
                            "SummaryText": "activities of the hepatic microsomal drug-metabolizing energy cytochrome P-450 A1/2, CYP2E1, and CYP3A2 were decreased in rats treated with ET-743", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083b50"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10770928", 
                                "Name": "J Biol Chem 2000 Jun 30 275(26) 20136-45"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The ability of ethanol and arachidonic acid (AA), as inducers of oxidative stress and key factors in alcoholic liver disease, to up-regulate alpha 2 collagen type I (COL1A2) gene expression was studied in a hepatic stellate cell line overexpressing the ethanol-inducible cytochrome P450 2E1 (CYP2E1) (E5 cells). A time- and dose-dependent induction in COL1A2 mRNA by ethanol or AA was observed that was prevented by diallylsulfide, a CYP2E1 inhibitor.", 
                            "Cell": "hepatic stellate cell", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083a71"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12777962", 
                                "Name": "Pharmacogenetics 2003 Jun 13(6) 321-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP2E1 bioactivates environmental protoxins and metabolizes alcohol.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083b1e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11816819", 
                                "Name": "Eur Respir J Suppl 2001 Sep 32 122s-126s"
                            }, 
                            "Disease": "", 
                            "SummaryText": "he expression of pulmonary CYP2E1 mRNA and protein have been established in several studies 17, 19, 21, 29, 37, 42, 43. CYP2E1 is an interesting CYP form because it is the most active CYP enzyme in forming oxygen radicals, causing tissue injury 44", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083ae4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16621933", 
                                "Name": "Drug Metab Dispos 2006 Jul 34(7) 1160-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The rapid and direct effects of nitric oxide (NO) donors sodium nitroprusside (SNP) and isosorbide dinitrate (ISDN) on the hepatic and biliary disposition of chlorzoxazone (CZX), a marker of CYP2E1, and dextromethorphan (DEM), a marker of CYP2D1, were studied in a single-pass isolated perfused rat liver model. Livers (n = 30) were perfused with constant concentrations of NO donors (0-120 min) in addition to infusion of CZX or DEM (60-120 min), and periodical outlet and bile samples were collected. Both ISDN and SNP significantly reduced (30 and 60%, respectively) the hepatic extraction ratio of CZX and decreased (50 and 70%, respectively) the recovery of the CYP2E1-mediated metabolite, 6-hydroxychlorzoxazone, in the outlet perfusate and bile. As for DEM, both NO donors increased (up to 3.5-fold) the recovery of the CYP2D1-mediated metabolite dextrorphan (DOR) in the outlet perfusate. However, this was associated with a simultaneous decrease (50-75%) in the excretion of the metabolite into the bile, thus resulting in no change in the overall recovery of DOR as a result of NO donor treatment. The decrease in the biliary excretion of DOR was caused by NO-induced simultaneous reductions in both the conjugation of DOR and biliary clearance of DOR conjugate. Additionally, both SNP and ISDN significantly reduced the metabolism of DEM to 3-hydroxymorphinan, which is mostly regulated by CYP3A2. These studies in an intact liver model confirm the selectivity of the inhibitory effects of NO donors on cytochrome P450 enzymes, which was recently reported in microsomal studies, and expand these inhibitory effects to conjugation pathways.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083b3f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14642533", 
                                "Name": "Cell Biol Int 2003 27(12) 1011-5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Using histidine decarboxylase gene targeted (HDC(-/-)) BALB/c mice, we studied the effect of the absence of histamine on four cytochrome p450 enzyme activities. Their selective substrates were measured: ethoxyresorufin O-dealkylase activity of CYP1A, pentoxyresorufin O-dealkylase activity of CYP2B, chlorzoxazone 6-hydroxylase activity of CYP2E1 and ethylmorphine N-demethylase activity of CYP3A.The results indicate a significant elevation of CYP2E1 and CYP3A activities", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083bea"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8211999", 
                                "Name": "Toxicol Appl Pharmacol 1993 Oct 122(2) 172-81"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Cytochrome P450 2E1 metabolized phenol with an affinity and capacity comparable to those of benzene.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083a24"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12927920", 
                                "Name": "J Hepatol 2003 Sep 39(3) 349-56"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Treatment of the LPS-sensitive mice with intraperitoneal indomethacin (5 mg/kg per day, 3 days) significantly decreased enzyme activities for CYP3A11, CYP2D9 and CYP1A2 but not CYP2E1.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083c3f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16553429", 
                                "Name": "J Phys Chem B 2006 Mar 30 110(12) 6154-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "cytochrome P450 2E1 (CYP2E1) could metabolize not only ethanol but also its primary product, acetaldehyde", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083c4c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16958665", 
                                "Name": "J Gastroenterol Hepatol 2006 Oct 21 Suppl 3 S22-5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The E47 cells had higher glutathione levels than control HepG2 cells due to activation of the genes encoding the heavy and light subunits of gamma glutamyl cysteine synthetase (GCLC and GCLM). There was also a twofold increase in catalase, cytosolic and microsomal glutathione transferase, and heme oxygenase-1 (HO-1)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083b60"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14670949", 
                                "Name": "J Biol Chem 2004 Apr 16 279(16) 15734-42"
                            }, 
                            "Disease": "", 
                            "SummaryText": "(MKK3) was phosphorylated in response to LPS, and expression of constitutively active MKK3, but not the MAP kinase kinases MEKK1 or MKK1, activated CYP2E1.", 
                            "Cell": "astrocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083a7b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12803597", 
                                "Name": "Acta Anaesthesiol Scand 2003 Jul 47(6) 765-70"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Disulfiram inhibition of CYP2E1-mediated halothane oxidation prevents hepatic protein trifluoroacetylation", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083c16"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8470120", 
                                "Name": "Toxicol Appl Pharmacol 1993 Mar 119(1) 17-22"
                            }, 
                            "Disease": "", 
                            "SummaryText": "inhibitory toward vinyl chloride metabolism catalyzed by the isoniazid-inducible CYP2E1. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083bbd"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15666840", 
                                "Name": "Endocr Res 2004 Nov 30(4) 881-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In 1986 we postulated that this disorder might be due to mutations in P450 oxidoreductase (POR), the flavoprotein that donates electron to these and all other microsomal P450 enzymes,", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083b23"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10678302", 
                                "Name": "Pharmacotherapy 2000 Feb 20(2) 229-33"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Acetaminophen is metabolized in part by cytochrome P450 (CYP) 2E1, and inducers of CYP2E1 are known to predispose patients to acetaminophen-related hepatotoxicity.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083b32"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17446309", 
                                "Name": "Am J Physiol Gastrointest Liver Physiol 2007 Jul 293(1) G91-103"
                            }, 
                            "Disease": "", 
                            "SummaryText": " SAM administration inhibited CYP2E1 activity but not CYP2E1 content. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP2E1) actsIn cat(p(HGNC:CYP2E1))", 
                                "eid": "524b352dd3fbfd4c34083a52"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:BRCA1)", 
                "relation": "directlyDecreases", 
                "target": "tscript(p(HGNC:ESR1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The protein abundance of BRCA1 directly decreases the transcriptional activity of the protein abundance of ESR1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:BRCA1) directlyDecreases tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11493692", 
                                "Name": "Proc Natl Acad Sci U S A 2001 Aug 14 98(17) 9587-92"
                            }, 
                            "Disease": "", 
                            "SummaryText": "that BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor alpha (ERalpha), a principal determinant of the growth, differentiation, and normal functional status of breasts and ovaries. Ectopic expression in Brca1-deficient cells of wild-type BRCA1, but not clinically validated BRCA1 missense mutants, restored ligand-independent repression of ERalpha in a manner dependent upon apparent histone deacetylase activity. In estrogen-dependent human breast cancer cells, chromatin immunoprecipitation analysis revealed the association of BRCA1 with ERalpha at endogenous estrogen-response elements before, but not after estrogen stimulation.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:BRCA1) directlyDecreases tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083a76"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:BRCA1) directlyDecreases tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11244506", 
                                "Name": "Oncogene 2001 Jan 4 20(1) 77-87"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "The BRCA1 gene was previously found to inhibit the transcriptional activity of the estrogen receptor [ER-alpha] in human breast and prostate cancer cell lines. The BRCA1 protein was found to associate with ER-alpha in vivo and to bind to ER-alpha in vitro, by an estrogen-independent interaction that mapped to the amino-terminal region of BRCA1 (ca. amino acid 1-300) and the conserved carboxyl-terminal activation function [AF-2] domain of ER-alpha.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:BRCA1) directlyDecreases tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083993"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:BRCA1) directlyDecreases tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11244506", 
                                "Name": "Oncogene 2001 Jan 4 20(1) 77-87"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The BRCA1 protein was found to associate with ER-alpha in vivo and to bind to ER-alpha in vitro, by an estrogen-independent interaction that mapped to the amino-terminal region of BRCA1 (ca. amino acid 1-300) and the conserved carboxyl-terminal activation function [AF-2] domain of ER-alpha", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:BRCA1) directlyDecreases tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b1a"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:BRCA1)", 
                "relation": "increases", 
                "target": "tscript(p(HGNC:NFE2L2))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The protein abundance of BRCA1 increases the transcriptional activity of the protein abundance of NFE2L2.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:BRCA1) increases tscript(p(HGNC:NFE2L2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15520196", 
                                "Name": "Cancer Res 2004 Nov 1 64(21) 7893-909"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Finally, BRCA1 stimulated antioxidant response element-driven transcriptional activity and enhanced the activity of the antioxidant response transcription factor nuclear factor erythroid-derived 2 like 2 [also called NRF2 (NFE2L2)]. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:BRCA1) increases tscript(p(HGNC:NFE2L2))", 
                                "eid": "524b352dd3fbfd4c34083b4f"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:BRCA1)", 
                "relation": "increases", 
                "target": "p(HGNC:ARNT)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The protein abundance of BRCA1 increases the protein abundance of ARNT.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "p(HGNC:BRCA1) increases p(HGNC:ARNT)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16567799", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "The results suggest that BRCA1 stabilizesARNTwhen cells are under TCDD stress (Fig. 8C). Relatively unstable ARNT was detected in cells transfected with pKD-BRCA1 (Fig. 8D)", 
                            "Cell": "", 
                            "Tissue": "T47D cell line", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Particulate Matter\")", 
                "relation": "increases", 
                "target": "p(HGNC:CYP2E1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Particulate Matter\" increases the protein abundance of CYP2E1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Particulate Matter\") increases p(HGNC:CYP2E1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Particulate Matter\") increases p(HGNC:CYP2E1)", 
                                "eid": "524b352dd3fbfd4c340839bd"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Particulate Matter\")", 
                "relation": "increases", 
                "target": "p(HGNC:NQO1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Particulate Matter\" increases the protein abundance of NQO1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Particulate Matter\") increases p(HGNC:NQO1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Particulate Matter\") increases p(HGNC:NQO1)", 
                                "eid": "524b352dd3fbfd4c340839ce"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Particulate Matter\")", 
                "relation": "increases", 
                "target": "tscript(p(HGNC:AHR))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Particulate Matter\" increases the transcriptional activity of the protein abundance of AHR.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Particulate Matter\") increases tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20663163", 
                                "Name": "Part Fibre Toxicol 2010 7 18"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Polycyclic aromatic hydrocarbon components contribute to the mitochondria-antiapoptotic effect of fine particulate matter on human bronchial epithelial cells via the aryl hydrocarbon receptor", 
                            "Cell": "bronchial epithelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Particulate Matter\") increases tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839ed"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\")", 
                "relation": "isA", 
                "target": "a(SCHEM:\"Particulate Matter\")", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The abundance of \"Polycyclic Aromatic Hydrocarbons\" is a abundance of \"Particulate Matter\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") isA a(SCHEM:\"Particulate Matter\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") isA a(SCHEM:\"Particulate Matter\")", 
                                "eid": "524b352dd3fbfd4c34083aa5"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:Soot)", 
                "relation": "isA", 
                "target": "a(SCHEM:\"Particulate Matter\")", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The abundance of Soot is a abundance of \"Particulate Matter\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:Soot) isA a(SCHEM:\"Particulate Matter\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:Soot) isA a(SCHEM:\"Particulate Matter\")", 
                                "eid": "524b352dd3fbfd4c34083ade"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Particulate Matter\")", 
                "relation": "increases", 
                "target": "p(HGNC:CYP1A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Particulate Matter\" increases the protein abundance of CYP1A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Particulate Matter\") increases p(HGNC:CYP1A1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Particulate Matter\") increases p(HGNC:CYP1A1)", 
                                "eid": "524b352dd3fbfd4c34083b9a"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Particulate Matter\")", 
                "relation": "increases", 
                "target": "p(HGNC:GSTP1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Particulate Matter\" increases the protein abundance of GSTP1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Particulate Matter\") increases p(HGNC:GSTP1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Particulate Matter\") increases p(HGNC:GSTP1)", 
                                "eid": "524b352dd3fbfd4c34083bb8"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Particulate Matter\")", 
                "relation": "increases", 
                "target": "p(HGNC:CYP2F1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Particulate Matter\" increases the protein abundance of CYP2F1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Particulate Matter\") increases p(HGNC:CYP2F1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Particulate Matter\") increases p(HGNC:CYP2F1)", 
                                "eid": "524b352dd3fbfd4c34083bfe"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Particulate Matter\")", 
                "relation": "increases", 
                "target": "p(HGNC:GSTM3)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Particulate Matter\" increases the protein abundance of GSTM3.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Particulate Matter\") increases p(HGNC:GSTM3)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Particulate Matter\") increases p(HGNC:GSTM3)", 
                                "eid": "524b352dd3fbfd4c34083c33"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Particulate Matter\")", 
                "relation": "increases", 
                "target": "p(HGNC:HSP90AA1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Particulate Matter\" increases the protein abundance of HSP90AA1.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "a(SCHEM:Particulate Matter) increases p(HGNC:HSP90AA1)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19675143", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "levels of the UPR-related chaperone Hsp90 were significantly upregulated and increased with concentration with both PM size fractions", 
                            "Cell": "", 
                            "Tissue": "BEC (bronchoepithelial) cells", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Particulate Matter\")", 
                "relation": "increases", 
                "target": "a(CHEBI:\"reactive oxygen species\")", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Particulate Matter\" increases the abundance of \"reactive oxygen species\".", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "a(SCHEM:Particulate Matter) increases a(CHEBI:reactive oxygen species)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12899936", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "PM may exert oxidative stress on cells in the lung by presenting or by stimulating the cells to produce reactive oxygen (ROS)", 
                            "Cell": "", 
                            "Tissue": "lung", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:NQO1)", 
                "relation": "increases", 
                "target": "p(HGNC:GSTP1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The protein abundance of NQO1 increases the protein abundance of GSTP1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) increases p(HGNC:GSTP1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) increases p(HGNC:GSTP1)", 
                                "eid": "524b352dd3fbfd4c340839a2"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:NQO1)", 
                "relation": "actsIn", 
                "target": "cat(p(HGNC:NQO1))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of NQO1 acts in catalytic activity of the protein abundance of NQO1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17395013", 
                                "Name": "Free Radic Biol Med 2007 May 1 42(9) 1398-408"
                            }, 
                            "Disease": "", 
                            "SummaryText": "NE also increased NQO1 activity by 33.4 \u00b1 9 % in A549 cells (Figure 6C) and by 22.5 \u00b1 5% in NHBE cells (Figure 7C) as measured by dicumarol-inhibitable DCPIP reduction.", 
                            "Cell": "bronchial epithelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083b73"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12694753", 
                                "Name": "Mutat Res 2003 Apr 20 536(1-2) 131-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "# Ariadne: NQO1 protects cells from oxidative damage by preventing the generation of reactive oxygen species and reducing certain environmental carcinogens, such as nitroaromatic compounds, heterocyclic amines, and possible cigarette smoke condensate. [MolSynthesis]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083a8b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16877260", 
                                "Name": "Drug Metab Rev 2006 38(3) 411-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "However the cardioprotective properties of NQO1 and GSTA1 are mainly attributed to the antioxidant effect by decreasing ROS and increasing the levels of endogenous antioxidants. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083996"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12370194", 
                                "Name": "J Biol Chem 2003 Jan 10 278(2) 703-11"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In addition, expression of NQO1 or Nrf2 inhibited tumor necrosis factor-alpha-induced activation of VCAM-1 (vascular cell adhesion molecule-1) gene expression in EC", 
                            "Cell": "", 
                            "Tissue": "Endothelium", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083b79"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11567026", 
                                "Name": "J Biol Chem 2001 Nov 30 276(48) 44379-84"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Levels of NQO1 activity were much higher (40-fold) in confluent HeLa cells than in sparse cells, the former cells being much more resistant to H(2)O(2).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083b64"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10683249", 
                                "Name": "Arch Biochem Biophys 2000 Mar 1 375(1) 62-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Ariadne: A role of cytosolic NQO1 in protection of cells from oxidative stress, cytotoxicity, and mutagenicity of quinones was established. [Regulation]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083bc1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11085512", 
                                "Name": "Cancer Res 2000 Nov 1 60(21) 5959-62"
                            }, 
                            "Disease": "", 
                            "SummaryText": "DTD is implicated in the activation of MMC in target cells, and DTD down-regulation explains MMC resistance. MMC resistance induced by TCF-3 overexpression is probably due to DTD down-regulation, which might provide a possible target for new therapy of drug-resistant gastric cancer.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c340839fc"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12947090", 
                                "Name": "J Biol Chem 2003 Nov 7 278(45) 44675-82"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Calphostin C was also able to inhibit the induction of NQO1 activity in vivo (Fig. 3)....Both NQO1 activity and the amount of NQO1 protein decreased in a dosedependent manner in response to treatment with the PKC inhibitor.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c3408395e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15477004", 
                                "Name": "Free Radic Biol Med 2004 Nov 15 37(10) 1527-33"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Exposure of the lungs to PP resulted in an increase in NQO1 activity of 70% compared with sham-treated animals ( p b .0001). The NQO1 activity of gas phaseexposed lungs was 50% higher than sham ( p b .0001). Both increases in NQO1 activity were consistent with the observed changes in NQO1 protein.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083c23"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19646463", 
                                "Name": "Toxicol Appl Pharmacol 2009 Jul 29"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Enhanced mRNA expression and enzyme activity of NQO1 and gamma glutamyl cysteine ligase (GCL) were elicited by oxidant exposure (e.g., hyperoxia, hydrogen peroxide) in pulmonary tissues or cells (Whitney and Frank, 1993; Rahman et al., 1996).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083c0a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15520857", 
                                "Name": "J Clin Invest 2004 Nov 114(9) 1248-59"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Enzyme assays of selected gene products (NQO1, GSR, Prx, glutathione peroxidase [GPx] and G6PDH) were carried out to determine the extent to which their transcriptional induction in the lung paralleled changes in their activities (Figure 7B). There were significant increases in the activities of all enzymes in the lungs of CS-exposed Nrf2+/+ mice when compared to those of CSexposed Nrf2\u2013/\u2013 mice as well as those of the air-exposed mice of both genotypes.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083b11"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17588258", 
                                "Name": "J Pharm Sci 2007 Oct 96(10) 2795-807"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Both TNF-alpha and LPS repressed the beta-naphthoflavone (betaNF)-mediated induction of Cyp1a1 and Nqo1 at mRNA and activity levels. The downregulation of Cyp1a1, but not Nqo1, was significantly prevented by L-NIL, a Nos2 inhibitor.", 
                            "Cell": "hepatocyte", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083af1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15102952", 
                                "Name": "Mol Pharmacol 2004 May 65(5) 1238-47"
                            }, 
                            "Disease": "", 
                            "SummaryText": "All of these findings suggest a more direct role for NQO1 in protection against oxidative stress than considered previously. In this work, we demonstrate that NQO1 has the ability to directly scavenge superoxide. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083a9b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12234984", 
                                "Name": "Cancer Res 2002 Sep 15 62(18) 5196-203"
                            }, 
                            "Disease": "", 
                            "SummaryText": "NQO1 and GST enzyme activities were induced 1.6- and 1.3-fold, respectively, by treatment of wild-type mice with sulforaphane. Moreover, their basal activities were significantly lower in the untreated nrf2-deficient mice when compared with the untreated wild-type mice. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083a46"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17395013", 
                                "Name": "Free Radic Biol Med 2007 May 1 42(9) 1398-408"
                            }, 
                            "Disease": "", 
                            "SummaryText": "NE also increased NQO1 activity by 33.4 \u00b1 9 % in A549 cells (Figure 6C) and by 22.5 \u00b1 5% in NHBE cells (Figure 7C) as measured by dicumarol-inhibitable DCPIP reduction.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083a9d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12232053", 
                                "Name": "Proc Natl Acad Sci U S A 2002 Oct 1 99(20) 13125-30"
                            }, 
                            "Disease": "", 
                            "SummaryText": "# Ariadne: Reactive oxygen species  increase NQO1 activity ( 38 ), which in turn further stabilizes p53. [Regulation]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c3408397a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10681517", 
                                "Name": "J Biol Chem 2000 Feb 25 275(8) 5416-24"
                            }, 
                            "Disease": "", 
                            "SummaryText": "# Ariadne: M dicoumarol, which inhibited all  measurable NQO1 activity. [Regulation]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:NQO1) actsIn cat(p(HGNC:NQO1))", 
                                "eid": "524b352dd3fbfd4c34083b7e"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"8-Methyl-IQX\")", 
                "relation": "increases", 
                "target": "tscript(p(HGNC:AHR))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"8-Methyl-IQX\" increases the transcriptional activity of the protein abundance of AHR.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"8-Methyl-IQX\") increases tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20816883", 
                                "Name": "Toxicol Appl Pharmacol 2010 Nov 15 249(1) 91-100"
                            }, 
                            "Disease": "hepatocellular carcinoma", 
                            "SummaryText": "these results identify the AhR gene battery as the preferential target of PhIP and MeIQx in HepaRG cells", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"8-Methyl-IQX\") increases tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b10"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "cat(p(HGNC:CYP2E1))", 
                "relation": "increases", 
                "target": "a(CHEBI:\"reactive oxygen species\")", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The catalytic activity of the protein abundance of CYP2E1 increases the abundance of \"reactive oxygen species\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "cat(p(HGNC:CYP2E1)) increases a(CHEBI:\"reactive oxygen species\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16624972", 
                                "Name": "J Pharmacol Exp Ther 2006 Jul 318(1) 360-72"
                            }, 
                            "Disease": "", 
                            "SummaryText": "PI3-kinase/AKT may serve as a survival pathway against CYP2E1-dependent toxicity.E47 cells (HepG2 cells transfected with human CYP2E1 cDNA) exposed to 25 microM iron-nitrilotriacetate+5 microM arachidonic acid (AA+Fe) developed higher toxicity than C34 cells (HepG2 cells transfected with empty plasmid). Toxicity was associated with increased oxidative stress and activation of calcium-dependent hydrolases calpain and phospholipase A2.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "cat(p(HGNC:CYP2E1)) increases a(CHEBI:\"reactive oxygen species\")", 
                                "eid": "524b352dd3fbfd4c34083aba"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "cat(p(HGNC:CYP2E1)) increases a(CHEBI:\"reactive oxygen species\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11816819", 
                                "Name": "Eur Respir J Suppl 2001 Sep 32 122s-126s"
                            }, 
                            "Disease": "", 
                            "SummaryText": "he expression of pulmonary CYP2E1 mRNA and protein have been established in several studies 17, 19, 21, 29, 37, 42, 43. CYP2E1 is an interesting CYP form because it is the most active CYP enzyme in forming oxygen radicals, causing tissue injury 44", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "cat(p(HGNC:CYP2E1)) increases a(CHEBI:\"reactive oxygen species\")", 
                                "eid": "524b352dd3fbfd4c34083aec"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:CYP1A1)", 
                "relation": "actsIn", 
                "target": "cat(p(HGNC:CYP1A1))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of CYP1A1 acts in catalytic activity of the protein abundance of CYP1A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "22053912", 
                                "Name": "Chem Res Toxicol 2012 Jan 13 25(1) 113-21"
                            }, 
                            "Disease": "", 
                            "SummaryText": "B[a]P can be converted into DNA reactive metabolites via three pathways. The first pathway utilizes enzymes from the cytochrome P450 family (CYP1A1 and CYP1B1) and epoxide hydrolases to form (\u00b1)anti-BPDE. PAHs are metabolized to (\u00b1)-anti-diol epoxides, such as (\u00b1)-anti-benzo[a]pyrene diol epoxide ((\u00b1)-anti-BPDE)), by the combined action of P4501A1/1B1 and epoxide hydrolase. (\u00b1)-anti-BPDE forms DNA adducts directly", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083961"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8245718", 
                                "Name": "J Lipid Res 1993 Oct 34(10) 1675-85"
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP1B1 metabolises oestradiol to the catechol oestrogen 4-hydroxyestradiol", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083bc3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18842620", 
                                "Name": "Toxicol Sci 2009 Jan 107(1) 1-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Here, we observed that the loss of BRG-1/BRM has an adverse effect on CYP1A1 induction after dioxin treatment,while displaying very little effect on CYP1B1 induction (Fig. 5B)....##BW## BRG1.BRM bind to promoters as a SWI/SNF chromatin remodeling complex.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083ac1"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17588258", 
                                "Name": "J Pharm Sci 2007 Oct 96(10) 2795-807"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Both TNF-alpha and LPS repressed the beta-naphthoflavone (betaNF)-mediated induction of Cyp1a1 and Nqo1 at mRNA and activity levels. The downregulation of Cyp1a1, but not Nqo1, was significantly prevented by L-NIL, a Nos2 inhibitor.", 
                            "Cell": "hepatocyte", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083ac4"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9726784", 
                                "Name": "J Toxicol Environ Health A 1998 Aug 21 54(8) 633-45"
                            }, 
                            "Disease": "", 
                            "SummaryText": "After exposure to lower toluene levels (125 ppm, 6 h/d, 3 d), the activities of lung AHH, CYP2B1, and CYP4B1 were also significantly decreased, but in a dose-related manner.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083b99"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16877260", 
                                "Name": "Drug Metab Rev 2006 38(3) 411-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Generally, induction of CYP1A1, CYP1A2, and CYP1B1 is considered cardiotoxic through generating reactive oxygen species (ROS)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083c0d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15666840", 
                                "Name": "Endocr Res 2004 Nov 30(4) 881-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In 1986 we postulated that this disorder might be due to mutations in P450 oxidoreductase (POR), the flavoprotein that donates electron to these and all other microsomal P450 enzymes,", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083a21"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18073400", 
                                "Name": "Proc Am Thorac Soc 2007 Dec 4(8) 671-4"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The two main CYP enzymes that are up-regulated by cigarette smoke are CYP1A1 and CYP1B1, which are regulated by ER{alpha} (18). Stimulation of estrogen receptor in the lungs increases protein expression of CYP1A1 by twofold (17). The increased CYP expression is also related to increased estradiol-? expression (19). CYPs are also involved in the bioactivation of 17?-estradiol, resulting in a positive feedback loop", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083b4d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10359656", 
                                "Name": "Biochem J 1999 Jun 15 340 ( Pt 3) 715-22"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The enzymic activity of CYP1A1 in intact MCF-7 cells treated with quercetin or kaempferol was assayed by measuring EROD activity. Incubation of the cells with quercetin for 48 h caused a concentration-dependent increase in EROD activity ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083980"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14637189", 
                                "Name": "Biochem Pharmacol 2003 Dec 15 66(12) 2313-21"
                            }, 
                            "Disease": "", 
                            "SummaryText": "As seen in Fig. 4, at 3 hr post-exposure, induction of EROD activity by indirubin and by TCDD was similar: 3.8- and 4.1-fold over the initial level, respectively.....we modified the EROD assay [29], which measures predominantly CYP1A1 enzyme activity [35],", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083c31"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16092727", 
                                "Name": "Exp Toxicol Pathol 2005 Jul 57 Suppl 1 189-204"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Consistent with these findings, we found increases in EROD activity similar to what has been previously reported (Foster et al., 1998; Hukkanen et al., 2000).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083b6f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15888666", 
                                "Name": "Toxicol Sci 2005 Aug 86(2) 342-53"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In this study, mouse cDNA microarrays representing 4858 genes were used to examine differences in basal gene expression between mouse Hepa-1c1c7 wild-type and c1 (truncated Cyp1a1 protein) and c4 (AhR nuclear translocator, ARNT, deficient) mutant cell lines. Fold change increase or decrease of 1.5 was used as a cut-off.  Data taken from tables 3,4,5.  ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083a3a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12785736", 
                                "Name": "Arch Pharm Res 2003 May 26(5) 394-404"
                            }, 
                            "Disease": "", 
                            "SummaryText": "When mice were treated intraperitoneally with 3, 10 and 30 mg/kg of individual PAHs for 3 consecutive days, the activities of ethoxyresorufin- and methoxyresorufin-O-dealkylases were significantly and differentially induced in both liver and lung. Moreover, other CYP isozyme-associated monooxygenase activities were also induced significantly in liver and lung with characteristic induction profiles. It was found that the activities of CYP 1A-selective EROD and MROD were significantly induced in both liver and lung tissues of treated mice (Figs. 2 to 5).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083a91"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "22187486", 
                                "Name": "Drug Metab Dispos 2012 Mar 40(3) 579-87"
                            }, 
                            "Disease": "lung adenocarcinoma", 
                            "SummaryText": "Exposure of A549, HepG2 hepatic carcinoma cells, and MCF-7 breast carcinoma cells to tetrachlorodibenzo-p-dioxin induced the expression and enzymatic activity of CYP1A1 and CYP1B1,", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083bb5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9698073", 
                                "Name": "Biochem Pharmacol 1998 Jul 15 56(2) 197-206"
                            }, 
                            "Disease": "", 
                            "SummaryText": "we measured the enzymatic activity of CYP1A1 in MCF-7 cells treated with curcumin using the EROD assay, which is specific for CYP1A1/2 monoxygenase activity. Twenty-four hours of curcumin treatment resulted in a biphasic response of CYP1A1 EROD activity. There was a concentration-dependent increase in activity up to 5 ?M of curcumin, but an absence of measurable activity in cells treated with 10 ?M (Fig. 5). After 48 hr, however, there was a linear, concentration-dependent increase in activity from 0.5 to 10 ?M of curcumin. By 72 hr, enzyme activity increased in a linear fashion but was much reduced compared with the earlier time points. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083bad"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11346483", 
                                "Name": "Food Chem Toxicol 2001 Jun 39(6) 541-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In vitro incubation of rat liver microsomes with each of the compounds--C[curcumin], dmC, bdmC, PITC and PEITC-...Significantly lower concentrations of curcumin(s) than isothiocyanates achieved 50% inhibition of activity of CYP 1A1 and 1A2", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083b1c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20435083", 
                                "Name": "Toxicology 2010 Jun 29 273(1-3) 35-44"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Catalytic activities of CYP1A1, CYP1A2 and CYP1B1, and inducibility of the activities were studied in intact human lung samples (from 23 human subjects) ex vivo. The activities [as measured by ethoxyresorufin O-deethylase (EROD), methoxyresorufin O-demethylase (MROD), and 3-cyano-7-ethoxycoumarin O-deethylase (CECOD)] were present in the lungs and were induced by benzo[a]pyrene (B[a]P) and diesel exhaust particle extract (DEE) but with extensive inter-subject variability. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083bec"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8080435", 
                                "Name": "Biochem Pharmacol 1994 Aug 17 48(4) 637-42"
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP1A1/2, contribute to the metabolism of styrene, (2) CYP2C11/6, which probably corresponds to CYP2C11, is the major form of P450 responsible for the metabolism in untreated rat liver microsomes, and also in those treated with ethanol.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083b1d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16966090", 
                                "Name": "Environ Health Perspect 2006 Sep 114(9) 1367-73"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Figure 6. CD significantly decreases both CYP1A1- and CYP2B1-dependent metabolism in the lung", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083b04"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "21376804", 
                                "Name": "Toxicol In Vitro 2011 Jun 25(4) 922-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "TCDD-induced CYP1A1/1B1 activity was observed for NCI-H292 (2.74 \u00b1 0.60 RLU/mg protein/min) and NHTBE cultures in the presence of retinoic acid (D1 \u2013 4.30 \u00b1 1.43; D2 \u2013 4.30 \u00b1 0.65; D3 \u2013 7.35 \u00b1 2.29; RLU/mg protein/min). This activity was inhibited by a-naphthoflavone, a CYP1A1/1B1 inhibitor. the presence of retinoic acid following treatment with TCDD (Fig. 3A and B).", 
                            "Cell": "bronchial epithelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083b5d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17200336", 
                                "Name": "Clin Cancer Res 2007 Jan 1 13(1) 38-45"
                            }, 
                            "Disease": "lung adenocarcinoma", 
                            "SummaryText": "Benzo(a)pyrene consistently induced the highest level of aryl hydrocarbon hydroxylase activity in H1355 cells (Fig. 2B).....The aryl hydrocarbon hydroxylase activity assay was used to measure CYP1A1 and CYP1B1 enzyme activity (24)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083c04"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18321868", 
                                "Name": "Carcinogenesis 2008 May 29(5) 1022-32"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Curcumin has been shown to increase CYP1A1 activity and AhR\u2013DNA binding in MCF7 cells (17).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083c20"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10519398", 
                                "Name": "Cancer Res 1999 Oct 1 59(19) 4870-5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "the genes responsible for CE formation via estrogen biosynthesis (CYP17) and hydroxylation (CYP1A1) and CE inactivation (COMT)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:CYP1A1) actsIn cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083a53"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:NR1I2))", 
                "relation": "increases", 
                "target": "p(HGNC:CYP1A2)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of NR1I2 increases the protein abundance of CYP1A2.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:NR1I2)) increases p(HGNC:CYP1A2)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:NR1I2)) increases p(HGNC:CYP1A2)", 
                                "eid": "524b352dd3fbfd4c3408396e"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:NR1I2))", 
                "relation": "increases", 
                "target": "p(HGNC:CYP1A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of NR1I2 increases the protein abundance of CYP1A1.", 
                    "approval_status": "active", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:NR1I2)) increases p(HGNC:CYP1A1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:NR1I2)) increases p(HGNC:CYP1A1)", 
                                "eid": "524b352dd3fbfd4c3408398c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:NR1I2)) increases p(HGNC:CYP1A1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "swapna30", 
                            "Citation": {
                                "Type": null, 
                                "ID": "12181440", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "In human hepatocytes, activation of PXR by\nrifampicin results in a modest induction of AhR and a\nmarked induction of its target genes CYP1A1 and CYP1A2", 
                            "Cell": "cell line", 
                            "Tissue": "hepatocyte", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:NR1I2)) increases p(HGNC:CYP1A1)", 
                                "eid": "5303365a89e36206c02a21eb"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:\"reactive oxygen species\")", 
                "relation": "increases", 
                "target": "a(SCHEM:\"4-Hydroxy-2-nonenal\")", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"reactive oxygen species\" increases the abundance of \"4-Hydroxy-2-nonenal\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:\"reactive oxygen species\") increases a(SCHEM:\"4-Hydroxy-2-nonenal\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15313424", 
                                "Name": "Biochem Pharmacol 2004 Sep 15 68(6) 1255-67"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Reactive oxygen species (ROS), either directly or via the formation of lipid peroxidation products, such as 4-hydroxy-2-nonenal, acrolein", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:\"reactive oxygen species\") increases a(SCHEM:\"4-Hydroxy-2-nonenal\")", 
                                "eid": "524b352dd3fbfd4c34083aa7"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:dexamethasone)", 
                "relation": "increases", 
                "target": "p(HGNC:CYP3A5)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of dexamethasone increases the protein abundance of CYP3A5.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:dexamethasone) increases p(HGNC:CYP3A5)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:dexamethasone) increases p(HGNC:CYP3A5)", 
                                "eid": "524b352dd3fbfd4c34083be4"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:dexamethasone)", 
                "relation": "increases", 
                "target": "tscript(p(HGNC:NR3C1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of dexamethasone increases the transcriptional activity of the protein abundance of NR3C1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12414793", 
                                "Name": "J Biol Chem 2003 Feb 14 278(7) 5091-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The capacity of GR to transactivate the native angiotensinogen glucocorticoid-responsive element (GRE) using chromatin-IP was not impaired.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                                "eid": "524b352dd3fbfd4c34083a28"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19628874", 
                                "Name": "J Biol Chem 2009 Sep 18 284(38) 25593-601"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Using bioinformatics and chromatin immunoprecipitation, we identified a GR binding site within the rat Angptl4 sequence. A reporter plasmid containing this site was markedly activated by dexamethasone, indicative of a functional glucocorticoid response element. Dexamethasone treatment also increased histone H4 acetylation and DNase I accessibility in genomic regions near this site, further supporting that it is a glucocorticoid response element. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                                "eid": "524b352dd3fbfd4c34083bc8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9804617", 
                                "Name": "Mol Pharmacol 1998 Nov 54(5) 825-33"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We conclude that glucocorticoid receptor rapidly suppresses activity of the AhR/AhR nuclear translocator complex in the CYP1B1 enhancer region, even though lacking glucocorticoid responsive element(s).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                                "eid": "524b352dd3fbfd4c34083afa"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9804617", 
                                "Name": "Mol Pharmacol 1998 Nov 54(5) 825-33"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We conclude that glucocorticoid receptor rapidly suppresses activity of the AhR/AhR nuclear translocator complex in the CYP1B1 enhancer region, even though lacking glucocorticoid responsive element(s).", 
                            "Cell": "Fibroblasts", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                                "eid": "524b352dd3fbfd4c34083b48"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16092727", 
                                "Name": "Exp Toxicol Pathol 2005 Jul 57 Suppl 1 189-204"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Consequently, CYP3A5 is inducible by dexamethasone and other glucocorticoidsthrough a GR-mediated mechanism, in A549 cells ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                                "eid": "524b352dd3fbfd4c34083b93"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12112005", 
                                "Name": "J Cell Biochem 2002 86(2) 357-64"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Dexamethasone time-dependently increased the levels of HSP27, while having no effect on the levels of HSP70 or HSP90.", 
                            "Cell": "osteoblast", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                                "eid": "524b352dd3fbfd4c34083c32"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14566398", 
                                "Name": "Sheng Li Xue Bao 2003 Oct 25 55(5) 525-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The following results were observed: (1) dexamethasone induced the expression of SIP24/24p3 in both Balb/c 3T3 and BNL cells, the induction was more significant in BNL cells;", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                                "eid": "524b352dd3fbfd4c34083b94"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12112005", 
                                "Name": "J Cell Biochem 2002 86(2) 357-64"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Dexamethasone time-dependently increased the levels of HSP27, while having no effect on the levels of HSP70 or HSP90.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                                "eid": "524b352dd3fbfd4c34083ab9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9873044", 
                                "Name": "J Biol Chem 1999 Jan 8 274(2) 1005-10"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Treatment of the cells with the beta2-AR agonists, salbutamol or salmeterol, resulted in translocation of GR into the nucleus beginning at 30 min activation of GR induced by the corticosteroids dexamethasone and fluticasone occurred at the same time after treatment (30 min)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                                "eid": "524b352dd3fbfd4c340839d0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "3126194", 
                                "Name": "J Cell Biol 1988 Mar 106(3) 971-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "modulated by the synthetic glucocorticoid dexamethasone Northern blot hybridization and nuclear Run-on transcription assays demonstrated that the increase of t-PA and PAI-1 and the decrease of u-PA were associated with equivalent changes of gene template activity. Modulation of u-PA, t-PA and PAI-1 gene expression by Dex was completely blocked by the glucocorticoid antagonist RU 38486, suggesting that all effects were mediated through the glucocorticoid receptor.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                                "eid": "524b352dd3fbfd4c34083a1e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10391127", 
                                "Name": "Mol Cell Biochem 1999 Apr 194(1-2) 79-91"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Lysyl oxidase transcription was stimulated by dexamethasone treatment of cells, but this effect could not be assigned within the approximately 3 kb region tested in reporter gene constructs.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))", 
                                "eid": "524b352dd3fbfd4c340839e2"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:ESR1))", 
                "relation": "increases", 
                "target": "p(HGNC:CYP1A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of ESR1 increases the protein abundance of CYP1A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:ESR1)) increases p(HGNC:CYP1A1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:ESR1)) increases p(HGNC:CYP1A1)", 
                                "eid": "524b352dd3fbfd4c340839c2"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:ESR1))", 
                "relation": "directlyIncreases", 
                "target": "p(HGNC:CYP1B1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of ESR1 directly increases the protein abundance of CYP1B1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:ESR1)) directlyIncreases p(HGNC:CYP1B1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:ESR1)) directlyIncreases p(HGNC:CYP1B1)", 
                                "eid": "524b352dd3fbfd4c34083a6a"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "cat(p(HGNC:ALDH3A1))", 
                "relation": "decreases", 
                "target": "a(SCHEM:\"4-Hydroxy-2-nonenal\")", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The catalytic activity of the protein abundance of ALDH3A1 decreases the abundance of \"4-Hydroxy-2-nonenal\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "cat(p(HGNC:ALDH3A1)) decreases a(SCHEM:\"4-Hydroxy-2-nonenal\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16716894", 
                                "Name": "Free Radic Biol Med 2006 Jun 1 40(11) 1929-38"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We found that human lung tumor (A549) cells, which express high levels of ALDH3A1 protein, were significantly less susceptible to the antiproliferative effects of 4-hydroxynonenal compared to human hepatoma HepG2 or SK-HEP-1 cells that lack ALDH3A1 expression.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "cat(p(HGNC:ALDH3A1)) decreases a(SCHEM:\"4-Hydroxy-2-nonenal\")", 
                                "eid": "524b352dd3fbfd4c34083a2a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "cat(p(HGNC:ALDH3A1)) decreases a(SCHEM:\"4-Hydroxy-2-nonenal\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17567582", 
                                "Name": "J Biol Chem 2007 Aug 31 282(35) 25668-76"
                            }, 
                            "Disease": "", 
                            "SummaryText": "ALDH3A1 and ALDH1A1 protect the corneal epithelium from UV-induced oxidative damage is the detoxification of highly reactive products of LPO, such as 4-hydroxy-2-nonenal (4-HNE) and malondialdehyde (MDA). ALDH3A1 metabolizes 4-HNE (23), whereas ALDH1A1 metabolizes both 4-HNE and MDA (24).", 
                            "Cell": "Epithelial Cells", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "cat(p(HGNC:ALDH3A1)) decreases a(SCHEM:\"4-Hydroxy-2-nonenal\")", 
                                "eid": "524b352dd3fbfd4c340839c7"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:phenobarbital)", 
                "relation": "increases", 
                "target": "p(HGNC:CYP2B6)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of phenobarbital increases the protein abundance of CYP2B6.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:phenobarbital) increases p(HGNC:CYP2B6)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:phenobarbital) increases p(HGNC:CYP2B6)", 
                                "eid": "524b352dd3fbfd4c34083a01"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:phenobarbital)", 
                "relation": "increases", 
                "target": "cat(p(HGNC:CYP2B6))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of phenobarbital increases the catalytic activity of the protein abundance of CYP2B6.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:phenobarbital) increases cat(p(HGNC:CYP2B6))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16092727", 
                                "Name": "Exp Toxicol Pathol 2005 Jul 57 Suppl 1 189-204"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Phenobarbital also produced a very weak induction of CYP2B6 both at mRNA and activity level (Fig. 6). ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:phenobarbital) increases cat(p(HGNC:CYP2B6))", 
                                "eid": "524b352dd3fbfd4c34083a43"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "cat(p(HGNC:NQO1))", 
                "relation": "decreases", 
                "target": "a(CHEBI:\"reactive oxygen species\")", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The catalytic activity of the protein abundance of NQO1 decreases the abundance of \"reactive oxygen species\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "cat(p(HGNC:NQO1)) decreases a(CHEBI:\"reactive oxygen species\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15102952", 
                                "Name": "Mol Pharmacol 2004 May 65(5) 1238-47"
                            }, 
                            "Disease": "", 
                            "SummaryText": "All of these findings suggest a more direct role for NQO1 in protection against oxidative stress than considered previously. In this work, we demonstrate that NQO1 has the ability to directly scavenge superoxide. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "cat(p(HGNC:NQO1)) decreases a(CHEBI:\"reactive oxygen species\")", 
                                "eid": "524b352dd3fbfd4c34083aff"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "cat(p(HGNC:NQO1)) decreases a(CHEBI:\"reactive oxygen species\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12694753", 
                                "Name": "Mutat Res 2003 Apr 20 536(1-2) 131-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "# Ariadne: NQO1 protects cells from oxidative damage by preventing the generation of reactive oxygen species and reducing certain environmental carcinogens, such as nitroaromatic compounds, heterocyclic amines, and possible cigarette smoke condensate. [MolSynthesis]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "cat(p(HGNC:NQO1)) decreases a(CHEBI:\"reactive oxygen species\")", 
                                "eid": "524b352dd3fbfd4c340839e9"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "cat(p(HGNC:NQO1)) decreases a(CHEBI:\"reactive oxygen species\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10683249", 
                                "Name": "Arch Biochem Biophys 2000 Mar 1 375(1) 62-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Ariadne: A role of cytosolic NQO1 in protection of cells from oxidative stress, cytotoxicity, and mutagenicity of quinones was established. [Regulation]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "cat(p(HGNC:NQO1)) decreases a(CHEBI:\"reactive oxygen species\")", 
                                "eid": "524b352dd3fbfd4c34083b22"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "cat(p(HGNC:NQO1)) decreases a(CHEBI:\"reactive oxygen species\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16877260", 
                                "Name": "Drug Metab Rev 2006 38(3) 411-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "However the cardioprotective properties of NQO1 and GSTA1 are mainly attributed to the antioxidant effect by decreasing ROS and increasing the levels of endogenous antioxidants. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "cat(p(HGNC:NQO1)) decreases a(CHEBI:\"reactive oxygen species\")", 
                                "eid": "524b352dd3fbfd4c34083a3e"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:curcumin)", 
                "relation": "decreases", 
                "target": "cat(p(HGNC:CYP1A1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of curcumin decreases the catalytic activity of the protein abundance of CYP1A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:curcumin) decreases cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11346483", 
                                "Name": "Food Chem Toxicol 2001 Jun 39(6) 541-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In vitro incubation of rat liver microsomes with each of the compounds--C[curcumin], dmC, bdmC, PITC and PEITC-...Significantly lower concentrations of curcumin(s) than isothiocyanates achieved 50% inhibition of activity of CYP 1A1 and 1A2", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:curcumin) decreases cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083a79"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:curcumin)", 
                "relation": "decreases", 
                "target": "cat(p(HGNC:CYP2B6))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of curcumin decreases the catalytic activity of the protein abundance of CYP2B6.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:curcumin) decreases cat(p(HGNC:CYP2B6))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17433521", 
                                "Name": "Toxicology 2007 Jun 3 235(1-2) 83-91"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Curcumin showed a competitive type of inhibition towards CYP1A2, CYP3A4 and CYP2B6. Curcumin inhibited CYP1A2 (IC(50), 40.0 microM), CYP3A4 (IC(50), 16.3 microM), CYP2D6 (IC(50), 50.3 microM), CYP2C9 (IC(50), 4.3 microM) and CYP2B6 (IC(50), 24.5 microM). ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:curcumin) decreases cat(p(HGNC:CYP2B6))", 
                                "eid": "524b352dd3fbfd4c34083b20"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:curcumin)", 
                "relation": "decreases", 
                "target": "cat(p(HGNC:CYP1A2))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of curcumin decreases the catalytic activity of the protein abundance of CYP1A2.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:curcumin) decreases cat(p(HGNC:CYP1A2))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11346483", 
                                "Name": "Food Chem Toxicol 2001 Jun 39(6) 541-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In vitro incubation of rat liver microsomes with each of the compounds--C[curcumin], dmC, bdmC, PITC and PEITC-...Significantly lower concentrations of curcumin(s) than isothiocyanates achieved 50% inhibition of activity of CYP 1A1 and 1A2", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:curcumin) decreases cat(p(HGNC:CYP1A2))", 
                                "eid": "524b352dd3fbfd4c34083c0e"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:Tetrachlorodibenzodioxin)", 
                "relation": "increases", 
                "target": "p(HGNC:CYP1A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of Tetrachlorodibenzodioxin increases the protein abundance of CYP1A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:Tetrachlorodibenzodioxin) increases p(HGNC:CYP1A1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17070097", 
                                "Name": "Oral Oncol 2007 Aug 43(7) 693-700"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Activation of the AHR signaling pathway by either TCDD or CSC is indicated by the increase in CYP1A1 protein expression relative to the DMSO control at all time points examined. Treatment with either TCDD or CSC resulted in a decrease in protein expression of p15INK4b, p16INK4a and p53 that was most clearly evident at the day 6 time point.", 
                            "Cell": "Keratinocytes", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:Tetrachlorodibenzodioxin) increases p(HGNC:CYP1A1)", 
                                "eid": "524b352dd3fbfd4c340839d1"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:Tetrachlorodibenzodioxin)", 
                "relation": "increases", 
                "target": "p(HGNC:CYP1B1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of Tetrachlorodibenzodioxin increases the protein abundance of CYP1B1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:Tetrachlorodibenzodioxin) increases p(HGNC:CYP1B1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15364539", 
                                "Name": "Toxicol Appl Pharmacol 2004 Sep 15 199(3) 220-38"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In each set of cells, suspension-mediated expression of CYP1B1 protein peaked within 6?9 h and then gradually declined. By contrast, CYP1B1 protein induced by TCDD in monolayer culture did not decline, but remained at a steady-state level (Fig. 1A).", 
                            "Cell": "Fibroblasts", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:Tetrachlorodibenzodioxin) increases p(HGNC:CYP1B1)", 
                                "eid": "524b352dd3fbfd4c34083a29"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:Tetrachlorodibenzodioxin)", 
                "relation": "increases", 
                "target": "cat(p(HGNC:CYP1B1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of Tetrachlorodibenzodioxin increases the catalytic activity of the protein abundance of CYP1B1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:Tetrachlorodibenzodioxin) increases cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:Tetrachlorodibenzodioxin) increases cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083bd9"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:Tetrachlorodibenzodioxin)", 
                "relation": "increases", 
                "target": "cat(p(HGNC:CYP1A1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of Tetrachlorodibenzodioxin increases the catalytic activity of the protein abundance of CYP1A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:Tetrachlorodibenzodioxin) increases cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14637189", 
                                "Name": "Biochem Pharmacol 2003 Dec 15 66(12) 2313-21"
                            }, 
                            "Disease": "", 
                            "SummaryText": "As seen in Fig. 4, at 3 hr post-exposure, induction of EROD activity by indirubin and by TCDD was similar: 3.8- and 4.1-fold over the initial level, respectively.....we modified the EROD assay [29], which measures predominantly CYP1A1 enzyme activity [35],", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:Tetrachlorodibenzodioxin) increases cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083bf5"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:ALDH3A1)", 
                "relation": "actsIn", 
                "target": "cat(p(HGNC:ALDH3A1))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of ALDH3A1 acts in catalytic activity of the protein abundance of ALDH3A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ALDH3A1) actsIn cat(p(HGNC:ALDH3A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17567582", 
                                "Name": "J Biol Chem 2007 Aug 31 282(35) 25668-76"
                            }, 
                            "Disease": "", 
                            "SummaryText": "ALDH3A1 and ALDH1A1 protect the corneal epithelium from UV-induced oxidative damage is the detoxification of highly reactive products of LPO, such as 4-hydroxy-2-nonenal (4-HNE) and malondialdehyde (MDA). ALDH3A1 metabolizes 4-HNE (23), whereas ALDH1A1 metabolizes both 4-HNE and MDA (24).", 
                            "Cell": "Epithelial Cells", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ALDH3A1) actsIn cat(p(HGNC:ALDH3A1))", 
                                "eid": "524b352dd3fbfd4c34083b49"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:ALDH3A1) actsIn cat(p(HGNC:ALDH3A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16716894", 
                                "Name": "Free Radic Biol Med 2006 Jun 1 40(11) 1929-38"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We found that human lung tumor (A549) cells, which express high levels of ALDH3A1 protein, were significantly less susceptible to the antiproliferative effects of 4-hydroxynonenal compared to human hepatoma HepG2 or SK-HEP-1 cells that lack ALDH3A1 expression.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:ALDH3A1) actsIn cat(p(HGNC:ALDH3A1))", 
                                "eid": "524b352dd3fbfd4c34083b19"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:AHR))", 
                "relation": "increases", 
                "target": "p(HGNC:CYP1B1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of AHR increases the protein abundance of CYP1B1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:AHR)) increases p(HGNC:CYP1B1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:AHR)) increases p(HGNC:CYP1B1)", 
                                "eid": "524b352dd3fbfd4c3408397d"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:AHR))", 
                "relation": "increases", 
                "target": "p(HGNC:AHRR)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of AHR increases the protein abundance of AHRR.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:AHR)) increases p(HGNC:AHRR)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:AHR)) increases p(HGNC:AHRR)", 
                                "eid": "524b352dd3fbfd4c34083a5a"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:AHR))", 
                "relation": "increases", 
                "target": "p(HGNC:NFE2L2)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of AHR increases the protein abundance of NFE2L2.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:AHR)) increases p(HGNC:NFE2L2)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19185948", 
                                "Name": "Lung Cancer 2009 Aug 65(2) 129-37"
                            }, 
                            "Disease": "", 
                            "SummaryText": "There may be bidirectional regulation; recent studies suggest that Nrf2 is an AhR target gene, and the Nrf2 expression is directly modulated by AhR activation [19]\ufffdand\ufffd[20]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:AHR)) increases p(HGNC:NFE2L2)", 
                                "eid": "524b352dd3fbfd4c34083a62"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:AHR))", 
                "relation": "directlyIncreases", 
                "target": "p(HGNC:CYP1A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of AHR directly increases the protein abundance of CYP1A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:AHR)) directlyIncreases p(HGNC:CYP1A1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:AHR)) directlyIncreases p(HGNC:CYP1A1)", 
                                "eid": "524b352dd3fbfd4c34083b3a"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:AHR))", 
                "relation": "directlyIncreases", 
                "target": "p(HGNC:CYP1A2)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of AHR directly increases the protein abundance of CYP1A2.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:AHR)) directlyIncreases p(HGNC:CYP1A2)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:AHR)) directlyIncreases p(HGNC:CYP1A2)", 
                                "eid": "524b352dd3fbfd4c34083b44"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:AHR))", 
                "relation": "increases", 
                "target": "p(HGNC:NQO1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of AHR increases the protein abundance of NQO1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:AHR)) increases p(HGNC:NQO1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:AHR)) increases p(HGNC:NQO1)", 
                                "eid": "524b352dd3fbfd4c34083bfb"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:AHR))", 
                "relation": "increases", 
                "target": "p(HGNC:ALDH3A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of AHR increases the protein abundance of ALDH3A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:AHR)) increases p(HGNC:ALDH3A1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:AHR)) increases p(HGNC:ALDH3A1)", 
                                "eid": "524b352dd3fbfd4c340839a5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "tscript(p(HGNC:AHR)) increases p(HGNC:ALDH3A1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "swapna30", 
                            "Citation": {
                                "Type": null, 
                                "ID": "19410595", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "We believe that oxidative stress is associated with the activation of both the Ah receptors and subsequent binding to xenobiotic response elements (XRE), as well as activation of antioxidant response elements (ARE) and Nrf-2 signaling pathways (Kong et al., 2001; Risom et al., 2005; Li and Nel, 2006). Both pathways are important in the gene regulation of the most highly induced marker genes observed in this study ALDH3A1, NQO1, and AKR1C1.", 
                            "Cell": "cell line", 
                            "Tissue": "bronchial epithelial", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "tscript(p(HGNC:AHR)) increases p(HGNC:ALDH3A1)", 
                                "eid": "53033ca989e36206c02a5477"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:AHR))", 
                "relation": "directlyIncreases", 
                "target": "p(HGNC:GSTA2)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of AHR directly increases the protein abundance of GSTA2.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "tscript(p(HGNC:AHR)) directlyIncreases p(HGNC:GSTA2)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18288955", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "The AhR battery of controlled genes includes phase I xenobiotic metabolizing enzymes (CYP1A1, 1A2 and 1B1) and phase II enzymes (NQO1, GSTA2, UGT1A1 and UGT1A6)[11, 16]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:AHR))", 
                "relation": "directlyIncreases", 
                "target": "p(HGNC:UGT1A6)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of AHR directly increases the protein abundance of UGT1A6.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "tscript(p(HGNC:AHR)) directlyIncreases p(HGNC:UGT1A6)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18288955", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "The AhR battery of controlled genes includes phase I xenobiotic metabolizing enzymes (CYP1A1, 1A2 and 1B1) and phase II enzymes (NQO1, GSTA2, UGT1A1 and UGT1A6)[11, 16]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:AHR))", 
                "relation": "directlyIncreases", 
                "target": "p(HGNC:UGT1A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of AHR directly increases the protein abundance of UGT1A1.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "tscript(p(HGNC:AHR)) directlyIncreases p(HGNC:UGT1A1)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18288955", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "The AhR battery of controlled genes includes phase I xenobiotic metabolizing enzymes (CYP1A1, 1A2 and 1B1) and phase II enzymes (NQO1, GSTA2, UGT1A1 and UGT1A6)[11, 16]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(p(HGNC:AHR))", 
                "relation": "increases", 
                "target": "tscript(p(HGNC:ARNT))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the protein abundance of AHR increases the transcriptional activity of the protein abundance of ARNT.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "tscript(p(HGNC:AHR)) increases tscript(p(HGNC:ARNT))", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15800033", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "Many, if not all, of these effects are due to alterations in gene expression mediated via the activation of the aryl hydrocarbon receptor (AhR), a member of the basic-helix-loop-helix-PAS (bHLH-PAS) family. Ligand binding to the cytoplasmic AhR complex triggers the dissociation of interacting proteins and results in the subsequent translocation of the l igand-bound AhR to the nucleus, where it heterodimerizes with the aryl hydrocarbon receptor nuclear translocator (ARNT), another member of the bHLH-PAS family. This heterodimer then binds specific DNA elements, termed dioxin response elements (DREs), in the regulatory regions of target genes leading to changes in gene expression that ultimately result in the observed toxic and biochemical responses", 
                            "Cell": "", 
                            "Tissue": "liver", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\")", 
                "relation": "increases", 
                "target": "cat(p(HGNC:CYP1A1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Polycyclic Aromatic Hydrocarbons\" increases the catalytic activity of the protein abundance of CYP1A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") increases cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12785736", 
                                "Name": "Arch Pharm Res 2003 May 26(5) 394-404"
                            }, 
                            "Disease": "", 
                            "SummaryText": "When mice were treated intraperitoneally with 3, 10 and 30 mg/kg of individual PAHs for 3 consecutive days, the activities of ethoxyresorufin- and methoxyresorufin-O-dealkylases were significantly and differentially induced in both liver and lung. Moreover, other CYP isozyme-associated monooxygenase activities were also induced significantly in liver and lung with characteristic induction profiles. It was found that the activities of CYP 1A-selective EROD and MROD were significantly induced in both liver and lung tissues of treated mice (Figs. 2 to 5).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") increases cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083a5c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") increases cat(p(HGNC:CYP1A1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17200336", 
                                "Name": "Clin Cancer Res 2007 Jan 1 13(1) 38-45"
                            }, 
                            "Disease": "lung adenocarcinoma", 
                            "SummaryText": "Benzo(a)pyrene consistently induced the highest level of aryl hydrocarbon hydroxylase activity in H1355 cells (Fig. 2B).....The aryl hydrocarbon hydroxylase activity assay was used to measure CYP1A1 and CYP1B1 enzyme activity (24)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") increases cat(p(HGNC:CYP1A1))", 
                                "eid": "524b352dd3fbfd4c34083a81"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\")", 
                "relation": "increases", 
                "target": "cat(p(HGNC:CYP1B1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Polycyclic Aromatic Hydrocarbons\" increases the catalytic activity of the protein abundance of CYP1B1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") increases cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15667830", 
                                "Name": "Toxicol Appl Pharmacol 2005 Feb 1 202(3) 244-57"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We have shown that BP and DMBA can comparably induce CYP1B1 in the bone marrow and lung of AhRb mice while this form is not detected in the liver. #BP and DMBA are Polycyclic Aromatic Hydrocarbons #", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") increases cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083976"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") increases cat(p(HGNC:CYP1B1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17200336", 
                                "Name": "Clin Cancer Res 2007 Jan 1 13(1) 38-45"
                            }, 
                            "Disease": "lung adenocarcinoma", 
                            "SummaryText": "Benzo(a)pyrene consistently induced the highest level of aryl hydrocarbon hydroxylase activity in H1355 cells (Fig. 2B).....The aryl hydrocarbon hydroxylase activity assay was used to measure CYP1A1 and CYP1B1 enzyme activity (24)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") increases cat(p(HGNC:CYP1B1))", 
                                "eid": "524b352dd3fbfd4c34083a8c"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Benzo(a)pyrene\")", 
                "relation": "isA", 
                "target": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\")", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The abundance of \"Benzo(apyrene\") is a abundance of \"Polycyclic Aromatic Hydrocarbons\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Benzo(a)pyrene\") isA a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Benzo(a)pyrene\") isA a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\")", 
                                "eid": "524b352dd3fbfd4c34083baa"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\")", 
                "relation": "increases", 
                "target": "tscript(p(HGNC:AHR))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"Polycyclic Aromatic Hydrocarbons\" increases the transcriptional activity of the protein abundance of AHR.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") increases tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20663163", 
                                "Name": "Part Fibre Toxicol 2010 7 18"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Polycyclic aromatic hydrocarbon components contribute to the mitochondria-antiapoptotic effect of fine particulate matter on human bronchial epithelial cells via the aryl hydrocarbon receptor", 
                            "Cell": "bronchial epithelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") increases tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083bed"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") increases tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18321868", 
                                "Name": "Carcinogenesis 2008 May 29(5) 1022-32"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Although curcumin alone did not alter the basal levels of aryl hydrocarbon receptor (AhR), it significantly decreased the B[a]P-induced AhR protein levels, its phosphorylation, nuclear translocation and subsequent binding to DNA, thereby decreasing the transactivation of CYP1A. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:\"Polycyclic Aromatic Hydrocarbons\") increases tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083973"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:AHRR)", 
                "relation": "decreases", 
                "target": "tscript(p(HGNC:AHR))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The protein abundance of AHRR decreases the transcriptional activity of the protein abundance of AHR.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHRR) decreases tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9887096", 
                                "Name": "Genes Dev 1999 Jan 1 13(1) 20-5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Transfection of AhRR expression vector into HeLa cells, together with the expression vectors of AhR and Arnt and the reporter gene pX4TK\u2013Luc, repressed luciferase expression originally induced by AhR and Arnt plasmids in a dose-dependent fashion (Fig. 3A, lanes 3\u20135). This repression was reversed by further addition of AhR expression vector (data not shown). These results indicate that AhRR functions as a competitive repressor of AhR.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHRR) decreases tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839e7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHRR) decreases tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16755028", 
                                "Name": "Biol Pharm Bull 2006 Jun 29(6) 1254-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Although the 3-MC-induced AhR-mediated induction of luciferase activity was observed in all cell lines, a decreased response was observed with variant cells compared to MCF-7 cells (Fig. 1B). The higher the expression level of AhRR, the lower the luciferase activity, among the 3 employed cell lines.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHRR) decreases tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839f2"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:AHRR)", 
                "relation": "directlyDecreases", 
                "target": "tscript(p(HGNC:ESR1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The protein abundance of AHRR directly decreases the transcriptional activity of the protein abundance of ESR1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHRR) directlyDecreases tscript(p(HGNC:ESR1))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18565642", 
                                "Name": "Mol Cell Endocrinol 2008 Sep 10 291(1-2) 87-94"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Aryl hydrocarbon receptor repressor (AhRR) suppressed, in a ligand independent manner, the ability of estrogen receptor alpha (ERalpha) to enhance the transcription of heterologous estrogen-responsive reporter plasmids in transient transfection assays", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHRR) directlyDecreases tscript(p(HGNC:ESR1))", 
                                "eid": "524b352dd3fbfd4c34083b59"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:nicotine)", 
                "relation": "increases", 
                "target": "p(HGNC:CYP1A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of nicotine increases the protein abundance of CYP1A1.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:nicotine) increases p(HGNC:CYP1A1)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9764926", 
                                "Name": "Xenobiotica 1998 Sep 28(9) 827-43"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The findings show that nicotine is a potent, rapid but transient inducer of CYP1A1 in the rat lung and suggest that the alkaloid is a likely contributor to CYP1A1 induction by cigarette smoke.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:nicotine) increases p(HGNC:CYP1A1)", 
                                "eid": "524b352dd3fbfd4c34083b75"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:nicotine)", 
                "relation": "increases", 
                "target": "p(HGNC:CYP3A5)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of nicotine increases the protein abundance of CYP3A5.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(CHEBI:nicotine) increases p(HGNC:CYP3A5)", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(CHEBI:nicotine) increases p(HGNC:CYP3A5)", 
                                "eid": "524b352dd3fbfd4c34083c49"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:Indirubin)", 
                "relation": "increases", 
                "target": "tscript(p(HGNC:AHR))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of Indirubin increases the transcriptional activity of the protein abundance of AHR.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:Indirubin) increases tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "0", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.", 
                            "Cell": null, 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:Indirubin) increases tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b83"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "cat(p(HGNC:CYP1A2))", 
                "relation": "increases", 
                "target": "a(CHEBI:\"reactive oxygen species\")", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The catalytic activity of the protein abundance of CYP1A2 increases the abundance of \"reactive oxygen species\".", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "cat(p(HGNC:CYP1A2)) increases a(CHEBI:\"reactive oxygen species\")", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16877260", 
                                "Name": "Drug Metab Rev 2006 38(3) 411-50"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Generally, induction of CYP1A1, CYP1A2, and CYP1B1 is considered cardiotoxic through generating reactive oxygen species (ROS)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "cat(p(HGNC:CYP1A2)) increases a(CHEBI:\"reactive oxygen species\")", 
                                "eid": "524b352dd3fbfd4c340839cb"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:Soot)", 
                "relation": "increases", 
                "target": "tscript(p(HGNC:AHR))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of Soot increases the transcriptional activity of the protein abundance of AHR.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "a(SCHEM:Soot) increases tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18367723", 
                                "Name": "Am J Respir Cell Mol Biol 2008 Aug 39(2) 198-207"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We previously described the physicochemical characteristics (particle size, adsorbed polynuclear aromatic hydrocarbons [PAHs], oxygen, and metal content) of butadiene soot (BDS) ....Microarray and qRT-PCR analyses revealed up-regulation of (1) aryl hydrocarbon receptor (AhR)-responsive genes: AhR repressor (Ahrr) and cytochrome P450 IA1 and IB1(Cyp1a1, Cyp1b1);(2) oxidative stress response genes: heme oxygenase 1 (Hmox1), nuclear factor erythroid-derived 2-like 2 (Nfe2l2), NADPH dehydrogenase quinone 1 (Nqo1), and glutathione peroxidase 2 (Gpx2); and (3) pro-inflammatory genes: interleukin-6 (IL-6), C-X-C motif ligand 2 (Cxcl2; analog to human IL-8) and ligand 3 (Cxcl3), and granulocyte chemotactic protein (Cxcl6)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "a(SCHEM:Soot) increases tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083970"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:AHR)", 
                "relation": "actsIn", 
                "target": "tscript(p(HGNC:AHR))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of AHR acts in transcriptional activity of the protein abundance of AHR.", 
                    "approval_status": "open", 
                    "createdby": "selventa", 
                    "evidences": [
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18321868", 
                                "Name": "Carcinogenesis 2008 May 29(5) 1022-32"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Although curcumin alone did not alter the basal levels of aryl hydrocarbon receptor (AhR), it significantly decreased the B[a]P-induced AhR protein levels, its phosphorylation, nuclear translocation and subsequent binding to DNA, thereby decreasing the transactivation of CYP1A. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083afe"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19933214", 
                                "Name": "Toxicol Sci 2010 Mar 114(1) 90-100"
                            }, 
                            "Disease": "", 
                            "SummaryText": "One candidate endogenous ligand, 2-(1'H-indolo-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE), is a potent AhR agonist in vitro, activates the murine AhR in vivo", 
                            "Cell": "Fibroblasts", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083afc"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10953044", 
                                "Name": "Mol Pharmacol 2000 Sep 58(3) 515-25"
                            }, 
                            "Disease": "", 
                            "SummaryText": "60 or 90 ?M galangin induced AhR nuclear translocation in both cell types (Fig. 11A, lanes 7, 8; Fig. 11B, lane 6). ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083964"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14762110", 
                                "Name": "J Cell Sci 2004 Feb 29 117(Pt 6) 849-59"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Negative regulation of T-cadherin expression by the AhR has been previously suggested (Niermann et al., 2003 ).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b96"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17502624", 
                                "Name": "Proc Natl Acad Sci U S A 2007 May 22 104(21) 8851-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "To assess whether UVB-induced CYP1A1 expression was AhR-dependent, we next treated HaCaT cells for 1 h before irradiation with the competitive AhR inhibitor 3'methoxy-4'nitroflavone (MNF, 10 uM), that specifically targets the AhR ligand-binding site (29). MNF pretreatment caused an inhibition of UVB-induced CYP1A1 mRNA expression (Fig. 1C).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083bc7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17827877", 
                                "Name": "J Reprod Dev 2007 Dec 53(6) 1191-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Diesel exhaust particles (DEPs) contain polycyclic aromatic hydrocarbons (PAH) that bind to aryl hydrocarbon receptors (AhRs) and decrease sperm production. These data suggest that DEP toxicity may affect the male reproductive system in an AhR-dependent manner.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083bc0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16755028", 
                                "Name": "Biol Pharm Bull 2006 Jun 29(6) 1254-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Although the 3-MC-induced AhR-mediated induction of luciferase activity was observed in all cell lines, a decreased response was observed with variant cells compared to MCF-7 cells (Fig. 1B). The higher the expression level of AhRR, the lower the luciferase activity, among the 3 employed cell lines.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083aa6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17502624", 
                                "Name": "Proc Natl Acad Sci U S A 2007 May 22 104(21) 8851-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "As is shown in Fig. 6, UVB irradiation induces Cyp1a1 and Cox-2 mRNAs in wild-type but not in AhR KO mice. Thus, AhR signaling appears to be involved in the UVB stress response in vivo as well.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c3408397e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20709182", 
                                "Name": "Pulm Pharmacol Ther 2011 Feb 24(1) 133-40"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Arylhydrocarbon receptor (AhR) activation in airway epithelial cells induces MUC5AC via reactive oxygen species (ROS) production", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839b3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11096091", 
                                "Name": "J Biol Chem 2001 Feb 16 276(7) 4819-27"
                            }, 
                            "Disease": "", 
                            "SummaryText": "This increase is not observed in the aromatic hydrocarbon receptor (AhR)-defective TAOc1BP(r)c1 and the AhR nuclear translocator (Arnt)-defective BP(r)c1 variants, demonstrating that the induction of mdr1 by 3-MC requires AhR.Arnt. We show that the mdr1 promoter (-1165 to +84) is able to activate the expression of a reporter gene in response to 3-MC in Hepa-1c1c7 but not in BP(r)c1 cells. Deletion analysis indicated that the region from -245 to -141 contains cis-acting sequences mediating the induction, including a potential p53 binding sequence. 3-MC treatment of the cells increased the levels of p53 and induced p53 binding to the mdr1 promoter in an AhR.Arnt-dependent manner. Mutations in the p53 binding site abrogated induction of mdr1 by 3-MC, indicating that p53 binding to the mdr1 promoter is essential for the induction.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839b8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19138943", 
                                "Name": "Cancer Prev Res (Phila Pa) 2008 Jul 1(2) 100-11"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The differentially expressed gene set was integrated with the set of signaling proteins previously shown to be activated by TS: ADAM17 (37), AhR (36, 38), cyclic AMP responsive element binding protein 1 (CREB1; ref. 36), mitogen- activated protein kinase [extracellular signal\u2013regulated kinase (ERK)-1/2; ref. 39], protein kinase A catalytic subunit (PRKACA; ref. 36), and SRC.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083c0f"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "21115475", 
                                "Name": "J Biol Chem 2010 Nov 29"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Confirming previous cell culture experiments using MEFs (35), we observed no elevation of Vav3 mRNA levels upon intraperitoneal administration of a strong Ahr activator (benzo[a]pyrene) to wild type mice (Fig. S1D).", 
                            "Cell": "Fibroblasts", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a5b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10699758", 
                                "Name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a48"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10860937", 
                                "Name": "Mol Pharmacol 2000 Jul 58(1) 152-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": " BaP enhanced c-Ha-ras expression in AhR+/+ and AhR+/- vSMCs compared with controls, but not in AhR-/- vSMCs (Fig. 6). ", 
                            "Cell": "", 
                            "Tissue": "Muscle, Smooth", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839cf"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15364539", 
                                "Name": "Toxicol Appl Pharmacol 2004 Sep 15 199(3) 220-38"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We further tested the AhR involvement in this suspension response by examining the effect of restoring AhR to AhR-null mouse embryo fibroblasts [AhR (-) MEFs], which do not respond to TCDD (Alexander et al., 1998).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b6e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9478971", 
                                "Name": "J Biol Chem 1998 Feb 27 273(9) 5174-83"
                            }, 
                            "Disease": "", 
                            "SummaryText": "TCDD induction and basal expression were dependent on positive regulatory elements present between -1075 and -810. Five XRE motifs localized in the enhancer region were completely conserved between mouse and human CYP1B1 sequences. Gel shift experiments established that TCDD stimulates AhR binding to the downstream XRE in the enhancer region.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083c41"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18159929", 
                                "Name": "Mol Pharm 5(1) 35-41"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Xenobiotic and drug metabolism and transport are managed by a large number of genes coordinately regulated by at least three nuclear receptors or xenosensors: aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR, NR1I3), and pregnane X receptor (PXR, NR1I2)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083972"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16952353", 
                                "Name": "Exp Cell Res 2006 Nov 1 312(18) 3585-94"
                            }, 
                            "Disease": "", 
                            "SummaryText": "When the 5?-flanking sequence of the Slug gene was fused to the luciferase gene (Fig. 2A; Slug-Luc-a: ?3371?+1 fused with luciferase and Slug- Luc-b: ?829?+1 fused with luciferase gene) and transfected into COS7 cells along with the expression plasmid of AhR, the Slug-luciferase activity was dependent on AhR as well as XREluciferase activity (Fig. 2B).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083bcd"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11114727", 
                                "Name": "Oncogene 2000 Nov 16 19(48) 5498-506"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c3408396a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10359656", 
                                "Name": "Biochem J 1999 Jun 15 340 ( Pt 3) 715-22"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Quercetin caused a concentration-dependent increase in the DNA-binding capacity of nuclear AhR, as shown by the band intensity (arbitrary units) shown at the top of the gel (Figure 6). ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083bcc"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15800033", 
                                "Name": "Toxicol Sci 2005 Jun 85(2) 1048-63"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Many, if not all, of these effects are due to alterations in gene expression mediated via the activation of the aryl hydrocarbon receptor (AhR), a member of the basic-helix-loop-helix-PAS (bHLH-PAS) family. Ligand binding to the cytoplasmic AhR complex triggers the dissociation of interacting proteins and results in the subsequent translocation of the l igand-bound AhR to the nucleus, where it heterodimerizes with the aryl hydrocarbon receptor nuclear translocator (ARNT), another member of the bHLH-PAS family. This heterodimer then binds specific DNA elements, termed dioxin response elements (DREs), in the regulatory regions of target genes leading to changes in gene expression that ultimately result in the observed toxic and biochemical responses", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a13"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14759523", 
                                "Name": "FEBS Lett 2004 Jan 30 558(1-3) 96-100"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The expression of MUP2 is known to be stimulated by growth hormone (GH), through the GH receptor (GHR), Janus kinase 2 (JAK2) and signal transducer and activator of transcription 5 (STAT5) signal transduction pathway.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b66"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "22500183", 
                                "Name": "J Allergy (Cairo) 2012 2012 372384"
                            }, 
                            "Disease": "Chronic Obstructive Pulmonary Disease", 
                            "SummaryText": "In our study, we found that AhR activation upregulates the expression of MUC5AC and mucin secretion in a NCIH292 cell line that was derived from a bronchiolar Clara cell [14] (Figure 1). Moreover, we concurrently showed that AhR activation induced ROS generation, and the antioxidant agent NAC inhibited B[a]P-induced MUC5AC upregulation.", 
                            "Cell": "", 
                            "Tissue": "Lung airway", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839c5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12859982", 
                                "Name": "Arch Biochem Biophys 2003 Aug 1 416(1) 53-67"
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP1B1 is unique among P450 cytochromes in exhibiting inductive responses mediated by both the Ah receptor (AhR) and cAMP.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a4b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8626473", 
                                "Name": "J Biol Chem 1996 Apr 5 271(14) 7942-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083c48"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20951181", 
                                "Name": "Toxicology 2010 Oct 14"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In the present study, we investigated the effects of potential endogenous ligand indirubin on the aryl hydrocarbon receptor (AhR) signalling, with a focus on the AhR-dependent gene expression and cell cycle progression in rat liver progenitor cells,", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839bc"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16275121", 
                                "Name": "Trends Endocrinol Metab 2005 Dec 16(10) 478-88"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Small heterodimer partner (SHP; NR0B2), an exceptional member of the mammalian nuclear receptor family, directly modulates the activities of conventional nuclear receptors by acting as an inducible and tissue-specific corepressor. Recent progress in dissecting underlying molecular mechanisms, identifying target factors and target genes, and uncovering physiological functions points to the regulatory involvement of SHP in diverse metabolic and intracellular pathways that awaits future clarification. In this review, we carry out a comprehensive survey of all published data and discuss our current understanding of molecular mechanisms and physiological consequences governing SHP action.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083c08"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15383530", 
                                "Name": "J Biol Chem 2004 Nov 26 279(48) 49842-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "reduction of CoCoA mRNA levels by small interfering RNA inhibited the transcriptional activation by AHR and ARNT", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a58"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15047159", 
                                "Name": "Biochem Biophys Res Commun 2004 Apr 23 317(1) 142-8"
                            }, 
                            "Disease": "Neoplasms", 
                            "SummaryText": "We transfected BP8 cells with full-length human AHR and found that presence of the AHR alone was sufficient to induce substantial CYP1A1 and CYP1B1 mRNA without any exogenous AHR ligand.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a54"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16214954", 
                                "Name": "Mol Pharmacol 2006 Jan 69(1) 140-53"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Expression of 456 ProbeSets was significantly altered by TCDD in an AHR-dependent manner", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083ba2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18223159", 
                                "Name": "Am J Physiol Lung Cell Mol Physiol 2008 Apr 294(4) L612-31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "There is extensive evidence from alveolar epithelial cell and alveolar macrophage cultures as well as whole mouse and human lung tissue that smoke directly evokes an inflammatory response by activating NF-kB, 195), and possibly the aryl hydrocarbon receptor (167) and Toll-like receptor-4, at least early on (98).", 
                            "Cell": "Macrophages", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083ba3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18223159", 
                                "Name": "Am J Physiol Lung Cell Mol Physiol 2008 Apr 294(4) L612-31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "There is extensive evidence from alveolar epithelial cell and alveolar macrophage cultures as well as whole mouse and human lung tissue that smoke directly evokes an inflammatory response by activating NF-kB, 195), and possibly the aryl hydrocarbon receptor (167) and Toll-like receptor-4, at least early on (98).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839c6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15863442", 
                                "Name": "Am J Physiol Lung Cell Mol Physiol 2005 Sep 289(3) L391-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Treatment with IL-1{beta} or 1% CSE resulted in a 6- to 7-fold increase in mPGES-1 protein expression in normal human lung fibroblasts (Fig. 6A, lane 5, and Fig. 6B). Pretreatment of human lung fibroblasts with MNF alone reduced basal levels of mPGES-1 (Fig. 6A, lane 3). Furthermore, the increase in mPGES-1 following treatment with 1% CSE was abrogated by pretreatment with the AHR antagonist MNF (Fig. 6A, compare lanes 5 and 6, and Fig. 6B).", 
                            "Cell": "Fibroblasts", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b57"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11883943", 
                                "Name": "Biochem Biophys Res Commun 2002 Mar 15 291(5) 1194-200"
                            }, 
                            "Disease": "", 
                            "SummaryText": "TCDD-induced expression of adseverin in thymus is dependent on AhR expression", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b55"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20133372", 
                                "Name": "Toxicol Sci 2010 May 115(1) 238-52"
                            }, 
                            "Disease": "", 
                            "SummaryText": "from full text - Another potential candidate of partial Nrf 2 regulation observed in this study is aldh3a1 (subcluster 1.2), a key component of aldehyde detoxification. Exhibiting an (Nrf2-independent) expression profile characteristic for phase 1 genes, which is also supported by a previous promoter analysis (Xie et al., 1996), this gene was found to be constitutively upregulated > 12-fold in lung tissue of unexposed mice exhibiting a Clara cell\u2013specific conditional knock out in the keap1 gene (Jon Maher and Keiko Taguchi, unpublished observation). Thus, we conclude that aldh3a1 is targeted by both the Ah receptor and the Nrf2 pathway, supporting the concept that drug-processing genes may be activated by an AhR-Nrf2 signaling axis (Yeager et al., 2009).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b51"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19158396", 
                                "Name": "Mol Biol Cell 2009 Mar 20(6) 1715-27"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In agreement with an AhR-dependent process, vav3 promoter activity was higher in wild-type 1c1c7 than in AhR-deficient c2 hepatoma cells (Figure 9A, right).....AhR binding to the XRE1, XRE2, and XRE3-4 elements was analyzed by PCR in AhR immunoprecipitates.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839ae"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15837795", 
                                "Name": "J Biol Chem 2005 Jun 3 280(22) 21607-11"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Furthermore, chromatin immunoprecipitation (ChIP) assays have shown that ER alpha is present at the Cyp1a1 enhancer only after co-treatment with E2 and TCDD, in MCF-7 cells. Sequential two-step ChIP assays were performed which demonstrate that AHR and ER alpha are present together at the same time on the Cyp1a1 enhancer during transrepression. Taken together these data support a role for ER-mediated transrepression of AHR-dependent gene regulation.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083c14"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "21226706", 
                                "Name": "Br J Haematol 2011 Feb 152(4) 469-84"
                            }, 
                            "Disease": "", 
                            "SummaryText": " Protein and mRNA levels of the AHR transcriptional target HES1 also increased.", 
                            "Cell": "megakaryocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083c09"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19114668", 
                                "Name": "J Exp Med 2009 Jan 16 206(1) 43-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Th17 development from wild-type mice is suboptimal in the presence of the AhR antagonist CH-223191, similar to the situation in AhR-deficient mice, which show attenuated IL-17 production and no IL-22 production.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083bac"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20831858", 
                                "Name": "Arch Biochem Biophys 2010 Dec 15 504(2) 221-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The intraperitoneal injection of 3-methylcholanthrene (3MC), a potent AHR ligand, into C57BL/6J mice significantly increased the levels of triglycerides and six long-chain monounsaturated fatty acids in the livers of mice, resulting in hepatic microvesicular steatosis. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a36"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19463884", 
                                "Name": "Toxicology 2009 Aug 3 262(2) 87-97"
                            }, 
                            "Disease": "", 
                            "SummaryText": "BaP and IND were able to activate transactivation of the AhR by up to 7\u20138-fold in the pAhRDtkLuc3 reporter and 4\u20135-fold in the p1646P1Luc3 reporter (Fig. 7A and B).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a5e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10639156", 
                                "Name": "Proc Natl Acad Sci U S A 2000 Jan 18 97(2) 779-82"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In the two groups of AhR-positive animals, +/+ and +/-, however, subcutaneous injection of B[a]P induced expression of Cyp1a1 in both skin and liver. Essentially no expression was observed in the AhR-null mice.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b5e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11302926", 
                                "Name": "Drug Metab Dispos 2001 May 29(5) 623-33"
                            }, 
                            "Disease": "", 
                            "SummaryText": "AhR-mediated expression of p27Kip1  inhibits cell cycle progression by repressing CDK2 activity, thus preventing  pRb phosphorylation.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b46"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17337447", 
                                "Name": "J Biol Chem 2007 Mar 2"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The environmental pollutant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) causes numerous and diverse toxic events via activation of the aryl hydrocarbon receptor (AHR), including atrophy of the thymus.", 
                            "Cell": "thymocyte", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083abd"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18289803", 
                                "Name": "Toxicol Lett 2008 Mar 15 177(2) 130-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Such an up-regulation was likely linked to aryl hydrocarbon receptor (AhR)-activation since BP-mediated IL-8 induction was reduced after AhR expression knock-down through RNA interference. Moreover, electrophoretic mobility shift assays (EMSAs) and chromatin immunoprecipitation experiments showed BP-triggered binding of AhR to a consensus xenobiotic responsive element (XRE) found in the human IL-8 promoter. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a9c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17069994", 
                                "Name": "Toxicol Lett 2006 Dec 15 167(3) 212-20"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Expression of AhR mRNA and of the markers of its activation, CYP1A1 and NQO1, was significantly increased by administration of TCDD, 3-MC and, to lower extent, BNF. These results indicate that binding of the ligands to AhR up-regulates the mRNA transcription not only of CYP1A1 and NQO1, but also of AhR itself.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a9e"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10953044", 
                                "Name": "Mol Pharmacol 2000 Sep 58(3) 515-25"
                            }, 
                            "Disease": "", 
                            "SummaryText": "60 or 90 ?M galangin induced AhR nuclear translocation in both cell types (Fig. 11A, lanes 7, 8; Fig. 11B, lane 6). ", 
                            "Cell": "bone marrow stromal cell", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083bfc"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11731439", 
                                "Name": "Cancer Res 2001 Dec 1 61(23) 8534-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Induction of NMT2 was confirmed in livers of mice in vivo. NMT2 induction was a direct consequence of Ah receptor activation in 5L cells.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083bfa"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16438934", 
                                "Name": "Biochem Biophys Res Commun 2006 Mar 17 341(3) 763-9"
                            }, 
                            "Disease": "", 
                            "SummaryText": "To further determine whether AhR was functional in EPCs, expression of the AhR-regulated enzyme CYP1A1 was analyzed in EPCs either untreated or exposed to BP or to TCDD, a very potent agonist of AhR [21], for 24 h....Both BP and TCDD were shown to markedly induce CYP1A1 mRNA levels in cultured EPCs as assessed by RT-PCR assays (Fig. 3B)", 
                            "Cell": "", 
                            "Tissue": "endothelial progenitor cell", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083ad2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19474220", 
                                "Name": "Toxicol Sci 2009 Oct 111(2) 238-46"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In mice, TCDD induction of Nrf2 and Nrf2 target, Nqo1, is dependent on AhR, and thus TCDD induction of drug-processing genes may be routed through an AhR-Nrf2 sequence. ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a07"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9698073", 
                                "Name": "Biochem Pharmacol 1998 Jul 15 56(2) 197-206"
                            }, 
                            "Disease": "", 
                            "SummaryText": ". Curcumin at 5 ?M by itself caused an increase in activated AhR (lanes 7 and 8). ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b2d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11408608", 
                                "Name": "Mol Pharmacol 2001 Jul 60(1) 135-42"
                            }, 
                            "Disease": "", 
                            "SummaryText": "A comparison between mouse strains with different TCDD responsiveness indicated that the induction of adseverin is dependent on the aryl hydrocarbon receptor, a transcription factor known to mediate most of TCDD's biological effects", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b2b"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19185948", 
                                "Name": "Lung Cancer 2009 Aug 65(2) 129-37"
                            }, 
                            "Disease": "", 
                            "SummaryText": "There may be bidirectional regulation; recent studies suggest that Nrf2 is an AhR target gene, and the Nrf2 expression is directly modulated by AhR activation [19]\ufffdand\ufffd[20]", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b38"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18223159", 
                                "Name": "Am J Physiol Lung Cell Mol Physiol 2008 Apr 294(4) L612-31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "There is extensive evidence from alveolar epithelial cell and alveolar macrophage cultures as well as whole mouse and human lung tissue that smoke directly evokes an inflammatory response by activating NF-kB, 195), and possibly the aryl hydrocarbon receptor (167) and Toll-like receptor-4, at least early on (98).", 
                            "Cell": "Macrophages", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839f5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18159929", 
                                "Name": "Mol Pharm 5(1) 35-41"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Xenobiotic and drug metabolism and transport are managed by a large number of genes coordinately regulated by at least three nuclear receptors or xenosensors: aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR, NR1I3), and pregnane X receptor (PXR, NR1I2)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b36"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18179178", 
                                "Name": "Chem Res Toxicol 2008 Feb 21(2) 472-82"
                            }, 
                            "Disease": "", 
                            "SummaryText": "M50354 and M50367 (ethyl ester derivative of M50354), were described as AhR ligands. In contrast to previously published data, both M50354 and M50367 were found to be potent inducers of several AhR target genes, namely, CYP1A1, CYP1B1, and UGT1A2", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083aef"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16513642", 
                                "Name": "J Biol Chem 2006 May 5 281(18) 12242-7"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Upon ligand treatment, endogenous GAC63 was recruited to the xenobiotic response element of the mouse CYP1A1 gene, an AHR-responsive gene.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839f0"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15735673", 
                                "Name": "Oncogene 2005 Apr 28 24(19) 3216-22"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In the glandular stomach of CA-AhR mice, we observed decreased mRNA expression of osteopontin", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a88"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10398686", 
                                "Name": "Genes Dev 1999 Jul 1 13(13) 1742-53"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Modified assertion", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a98"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18223159", 
                                "Name": "Am J Physiol Lung Cell Mol Physiol 2008 Apr 294(4) L612-31"
                            }, 
                            "Disease": "", 
                            "SummaryText": "There is extensive evidence from alveolar epithelial cell and alveolar macrophage cultures as well as whole mouse and human lung tissue that smoke directly evokes an inflammatory response by activating NF-kB, 195), and possibly the aryl hydrocarbon receptor (167) and Toll-like receptor-4, at least early on (98).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083aed"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20663163", 
                                "Name": "Part Fibre Toxicol 2010 7 18"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Polycyclic aromatic hydrocarbon components contribute to the mitochondria-antiapoptotic effect of fine particulate matter on human bronchial epithelial cells via the aryl hydrocarbon receptor", 
                            "Cell": "bronchial epithelial cell", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a10"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18367723", 
                                "Name": "Am J Respir Cell Mol Biol 2008 Aug 39(2) 198-207"
                            }, 
                            "Disease": "", 
                            "SummaryText": "We previously described the physicochemical characteristics (particle size, adsorbed polynuclear aromatic hydrocarbons [PAHs], oxygen, and metal content) of butadiene soot (BDS) ....Microarray and qRT-PCR analyses revealed up-regulation of (1) aryl hydrocarbon receptor (AhR)-responsive genes: AhR repressor (Ahrr) and cytochrome P450 IA1 and IB1(Cyp1a1, Cyp1b1);(2) oxidative stress response genes: heme oxygenase 1 (Hmox1), nuclear factor erythroid-derived 2-like 2 (Nfe2l2), NADPH dehydrogenase quinone 1 (Nqo1), and glutathione peroxidase 2 (Gpx2); and (3) pro-inflammatory genes: interleukin-6 (IL-6), C-X-C motif ligand 2 (Cxcl2; analog to human IL-8) and ligand 3 (Cxcl3), and granulocyte chemotactic protein (Cxcl6)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a8d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20816883", 
                                "Name": "Toxicol Appl Pharmacol 2010 Nov 15 249(1) 91-100"
                            }, 
                            "Disease": "hepatocellular carcinoma", 
                            "SummaryText": "these results identify the AhR gene battery as the preferential target of PhIP and MeIQx in HepaRG cells", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083c42"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15256435", 
                                "Name": "Cancer Res 2004 Jul 15 64(14) 4707-10"
                            }, 
                            "Disease": "", 
                            "SummaryText": " Table 2 Genes differentially expressed in liver of CA-AhR and AhR mice", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083c3a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16107552", 
                                "Name": "Toxicol Sci 2005 Nov 88(1) 265-73"
                            }, 
                            "Disease": "", 
                            "SummaryText": "These findings demonstrate that ET-1 activation of ET(A) receptors mediates an increase in ROS that is associated with cardiac hypertrophy in AhR null mice. In addition, the ET-1-mediated increase in ROS appears to be initiated via increased NAD(P)H oxidase activity.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083ae8"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15451023", 
                                "Name": "Cell Signal 2005 Jan 17(1) 39-48"
                            }, 
                            "Disease": "", 
                            "SummaryText": "In order to elucidate the role of c-src kinase in AhR signalling, we used two c-src inhibitors, the pyrazolopyrimidine compounds PP1 and PP2. When H4IIE cells transfected with the Gal4?AhR construct were treated with omeprazole or TCDD in the presence of increasing doses of PP1 or PP2, a dose-dependent decrease in luciferase activity was observed (not shown). At a concentration of 10 ?M PP1, a 69% and 60% inhibition of omeprazole- and TCDD-mediated Gal4?AhR activation were obtained, respectively (Fig. 2A). Similarly, the Gal4?AhR activation caused by omeprazole or TCDD was blocked by 58% and 57%, respectively, at 10 ?M PP2. Comparable results were also obtained in human hepatoma HepG2 cells, demonstrating that the effect of the pyrazolopyrimidines on AhR signalling was not limited to H4IIE cells (Fig. 2B). .......We next examined the effect of expression of a dominant-negative src cDNA (DN-src) on Gal4\u2013AhR activation. Cotransfection of H4IIE cells with DN-src and Gal4\u2013AhR vectors and subsequent stimulation with omeprazole or TCDD revealed a decrease in luciferase activity that inversely correlated to the amount of DN-src expression vector added to the cells (Fig. 3A). ", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083c3c"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18497156", 
                                "Name": "Environ Sci Technol 2008 Apr 15 42(8) 2992-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Diesel exhaust contains numerous toxic substances that show different modes of action such as triggering aryl hydrocarbon receptor (AhR)-mediated pathways", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a16"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15451023", 
                                "Name": "Cell Signal 2005 Jan 17(1) 39-48"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Northern blot analysis revealed an 81% and 54% inhibition of omeprazole-mediated CYP1A1 mRNA expression by tyrphostins AG17 and AG879, respectively (Fig. 4B). In contrast, tyrphostin treatment did not significantly affect CYP1A1 mRNA expression caused by TCDD. Neither tyrphostins caused an increased level of CYP1A1 mRNA expression, although a slight activation of the Gal4\u2013AhR construct was seen by tyrphostin AG879 treatment alone (see Fig. 4A).", 
                            "Cell": "hepatoblastoma cell", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083ae5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12359752", 
                                "Name": "Cancer Res 2002 Oct 1 62(19) 5451-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Electromobility shift assays demonstrated that similar to the established AhR ligand 2,3,7,8,-tetrachlorodibenzo-p-dioxin, curcumin inclusion resulted in AhR nuclear translocation and formation of the transcriptionally active AhR-aryl hydrocarbon receptor nuclear translocator complex.", 
                            "Cell": "Keratinocytes", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083aea"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11733032", 
                                "Name": "Genes Cells 2001 Nov 6(11) 943-53"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Both of the mouse Polk and the human POLK genes have two AhR-binding sites in the promoter regions and the expression of the mouse Polk gene is indeed enhanced upon AhR-activation.CONCLUSIONS: The AhR activation increases expression of the mouse Polk gene and probably the human POLK gene, the product of which bypasses benzo[a]pyrene-N2-dG lesions in a mostly accurate manner.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839ff"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16855052", 
                                "Name": "Drug Metab Dispos 2006 Jul 19"
                            }, 
                            "Disease": "", 
                            "SummaryText": "AhR ligands induced UGT1A6 and 1A7 in liver,", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083ae3"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18159929", 
                                "Name": "Mol Pharm 5(1) 35-41"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Xenobiotic and drug metabolism and transport are managed by a large number of genes coordinately regulated by at least three nuclear receptors or xenosensors: aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR, NR1I3), and pregnane X receptor (PXR, NR1I2)", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083bf2"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11455387", 
                                "Name": "Nat Genet 2001 Aug 28(4) 355-60"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Oocytes microinjected with a Bax promoter-reporter construct show Ahr-dependent transcriptional activation", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b27"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17200336", 
                                "Name": "Clin Cancer Res 2007 Jan 1 13(1) 38-45"
                            }, 
                            "Disease": "lung adenocarcinoma", 
                            "SummaryText": "AhR expression and responsiveness to benzo(a)pyrene, an AhR ligand, were compared in several human lung cancer cell lines to choose an appropriate model cell line for further experimentation.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b26"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16837569", 
                                "Name": "Drug Metab Dispos 2006 Oct 34(10) 1756-63"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The present study was therefore designed to carefully analyze expression of major drug transporters in primary human hepatocytes exposed to dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) (an AhR activator), rifampicin (RIF) (a PXR activator), phenobarbital (PB) (a CAR activator), and oltipraz (OPZ) (a Nrf2 activator), using mainly reverse transcription-real time polymerase chain reaction assays. ", 
                            "Cell": "hepatocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a0d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18842620", 
                                "Name": "Toxicol Sci 2009 Jan 107(1) 1-8"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Dioxin induced a rapid association of AHR to the enhancer regions of both genes.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a0a"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12566446", 
                                "Name": "J Biol Chem 2003 Apr 25 278(17) 15001-6"
                            }, 
                            "Disease": "", 
                            "SummaryText": "that in human hepatoma HepG2 cells the UGT1A1 gene is also inducible with aryl hydrocarbon receptor (Ah receptor) ligands such as 2,3,7,8-tetrachlodibenzo-p-dioxin (TCDD), beta-naphthoflavone, and benzo[a]pyrene metabolites.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083ac6"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "7488247", 
                                "Name": "Biochem Pharmacol 1995 Oct 12 50(8) 1295-302"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The aryl hydrocarbon receptor (AHR) mediates dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin)-induced transcriptional activation of a battery of genes by interaction with a cofactor, called aryl hydrocarbon receptor nuclear translocator (ARNT) protein.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839ec"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12646173", 
                                "Name": "Biochem Biophys Res Commun 2003 Mar 28 303(1) 105-11"
                            }, 
                            "Disease": "", 
                            "SummaryText": "It is intriguing to note two recent reports related to the regulation of CYP2B family genes, in which transcriptional coactivator SRC-1 was reported to enhance the AhR transcriptional activity [27] and also to potentiate the CAR activity for the transcription of the rat CYP2B1 gene", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a68"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17823304", 
                                "Name": "Mol Endocrinol 2007 Dec 21(12) 2941-55"
                            }, 
                            "Disease": "", 
                            "SummaryText": "RelB physically interacts with AhR and binds to an unrecognized RelB/AhR responsive element of the IL-8 promoter linking two signaling pathways to activate gene transcription. We found a time-dependent recruitment of AhR to the RelB/AhR responsive element site of IL-8 mediated by the AhR ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) and via activation of protein kinase A. ", 
                            "Cell": "Macrophages", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083983"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15919853", 
                                "Name": "Drug Metab Dispos 2005 Sep 33(9) 1276-82"
                            }, 
                            "Disease": "", 
                            "SummaryText": "AhR ligands (2,3,7,8-tetrachlorodibenzo-p-dioxin, polychlorinated biphenyl 126, and beta-naphthoflavone) increased Oatp2b1 and 3a1 mRNA expression in liver.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b13"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15620708", 
                                "Name": "FEBS Lett 2005 Jan 3 579(1) 167-72"
                            }, 
                            "Disease": "", 
                            "SummaryText": "cDNA derived from mouse ES cells treated or not with TCDD in order to isolate genes induced by TCDD. This procedure identified three genes, temporarily termed Dioxin Inducible Factor 1, 2, and 3 (DIF-1, DIF-2, and DIF-3), that were induced in TCDD-treated ES cells. DIF-1 is identical to the gene encoding histamine releasing factor (HRF) [7] and DIF-3 is the gene encoding a novel protein with a C2H2 zinc-finger domain [8].", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b16"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9804617", 
                                "Name": "Mol Pharmacol 1998 Nov 54(5) 825-33"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The synthetic glucocorticoid dexamethasone (DEX) suppresses TCDD-induced expression of CYP1B1 in RMF and REF.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839d7"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9804617", 
                                "Name": "Mol Pharmacol 1998 Nov 54(5) 825-33"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The synthetic glucocorticoid dexamethasone (DEX) suppresses TCDD-induced expression of CYP1B1 in RMF and REF.", 
                            "Cell": "Fibroblasts", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c340839d5"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "20619336", 
                                "Name": "Toxicol In Vitro 2010 Sep 24(6) 1775-81"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Efficient AhR knocking-down was performed through dimethyl sulfoxide-based transfection of small-interfering RNAs targeting AhR (siAhR). SiAhR-transfected human hepatocytes or HepaRG cells, exposed to TCDD, were found to exhibit reduced mRNA expression of various TCDD-responsive genes, i.e. CYP1A1, CYP1A2, CYP1B1, ALDH3A1, IL17RB, FER1L3 and SLC7A5, when compared to TCDD-treated counterparts transfected with non-targeting small-interfering RNAs", 
                            "Cell": "hepatocyte", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b8d"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14762110", 
                                "Name": "J Cell Sci 2004 Feb 29 117(Pt 6) 849-59"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Ltbp-1 mRNA and protein expression were markedly increased in AhR-/- MEF", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083aca"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "11683414", 
                                "Name": "J Cell Sci 2001 Aug 114(Pt 15) 2809-17"
                            }, 
                            "Disease": "", 
                            "SummaryText": "During clonal expansion, the AhR inhibited the pRB phosphorylation and the downregulation of p107 expression.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083acd"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9887096", 
                                "Name": "Genes Dev 1999 Jan 1 13(1) 20-5"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Transfection of AhRR expression vector into HeLa cells, together with the expression vectors of AhR and Arnt and the reporter gene pX4TK\u2013Luc, repressed luciferase expression originally induced by AhR and Arnt plasmids in a dose-dependent fashion (Fig. 3A, lanes 3\u20135). This repression was reversed by further addition of AhR expression vector (data not shown). These results indicate that AhRR functions as a competitive repressor of AhR.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083990"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "9478971", 
                                "Name": "J Biol Chem 1998 Feb 27 273(9) 5174-83"
                            }, 
                            "Disease": "", 
                            "SummaryText": "TCDD induction and basal expression were dependent on positive regulatory elements present between -1075 and -810. Five XRE motifs localized in the enhancer region were completely conserved between mouse and human CYP1B1 sequences. Gel shift experiments established that TCDD stimulates AhR binding to the downstream XRE in the enhancer region.", 
                            "Cell": "Fibroblasts", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a75"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "10620335", 
                                "Name": "Arch Biochem Biophys 2000 Jan 1 373(1) 163-74"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Estradiol reportedly blocked TCDD-induced accumulation of CYP1A1 mRNA and AHR-mediated activation of the CYP1A1 gene promoter in MCF-7 cells (32).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083bee"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16192470", 
                                "Name": "Toxicol Sci 2006 Jan 89(1) 75-82"
                            }, 
                            "Disease": "", 
                            "SummaryText": "These results demonstrate that AhR directly increases epiregulin expression", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Rat", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083a73"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "15667827", 
                                "Name": "Toxicol Appl Pharmacol 2005 Feb 1 202(3) 215-28"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Only 23 genes were similarly induced by TCDD regardless of conditions and 10 were suppressed. These 23 genes include: 4 genes previously recognized to contain AhR response elements (cytochrome P450 (CYP) 1B1, CYP1A1, NAD(P)H quinone reductase 1 (NQO1), and aldehyde dehydrogenase 3A1); two novel oxidative genes (alcohol dehydrogenase 3 and superoxide dismutase 3); and glypican 1, a plasma membrane proteoglycan that affects cell signaling. Further experiments demonstrated that TCDD maximally induced NQO1, glypican 1 and alcohol dehydrogenase 3 by 6 h.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b88"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14985336", 
                                "Name": "J Biol Chem 2004 Apr 30 279(18) 19209-16"
                            }, 
                            "Disease": "", 
                            "SummaryText": "When the cells were further grown to reach confluence on day 6, when AhR was predominantly distributed in the cytoplasm (Fig. 1A), the luciferase activity was reduced to basal levels. Another clone, XRE.11, yielded similar results (data not shown).....When XRE.3 cells in confluence on a 3-cm culture dish (day 6) were harvested with trypsin treatment followed by reseeding of 1.8 X 10^6 cells on a 6-cm culture dish on day 0, the luciferase activity increased.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083997"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12147270", 
                                "Name": "Arch Biochem Biophys 2002 Aug 15 404(2) 309-16"
                            }, 
                            "Disease": "", 
                            "SummaryText": "Genetic analyses reveal that induction is abolished in aromatic hydrocarbon receptor (AhR)- or aromatic hydrocarbon receptor nuclear translocator (Arnt)-defective variants but restored upon reconstitution of the variant cells with cDNAs expressing functional AhR or Arnt. Moreover, induction is largely reduced in cells expressing a deletion mutant of AhR or Arnt lacking the transcription activation (TA) domain, thus implicating the TA activities of both AhR and Arnt in the induction.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b85"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12612060", 
                                "Name": "Mol Cell Biol 2003 Mar 23(6) 1843-55"
                            }, 
                            "Disease": "", 
                            "SummaryText": "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and other aryl hydrocarbon receptor (AhR) ligands suppress 17beta-estradiol (E)-induced responses in the rodent uterus and mammary tumors and in human breast cancer cells. Treatment of ZR-75, T47D, and MCF-7 human breast cancer cells with TCDD induces proteasome-dependent degradation of endogenous estrogen receptor alpha (ERalpha).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b87"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19961161", 
                                "Name": "Chem Res Toxicol 2009 Dec 22(12) 1938-47"
                            }, 
                            "Disease": "", 
                            "SummaryText": "BaP, TCPOBOP, CDCA, T0901317, rifampicin, and PCN are respective ligands of the AhR", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b81"
                            }
                        }, 
                        {
                            "Status": "open", 
                            "ShortStatement": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                            "Network": "Xenobiotic Metabolism Response_v1.1", 
                            "Creator": "selventa", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14645679", 
                                "Name": "Mol Pharmacol 2003 Dec 64(6) 1485-93"
                            }, 
                            "Disease": "", 
                            "SummaryText": "The AhR-regulated xenobiotic-metabolizing enzymes (XMEs) involved in the detoxification of harmful compounds include both phase I (CYP1A1, CYP1A2, and CYP1B1) and phase II enzymes [aldehyde dehydrogenase 3A1 (ALDH3), NADPH quinone reductase (NQO1), and glutathione S-transferase Ya] (Gu et al., 2000).", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "Human", 
                            "Metadata": {
                                "OriginalBEL": "p(HGNC:AHR) actsIn tscript(p(HGNC:AHR))", 
                                "eid": "524b352dd3fbfd4c34083b9f"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:GSTA2)", 
                "relation": "actsIn", 
                "target": "bp(GO:\"xenobiotic metabolic process\")", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of GSTA2 acts in biological process of GO:\"xenobiotic metabolic process\".", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "p(HGNC:UGT1A1)", 
                "relation": "actsIn", 
                "target": "bp(GO:\"xenobiotic metabolic process\")", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of UGT1A1 acts in biological process of GO:\"xenobiotic metabolic process\".", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "p(HGNC:UGT1A6)", 
                "relation": "actsIn", 
                "target": "bp(GO:\"xenobiotic metabolic process\")", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of UGT1A6 acts in biological process of GO:\"xenobiotic metabolic process\".", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "complex(p(HGNC:ARNT),p(HGNC:AHR))", 
                "relation": "directlyIncreases", 
                "target": "tscript(p(HGNC:AHR))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The complex(protein abundance of ARNT and protein abundance of AHR) directly increases the transcriptional activity of the protein abundance of AHR.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "complex(p(HGNC:ARNT),p(HGNC:AHR)) directlyIncreases tscript(p(HGNC:AHR))", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "7598497", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "Coordination occurs by AhR/Arnt-binding to xenobiotic response elements (XREs, also termed dioxin response elements [DREs]), identified in the 50 upstream region of AhR target genes. The AhR gene battery is arguably one of the best-characterized examples of coordinately regulated genes in eukaryotes", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "complex(p(HGNC:ARNT),p(HGNC:AHR))", 
                "relation": "hasComponent", 
                "target": "p(HGNC:AHR)", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The complex(protein abundance of ARNT and protein abundance of AHR) has component protein abundance of AHR.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "complex(p(HGNC:ARNT),p(HGNC:AHR))", 
                "relation": "hasComponent", 
                "target": "p(HGNC:ARNT)", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The complex(protein abundance of ARNT and protein abundance of AHR) has component protein abundance of ARNT.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "complex(p(HGNC:ARNT),p(HGNC:AHR))", 
                "relation": "actsIn", 
                "target": "tscript(complex(p(HGNC:ARNT),p(HGNC:AHR)))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The complex(protein abundance of ARNT and protein abundance of AHR) acts in transcriptional activity of the complex(p(HGNC:ARNT and protein abundance of AHR)).", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "complex(p(HGNC:ARNT),g(HGNC:CYP1A1))", 
                "relation": "hasComponent", 
                "target": "p(HGNC:ARNT)", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The complex(protein abundance of ARNT,gene abundance of CYP1A1) has component protein abundance of ARNT.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "p(HGNC:ARNT)", 
                "relation": "increases", 
                "target": "tscript(p(HGNC:AHR))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The protein abundance of ARNT increases the transcriptional activity of the protein abundance of AHR.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "p(HGNC:ARNT) increases tscript(p(HGNC:AHR))", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "16275121", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "Small heterodimer partner (SHP; NR0B2), an exceptional member of the mammalian nuclear receptor family, directly modulates the activities of conventional nuclear receptors by acting as an inducible and tissue-specific corepressor. Recent progress in dissecting underlying molecular mechanisms, identifying target factors and target genes, and uncovering physiological functions points to the regulatory involvement of SHP in diverse metabolic and intracellular pathways that awaits future clarification. In this review, we carry out a comprehensive survey of all published data and discuss our current understanding of molecular mechanisms and physiological consequences governing SHP action.", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:ARNT)", 
                "relation": "directlyIncreases", 
                "target": "tscript(p(HGNC:ESR1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The protein abundance of ARNT directly increases the transcriptional activity of the protein abundance of ESR1.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "p(HGNC:ARNT) directlyIncreases tscript(p(HGNC:ESR1))", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17991765", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "Recruitment of the ERs and ARNT on the GREB-1 promoter is shown in Fig. 5A. MCF-7 wild type or ER cells were incubated for 45 min with 10 nM E2 or DPN, respectively, alone or in combination with 10 nM TCDD. Subsequently, cells were subjected to ChIP analysis with the indicated antibodies. ARNT is more potent on ER than on ER transcriptional activity", 
                            "Cell": "", 
                            "Tissue": "MCF-7 cell line", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:ARNT)", 
                "relation": "increases", 
                "target": "tscript(p(HGNC:ESR1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The protein abundance of ARNT increases the transcriptional activity of the protein abundance of ESR1.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "p(HGNC:ARNT) increases tscript(p(HGNC:ESR1))", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "17991765", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "Recruitment of the ERs and ARNT on the GREB-1 promoter is shown in Fig. 5A. MCF-7 wild type or ER cells were incubated for 45 min with 10 nM E2 or DPN, respectively, alone or in combination with 10 nM TCDD. Subsequently, cells were subjected to ChIP analysis with the indicated antibodies. ARNT is more potent on ER than on ER transcriptional activity", 
                            "Cell": "", 
                            "Tissue": "MCF-7 cell line", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:ARNT)", 
                "relation": "actsIn", 
                "target": "tscript(p(HGNC:ARNT))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of ARNT acts in transcriptional activity of the protein abundance of ARNT.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "p(HGNC:ARNT)", 
                "relation": "increases", 
                "target": "p(HGNC:NQO1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The protein abundance of ARNT increases the protein abundance of NQO1.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "p(HGNC:ARNT) increases p(HGNC:NQO1)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "14510636", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "Taken together, these results demonstrate that induction of NQO1 by TCDD requires AhR, Arnt and Nrf2", 
                            "Cell": "", 
                            "Tissue": "hepatoma cells", 
                            "Species": "mouse", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(complex(p(HGNC:ARNT),p(HGNC:AHR)))", 
                "relation": "increases", 
                "target": "p(HGNC:CYP1A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the complex(protein abundance of ARNT and p(HGNC:AHR)) increases the protein abundance of CYP1A1.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "tscript(complex(p(HGNC:ARNT),p(HGNC:AHR))) increases p(HGNC:CYP1A1)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12389869", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP1A1 induction in lung tissue and CYP1B1 induction in alveolar macrophages are probably mediated by the AHR/ARNT pathway, and these inductions are seen at the mRNA, protein, and catalytic activity levels", 
                            "Cell": "", 
                            "Tissue": "alveolar macrophages", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(complex(p(HGNC:ARNT),p(HGNC:AHR)))", 
                "relation": "increases", 
                "target": "p(HGNC:CYP1B1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the complex(protein abundance of ARNT and p(HGNC:AHR)) increases the protein abundance of CYP1B1.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "tscript(complex(p(HGNC:ARNT),p(HGNC:AHR))) increases p(HGNC:CYP1B1)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12389869", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP1A1 induction in lung tissue and CYP1B1 induction in alveolar macrophages are probably mediated by the AHR/ARNT pathway, and these inductions are seen at the mRNA, protein, and catalytic activity levels", 
                            "Cell": "", 
                            "Tissue": "alveolar macrophages", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(complex(p(HGNC:ARNT),p(HGNC:AHR)))", 
                "relation": "increases", 
                "target": "cat(p(HGNC:CYP1B1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the complex(protein abundance of ARNT and p(HGNC:AHR)) increases the catalytic activity of the protein abundance of CYP1B1.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "tscript(complex(p(HGNC:ARNT),p(HGNC:AHR))) increases cat(p(HGNC:CYP1B1))", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12389869", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP1A1 induction in lung tissue and CYP1B1 induction in alveolar macrophages are probably mediated by the AHR/ARNT pathway, and these inductions are seen at the mRNA, protein, and catalytic activity levels", 
                            "Cell": "", 
                            "Tissue": "alveolar macrophages", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "tscript(complex(p(HGNC:ARNT),p(HGNC:AHR)))", 
                "relation": "increases", 
                "target": "cat(p(HGNC:CYP1A1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The transcriptional activity of the complex(protein abundance of ARNT and p(HGNC:AHR)) increases the catalytic activity of the protein abundance of CYP1A1.", 
                    "approval_status": "", 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "tscript(complex(p(HGNC:ARNT),p(HGNC:AHR))) increases cat(p(HGNC:CYP1A1))", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "12389869", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "CYP1A1 induction in lung tissue and CYP1B1 induction in alveolar macrophages are probably mediated by the AHR/ARNT pathway, and these inductions are seen at the mRNA, protein, and catalytic activity levels", 
                            "Cell": "", 
                            "Tissue": "alveolar macrophages", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:NAT2)", 
                "relation": "actsIn", 
                "target": "bp(GO:\"xenobiotic metabolic process\")", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of NAT2 acts in biological process of GO:\"xenobiotic metabolic process\".", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "cat(p(HGNC:EPHX1))", 
                "relation": "actsIn", 
                "target": "bp(GO:\"xenobiotic metabolic process\")", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The catalytic activity of the protein abundance of EPHX1 acts in biological process of GO:\"xenobiotic metabolic process\".", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "p(HGNC:EPHX1)", 
                "relation": "actsIn", 
                "target": "cat(p(HGNC:EPHX1))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of EPHX1 acts in catalytic activity of the protein abundance of EPHX1.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "p(HGNC:SULT1A1)", 
                "relation": "actsIn", 
                "target": "cat(p(HGNC:SULT1A1))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of SULT1A1 acts in catalytic activity of the protein abundance of SULT1A1.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "p(HGNC:SULT1A1)", 
                "relation": "actsIn", 
                "target": "bp(GO:\"xenobiotic metabolic process\")", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of SULT1A1 acts in biological process of GO:\"xenobiotic metabolic process\".", 
                    "approval_status": null, 
                    "createdby": "Jamoboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "p(HGNC:HSP90AA1)", 
                "relation": "actsIn", 
                "target": "cat(p(HGNC:HSP90AA1))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of HSP90AA1 acts in catalytic activity of the protein abundance of HSP90AA1.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "complex(p(HGNC:AHR),p(HGNC:HSP90AA1))", 
                "relation": "hasComponent", 
                "target": "p(HGNC:AHR)", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The complex(protein abundance of AHR and protein abundance of HSP90AA1) has component protein abundance of AHR.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "complex(p(HGNC:AHR),p(HGNC:HSP90AA1))", 
                "relation": "hasComponent", 
                "target": "p(HGNC:HSP90AA1)", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The complex(protein abundance of AHR and protein abundance of HSP90AA1) has component protein abundance of HSP90AA1.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "a(SCHEM:Methylcholanthrene)", 
                "relation": "increases", 
                "target": "p(HGNC:NQO1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of Methylcholanthrene increases the protein abundance of NQO1.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "a(SCHEM:Methylcholanthrene) increases p(HGNC:NQO1)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18203689", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "The major finding was that MC persistently induced (3- to 10-fold) the expression of several phase II enzymes, including GST-alpha, NQO1, UGT1A1, ALDH, and epoxide hydrolase in both tissues for up to 28 days", 
                            "Cell": "", 
                            "Tissue": "lung", 
                            "Species": "rat", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(SCHEM:Methylcholanthrene)", 
                "relation": "increases", 
                "target": "p(HGNC:UGT1A1)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of Methylcholanthrene increases the protein abundance of UGT1A1.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "a(SCHEM:Methylcholanthrene) increases p(HGNC:UGT1A1)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "18203689", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "The major finding was that MC persistently induced (3- to 10-fold) the expression of several phase II enzymes, including GST-alpha, NQO1, UGT1A1, ALDH, and epoxide hydrolase in both tissues for up to 28 days", 
                            "Cell": "", 
                            "Tissue": "lung", 
                            "Species": "rat", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:\"hydrogen peroxide\")", 
                "relation": "increases", 
                "target": "a(CHEBI:\"reactive oxygen species\")", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"hydrogen peroxide\" increases the abundance of \"reactive oxygen species\".", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "a(CHEBI:hydrogen peroxide) increases a(CHEBI:reactive oxygen species)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "", 
                            "Cell": "", 
                            "Tissue": "", 
                            "Species": "", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:\"hydrogen peroxide\")", 
                "relation": "increases", 
                "target": "cat(p(HGNC:NQO1))", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"hydrogen peroxide\" increases the catalytic activity of the protein abundance of NQO1.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "a(CHEBI:hydrogen peroxide) increases cat(p(HGNC:NQO1))", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "8461317", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "Oxidants such as H2O2 can induce gene transcription of DT-diaphorase provide especially intriguing reasons to examine the possibility that lung DT-diaphorase could have an important antioxidant enzyme role versus pulmonary O2 toxicity during exposure to hyperoxia", 
                            "Cell": "", 
                            "Tissue": "lung", 
                            "Species": "rat", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "a(CHEBI:\"hydrogen peroxide\")", 
                "relation": "decreases", 
                "target": "p(HGNC:NAT2)", 
                "metadata": {
                    "causal": true, 
                    "bel2english": "The abundance of \"hydrogen peroxide\" decreases the protein abundance of NAT2.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": [
                        {
                            "Status": "Approve", 
                            "ShortStatement": "a(CHEBI:hydrogen peroxide) decreases p(HGNC:NAT2)", 
                            "Network": "Th1_Th2 Signaling_v1.1", 
                            "Creator": "Jamboree2014", 
                            "Citation": {
                                "Type": "PUBMED", 
                                "ID": "19248797", 
                                "Name": ""
                            }, 
                            "Disease": "", 
                            "SummaryText": "Exposure of Clara cells to 5 _M H2O2/min led to the inactivation of endogenous Nat2 activity", 
                            "Cell": "", 
                            "Tissue": "clara cells", 
                            "Species": "human", 
                            "Metadata": {
                                "OriginalBEL": "p(GO:\"gamma-secretase complex\") increases p(PFH:\"NOTCH Family\")", 
                                "eid": "JAMB386"
                            }
                        }
                    ]
                }
            }, 
            {
                "source": "p(HGNC:ABCC1)", 
                "relation": "actsIn", 
                "target": "tport(p(HGNC:ABCC1))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of ABCC1 acts in transport activity of the protein abundance of ABCC1.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "tport(p(HGNC:ABCC1))", 
                "relation": "actsIn", 
                "target": "bp(GO:\"xenobiotic metabolic process\")", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The transport activity of the protein abundance of ABCC1 acts in biological process of GO:\"xenobiotic metabolic process\".", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "p(HGNC:ABCG2)", 
                "relation": "actsIn", 
                "target": "tport(p(HGNC:ABCG2))", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The protein abundance of ABCG2 acts in transport activity of the protein abundance of ABCG2.", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }, 
            {
                "source": "tport(p(HGNC:ABCG2))", 
                "relation": "actsIn", 
                "target": "bp(GO:\"xenobiotic metabolic process\")", 
                "metadata": {
                    "causal": false, 
                    "bel2english": "The transport activity of the protein abundance of ABCG2 acts in biological process of GO:\"xenobiotic metabolic process\".", 
                    "approval_status": null, 
                    "createdby": "Jamboree", 
                    "evidences": []
                }
            }
        ], 
        "type": "BEL-V1.0", 
        "id": "Xenobiotic Metabolism Response_v1.2", 
        "metadata": {
            "boundaryconditions": "The human model sets represent healthy processes and were not enhanced with COPD data or literature due to the lack of relevant COPD literature for these processes at the time of construction. If COPD literature is identified, it is acceptable to add to these networks. We prioritized data collected from studies of lung-relevant cell types. We excluded cancer, idiopathic pulmonary fibrosis, cystic fibrosis, all virus infections, all bacterial infections, septic pneumonitis, acute respiratory distress syndrome (ARDS), allergic responses/asthma, pneumoconiosis, and COPD exacerbations. We also excluded animal inhalation studies with solid particles (titanium dioxide, quartz, asbestos, carbon black, diesel exhaust etc). For the in vitro-specific exclusion criteria we excluded tumor-derived cell lines, immortalized cell lines, neuronal cells, and cell types that cannot be found in the respiratory/vascular system. There were some exceptions where we included immortalized cell lines and non-lung cell types for canonical mechanisms where there was evidence that the relationship was not tissue-specific but could also take place in the lung. Human-specific connections were preferred, but rat and mouse were also included where human data was not available.", 
            "speciesName": "Human", 
            "species": "9606", 
            "description": "<p>The Xenobiotic Metabolism Response depicts the causal mechanisms that are involved in xenobiotic metabolism response, including the various environmental stressors and signaling components that regulate AHR and cytochrome p450 enzymes.</p>\n<h2>Jamboree Review Focus</h2>\n<p>Identify additional lung-relevant phase II (GST) and phase III (SLC) mechanisms that study protein/activity relationships as opposed to gene expression. Expand phase I regulation beyond AHR to include other transcription factors relevant for airway epithelia such as CAR, LXR and PXR.</p>\n<h3>Reviewed during Jamboree2014</h3>"
        }
    }
}
]
}